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ZUSAMMENFASSUNG 
 Die Niere der Säugetiere ist ein lebenswichtiges Organ, das eine Vielfalt von 
unterschiedlichen regulatorischen Funktionen erfüllt, wie z.B. die Aufrechterhaltung 
des systemischen Wasser-, Elektrolyte- und Säure-Basen Haushalts. Das renale 
Sammelrohrsystem setzt sich aus mindestens drei verschiedenen Zelltypen 
zusammen, die für die Feinabstimmung des finalen Urins verantwortlich sind. Dabei 
übernehmen die Hauptzellen (HZ) die Regulation von Wasser und Elektrolyten, 
wohingegen verschiedenen Arten von interkalierenden Schaltzellen (SZ) die 
Ausscheidung und Rückgewinnung von Säure-Basen Äquivalenten zukommt. Wie die 
Namensgebung andeutet, repräsentieren die Hauptzellen den am häufigsten 
vorkommenden Zelltypus im renalen Sammelrohrsystem und sind gelegentlich mit 
unterschiedlichen Typen von Schaltzellen (Typ A-SZ, Typ B-SZ) durchsetzt. Neben 
markanten Unterschieden in ihrer ultrastrukturellen Morphologie können die 
verschiedenen Zellen des renalen Sammelrohrs relativ einfach anhand von 
immunologischen Markern unterschieden werden. In der vorliegenden Studie werden 
Hauptzellen daher anhand eines immunologischen Nachweises des Wasserkanals 
Aqp2 (Aquaporin 2) identifiziert. Desweiteren werden die Säure sezernierenden Typ 
A-SZ von den Bikarbonat sezernierenden Typ B-SZ unterschieden, da diese beiden 
Typen am häufigsten im Sammelrohr vorkommen und bisher am ausführlichsten 
beschrieben wurden. Der immunologische Nachweis der V-ATPase (Protonenpumpe, 
a4 und B1 Untereinheit) dient im Allgemeinen als gemeinsamer Marker für Typen von 
Schaltzellen. Ferner gibt die subzelluläre Lokalisierung der V-ATPase Aufschluss über 
den Typus der SZ. Jedoch können die beiden Haupttypen der Schaltzellen eindeutig 
anhand der immunologischen Marker Ae1 (Anionen Austauscher 1, Slc4a1) für Typ A-
SZ und Pds (Pendrin) für Typ B-SZ identifiziert werden. 
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Intensive Studien der letzten zwanzig Jahre haben stetig dazu beigetragen die 
komplexen Prozesse induktiver und reziproker Signalwege der metanephrischen 
Nierenentwicklung zu entschlüsseln und zu verstehen. Auch das ausgereifte gesunde 
Organ wurde bisher intensiv studiert und charakterisiert. Leider ist nur sehr wenig 
über die Abläufe, Signalwege und genetischen Programme bekannt, die für eine 
regulierte Enddifferenzierung und Reifung des sich entwickelnden Organs wichtig 
sind. Glücklicherweise haben einige kürzlich veröffentliche Studien an verschiedenen 
Modellorganismen ein wenig Licht ins Dunkel gebracht. Verschiedene Modulatoren 
aus den p53 und Notch Signalwegen, sowie die Transkriptionsfaktoren Foxi1 und 
Cp2l1 konnten letztendlich in Zusammenhang mit der terminalen Differenzierung des 
renalen Sammelrohrsystems gebracht werden.  
Menschen und Mäuse, denen Ae1 in der Niere fehlt, entwickeln eine distale renale 
tubuläre Azidose (dRTA). Es ist bekannt, dass Störungen des Säure-Basen Haushalts 
eine adaptive Antwort der Niere induzieren, die auch eine morphologische 
Umwandlung des Nephron und Sammelrohrsystem zur Folge hat. In diesem Sinne 
führt eine chronische Säurebelastung zur Reduktion von Bikarbonat sezernierenden 
Typ B-SZ und gleichzeitigem Anstieg der Säure sezernierenden Typ A-SZ, wobei die 
individuelle und Zelltyp charakteristische Expression molekularer Marker (z.B. Ae1, 
Pds) unverändert bleibt. Interessanterweise konnte in der vorliegenden Studie eine 
ungewöhnliche Expression der Marker Pds und Aqp2 in den inneren medullären 
Sammelrohren von Ae1 defizienten Nieren mittels Immunfluoreszenz beobachtet 
werden. Hier wurde eine erhöhte Zahl an Pds exprimierenden Zellen sowie Aqp2/Pds 
coexprimierende Zellen im Nierenmark von Ae1 Knockout (KO) Tieren beobachtet. 
Dies steht im krassen Gegensatz zu Ae1 Wildtyp (WT) Nieren, bei denen eine 
Expression von Pds im Nierenmark nicht mehr vorkommt. Desweiteren konnten 
veränderte Expressionsmuster der Transkriptionsfaktoren Foxi1 und Cp2l1 in Ae1 
defizienten Mausnieren festgestellt werden.  
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Gleichfalls wurde eine veränderte Expression von molekularen Markern der 
Schaltzellen in einer Nierenbiopsie eines Patienten mit der AE1 Mutation S613F 
beobachtet. Bei Untersuchungen zweier weiterer Mausmodelle mit unvollständiger 
dRTA (Knockout von Atp6v1b1 oder Rhcg) konnten derartige Veränderungen der 
Differenzierung von Zellen des Sammelrohres jedoch nicht festgestellt werden. Ein 
ähnlich negatives Ergebnis, in Bezug auf die terminale Differenzierung von 
Sammelrohrzellen, wurde in Nieren von Mäusen mit induzierter chronischer 
metabolischer Azidose über 8 Wochen gefunden. Daher kann geschlussfolgert 
werden, dass nicht die begleitende Azidose (dRTA) verantwortlich für die 
beschriebene abnorme Differenzierung des Sammelrohrs in Ae1 KO Mäusen ist, 
sondern das physische Fehlen von Ae1 per se.  
Die vorliegende Studie bietet daher einige neue und interessante Erkenntnisse im 
Hinblick auf die terminale Differenzierung des renalen Sammelrohrsystems, die für 
die normale Entwicklung bzw. Regulation dieses Nephronabschnittes von Bedeutung 
sind. Es konnte gezeigt werden, dass die Transkriptionsfaktoren Foxi1 und Cp2l1 in 
unterschiedlichen Zelltypen des renalen Sammelrohrsystems exprimiert sind, was auf 
eine Modulation der terminalen Differenzierung durch benachbarte Zellen hindeutet. 
Im Einklang mit seiner Funktion als Regulator der Transkription verschiedener 
molekularer SZ Marker, wurde Foxi1 hauptsächlich in V-ATPase exprimierenden 
Schaltzellen gefunden. Cp2l1 hingegen wurde hauptsächlich in Aqp2 exprimierenden 
Hauptzellen detektiert, obwohl ein Fehlen von Cp2l1 auch in einem kompletten 
Verlust von renalen Schaltzellenmarkern (V-ATPase, Ae1, Pds) resultiert. Die Notch 
regulierte Signalkaskade scheint die Entwicklung der verschiedenen Zelllinien im 
renalen Sammelrohr der Maus zu dirigieren, vermutlich durch laterale Inhibition. 
Während eine Aktivierung von Notch die Präsenz von Hauptzellen in der Niere 
fördert, führt eine Inaktivierung von Notch zur Differenzierung von Nebenzellen.  
Unter Einbeziehung der Beobachtungen an der sich entwickelnden Haut von 
Amphibien, der beschriebenen Resultate aus verschiedenen Mausmodellen und der 
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Resultate der vorliegenden Arbeit kann daher ein neues Modell für die terminale 
Differenzierung von Sammelrohrzellen in der Mausniere vorgeschlagen werden. 
Dementsprechend führt eine Aktivierung von Notch, vermutlich durch p53, zur 
Differenzierung von Hauptzellen aus renalen Vorläuferzellen und der Aktivierung von 
Cp2l1. Gleichzeitig führt die Aktivierung von Cp2l1 zur Inaktivierung von Notch in 
benachbarten Zellen, wodurch wiederum eine Aktivierung von Foxi1 erfolgt, welches 
eine Differenzierung der Schaltzellen fördert. Die Expression von Cp2l1 im 
Nierenmark von Ae1 KO Mäusen war gestört. Dies könnte darauf hinweisen, dass eine 
reziproke Interaktion oder Feedback-Schleife von Cp2l1 mit einem anderen 
unbekannten Schlüsselmolekül und Signalweg, oder eine negative Autoregulation 
von Cp2l1, im weiteren Verlauf erforderlich ist. Diesem Modell fehlt ein weiteres 
Schlüsselmolekül, das die Differenzierung eines bestimmten Typs von Schaltzellen 
interaktiv regulieren kann, da Foxi1 sowohl die Transkription von Ae1 als auch Pds 
reguliert. Die Ergebnisse der vorliegenden Studie unterstützen die Annahme, dass es 
sich bei diesem Schlüsselmolekül um den Cl-/HCO3
- Austauscher Ae1 selbst handeln 
könnte oder Ae1 damit interagiert. Zumindest scheint die Präsenz von Ae1 eine 
wichtige Rolle bei der Aufrechterhaltung eines bestimmten Typus der Schaltzellen zu 
spielen, da die Expression von Pds und Aqp2 im inneren Mark Ae1 defizienter Nieren 
gestört ist. Diese Hypothese wird auch dadurch gestützt, dass zuerst V-ATPase und 
Ae1 exprimierende Zellen in der embryonalen Niere detektiert werden und erst später 
Pds positive Zellen. Das bedeutet, dass sich Typ A-SZ in der zeitlichen Abfolge vor 
den Typ B-SZ entwickeln. Ae1 oder ein auf Ae1 basierender Multi-Protein Komplex 
(z.B. mit CaII) könnte also das vorangehende Modell komplettieren. Demzufolge 
würde eine Aktivierung von Foxi1 zur Expression von Ae1 in Typ A-SZ führen. Dies 
wiederum könnte eine reziproke Interaktion von Ae1 allein oder einem Ae1-Multi-
Protein Komplex mit Foxi1 oder einem anderen unbekannten Molekül induzieren, um 
die Differenzierung von benachbarten Typ B-SZ im weiteren Verlauf zu regulieren und 
gleichzeitig den Typus der A-SZ in der Effektorzelle aufrechtzuerhalten.    
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SUMMARY 
 The mammalian kidney is an essential organ that serves a variety of distinct 
regulatory functions, such as maintenance of systemic water, electrolyte and acid-
base homeostasis. The fine tuning of the final urine takes place in the renal collecting 
duct (CD) system, which consists of at least 3 different types of cells. The principal 
cells (PC) are mostly responsible for renal water and electrolyte handling, while 
several types of intercalated cells (IC) regulate the excretion and recovery of acid-
base equivalents. As indicated by their name, principal cells represent the major CD 
cell type and are occasionally interspersed with distinct types of intercalated cells 
(type A-IC, type B-IC). Besides their marked ultrastructural morphologic differences, 
cells of the renal CD are easily distinguished by immunologic markers. Hence, the 
present study focuses on the identification of PCs by the immunologic presence of 
the water channel aquaporin 2 (Aqp2). Furthermore, acid secretory type A-ICs are 
distinguished from bicarbonate secretory type B-ICs, since these two types of ICs 
represent the most abundant and best characterized IC phenotype. The immunologic 
presence and subcellular localization of the V-ATPase (a4 and B1 subunit) is a 
common marker for the IC phenotype. However, the two major types of ICs are best 
distinguished using the immunologic markers anion exchanger 1 (Ae1, Slc4a1) for 
type A-ICs and pendrin (Pds) for type B-ICs.  
The complex processes of inductive and reciprocal signalling required for initial 
metanephric kidney development were intensively studied over the past two decades 
steadily improving our basic understanding of nephrogenesis. Similarly, the adult and 
healthy organ is relatively well studied and characterized. However, the signalling 
events and regulatory genetic networks necessary for terminal differentiation and 
maturation of the developing kidney are still a black box as only very little is known. 
Lately, few studies with different model organisms shed some light into the dark and 
revealed a role for transcriptional regulators of the p53 and Notch signalling pathway, 
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as well as the transcription factors Foxi1 and Cp2l1 in terminal differentiation of the 
renal CD system. 
Humans and mice deficient for renal Ae1 develop distal renal tubular acidosis (dRTA). 
Acid-base disturbances are known to induce adaptive responses in the kidney 
involving the remodelling of the nephron and collecting duct system. In addition, 
chronic acid challenges promote the reduction in number of base secretory type B-
ICs, while the relative abundance of type A-ICs increases concomitantly. Nevertheless, 
the individual characteristics of the IC phenotype are preserved under these 
circumstances. However, in kidneys of mice with Ae1 deficiency related dRTA, an 
abnormal expression of Pds and Aqp2 was detected in the inner medullary collecting 
ducts by immunofluorescence. In contrast to wildtype (WT) mouse kidneys, Pds 
expressing cells and unusual Aqp2/Pds coexpressing cells were increased in 
abundance in the inner medulla of Ae1 knockout (KO) mice. Furthermore, the 
expression pattern of the transcription factors Foxi1 and Cp2l1 was altered in Ae1 
deficient mouse kidneys.  
Consistent with the abnormal expression of CD cell marker in Ae1 deficient inner 
medullary collecting ducts, we found an altered expression of molecular IC markers in 
a renal biopsy of a patient with the AE1 S613F mutation.  
Investigations of two mouse models with incomplete dRTA (Atp6v1b1 deficiency and 
Rhcg deficiency) did not show any signs of abnormal CD cell differentiation. Likewise, 
chronic metabolic acidosis induced for eight weeks in wildtype mice did not alter the 
terminal differentiation of renal CD cells in mice. Hence, the accompanying dRTA or 
acidosis is most likely not responsible for the observed abnormal CD cell 
differentiation of Ae1 deficient mice, but the physical lack of Ae1 per se. 
The present study provides some interesting and unexpected new aspects regarding 
the terminal differentiation of the renal CD system. Surprisingly, we localized the 
transcription factors Foxi1 and Cp2l1 in distinct cell types of the renal CD system, 
suggesting a modulation of the terminal differentiation of adjacent cells. Consistent 
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with its regulatory role in molecular IC markers, Foxi1 was localized in V-ATPase 
expressing ICs. However, Cp2l1 was mostly observed in Aqp2 expressing PCs, 
although Cp2l1 deficiency results in loss of characteristic molecular markers (Ae1, V-
ATPase) of renal ICs. Notch signalling seems to determine the cell lineage of renal 
CDs in mouse, probably by lateral inhibition. While activated Notch favours the 
presence of PCs, inactivated Notch promotes the differentiation of renal ICs. 
Considering observations from amphibian skin development, other mouse models 
and results from the present study, we suggest the following new model of terminal 
CD cell differentiation in mouse kidney. Activation of Notch, probably by p53, leads to 
the differentiation of PCs from renal precursor and may activate Cp2l1. Active Cp2l1 
might promote the inactivation of Notch in adjacent cells, which in turn activates 
Foxi1 and IC differentiation. Cp2l1 was abnormally expressed in the renal inner 
medulla of Ae1 deficient mice. Therefore, a reciprocal interaction or feedback loop of 
Cp2l1 with another combinatorial unknown key molecule and signalling pathway or 
by sequential negative autoregulation seems necessary. However, another key 
regulatory molecule that determines the type of ICs is missing in this model. We 
provide data that suggest the Cl-/HCO3
- exchanger Ae1 as a required key protein in 
the induction or maintenance of terminal differentiation of renal ICs. During 
embryonic kidney development, V-ATPase and Ae1 expression are detected before 
Pds, suggesting that A-ICs differentiate before type B-ICs. Completing the proposed 
model, Ae1 itself or a multiprotein-Ae1 complex (i.e. with CaII) might reciprocally 
interact with Foxi1 or (an)other transcriptional regulator(s). Hence, activated Foxi1 
would primarily favour the differentiation of type A-ICs, which are characterized by 
their expression of Ae1. The multi-protein complex or Ae1 alone might than 
reciprocally interact with Foxi1 or another unknown molecule, which in turn regulates 
the differentiation of neighbouring type B-ICs and simultaneously maintains the A-IC 
phenotype in the effector cell.  
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1. INTRODUCTION 
Multicellular organisms have the ability to maintain their systemic pH within 
narrow ranges, despite constant local and systemic changes of acid and base 
equivalents due to metabolic and catabolic processes. A stable milieu interieur is 
essential to ensure an optimal (working) environment for all chemical and bio-
physical processes in the organism. In humans, the pH of most extracellular fluids 
ranges from 7.35 – 7.45 and is tightly regulated by two buffering systems, the volatile 
and non-volatile buffers. By definition, buffers are substances in aqueous solutions 
that are able to reversibly accept or donate hydrogen ions (H+) and thus stabilize a 
given pH. In mammals systemic pH is maintained by non-volatile buffers like calcium 
carbonate, phosphate, hemoglobine and other proteins, uric acid and ammonium. 
However, the most important buffer system is the volatile carbon dioxide/bicarbonate 
buffering system, which is enabled by the action of the lungs and kidneys. The 
constant exhalation of carbon dioxide (CO2) by the lungs and the renal regulation of 
bicarbonate (HCO3
-) makes this buffer pair a powerful and theoretically infinite, open 
buffering system.  
The pH dependency on the pCO2/HCO3
- ratio is described by the Henderson-
Hasselbalch equation (Eqn. 1). Accordingly, changes in blood pH are caused by shifts 
in the partial pressure of CO2 (pCO2) in blood, or by variations of blood bicarbonate 
concentrations. 
 
              [HCO3
-] 
Eqn. 1  pH = 6.1 + log     
      0.03 x pCO2 
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Carbon dioxide is a waste product of cell respiration and reacts slowly with water to 
form carbonic acid, which rapidly dissociates to a proton and bicarbonate (Eqn. 2). 
The hydration reaction is usually accelerated and catalyzed by isoforms of the enzyme 
carbonic anhydrase. 
 
Eqn. 2  CO2 + H2O           H2CO3           H
+ + HCO3
- 
 
In mammals volatile CO2 is a huge source of daily acid production (15,000 mmol 
CO2/day) [1]. However, since the lungs continuously remove this potential acid by 
regulated exhalation, this amount is less relevant in healthy individuals. Importantly, 
dietary metabolism and daily loss of base equivalents into stool lead to the 
accumulation of non-volatile acids (70 mmol/day) [1], which essentially consume 
plasma bicarbonate and thus need to be removed from the body. Here, the kidneys 
play the essential role in the removal of this daily load of non-volatile acids by 
recovering virtually all filtered bicarbonate as well as generating new bicarbonate. The 
kidneys generate new bicarbonate in two ways: the secretion of protons along with 
titratable acids (i.e. phosphate, citrate) and the synthesis and excretion of ammonium. 
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2. MAMMALIAN KIDNEY STRUCTURE AND DEVELOPMENT 
 
2.1 Organization of the mature mammalian Kidney 
 The mammalian kidney is a paired organ fulfilling a variety of essential 
functions. Besides the removal and excretion of metabolic waste products from the 
blood, it plays a central role in systemic acid-base balance, as well as maintaining salt 
and water homeostasis thereby regulating systemic blood pressure. The functional 
unit of the kidney is the nephron, which is organized in different segments (Fig. 2.1). 
In humans, each kidney consists of 800.000 – 1.200.000 nephrons, whereas in mouse 
approximately 11.000 nephrons are present [1, 2]. Each nephron begins with a 
glomerulum, which is a network of blood capillaries and podocytes that filter blood. 
The glomerulum is surrounded by the Bowman capsule that extends into an epithelial 
tubular structure (renal tubule) and finally connects to the collecting duct system 
(CDS). The nephron is subdivided into three domains, the proximal tubule (PT), the 
loop of Henle (LOH) and the distal tubule (DT). Based on ultrastructural and 
functional properties these domains are further distinguished into the early PT, the 
proximal convoluted and straight tubule, thin descending and ascending limbs of 
LOH, thick ascending limb of LOH, as well as distal convoluted tubule (DCT) and 
connecting tubule (CNT). Likewise, the renal collecting duct system shows a 
segmental organization and cortical collecting duct (CCD), outer medullary collecting 
duct (OMCD) and inner medullary collecting duct (IMCD) are distinguished. 
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Fig. 2.1 Structure of the mammalian kidney, taken from [2]. Each kidney is surrounded by a fibrous 
renal capsule. The kidney is organized into the peripheral renal cortex and the renal medulla, which is 
arranged in multiple pyramidal structures. The tip of each pyramid (papilla) ends into minor and major 
calyces that empty into the renal pelvis. The renal pelvis is connected to the ureter which transmits the 
urine into the bladder. Image enlargement shows segmental organization of the nephron and 
collecting duct [2].  
 
2.2 Development of the mammalian Kidney 
 The development of the mammalian kidney (metanephros) is unique, as it 
origins from two distinct embryonic precursor populations, the metanephric 
mesenchymal blastema and the ureteric bud epithelia [3]. Hence, morphogenetic and 
functional development of the kidney requires complex inductive interactions of the 
distinct precursor populations and their differentiation pathways are tightly regulated 
in time and space by different geneproducts. Among them are transcription factors, 
protooncogenes, growth factors, signalling molecules, and receptors. However, 
kidney morphogenesis is also dependent on cell adhesion molecule complexes (CAM) 
and their associations with the cytoskleleton, extracellular matrix (ECM) glycoproteins 
and ECM receptors like the integrins, as well as ECM degrading proteases [4]. 
Mammalian kidney development is further characterized by the formation of a more 
complex organ in three successive phases: the rudimentary pronephros, the transitory 
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mesonephros, and the permanent metanephros. In mammals and birds, the 
pronephros and mesonephros are transient structures, which degenerate or become 
modified to serve as a part of the male genital tract [5], while the metanephros 
differentiates into the permanent kidney. However, the pronephros is the functional 
filtering unit in larvae of amphibians and fish, while the mesonephros is the functional 
kidney in adults [6]. Thus, the three kidney forms of amniotes reflect the evolutionary 
development of the kidney approved by conserved genetic programming among 
different species [7].  
 
 The metanephros is the most complex structure and displays the functional 
kidney of adult mammals and birds. The development of the mammalian 
metanephric kidney is initiated at week 4-5 in humans and embryonic day 8.5 (E8.5) 
in mice [2, 4]. It begins with the formation of the pronephric duct (Wolffian duct) and 
mesonephric tubules from the intermediate mesoderm (Fig. 2.2). As they fuse and 
migrate into the adjacent metanephrogenic mesenchyme (MM), the ureteric bud (UB) 
emerges at the tip. 
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Fig. 2.2 Initiation of kidney 
development in mouse, taken from 
[2]. In mouse, kidney development 
starts at E8.5 with the formation of the 
nephric (Wolffian) duct primordium 
(blue) from the nephrogenic cord 
(intermediate mesoderm, yellow). 
Caudal nephric duct precursors grow 
towards the cloaca, while rostral cells 
become apoptotic. The extending 
nephric duct induces the formation of 
mesonephric tubules in the adjacent 
mesoderm. Rostral mesonephric 
tubules fuse to the nephric duct, while 
the ureteric bud (UB) emerges from 
the nephric duct near the cloaca at 
E10.5. The UB invades into a 
specialized population of nephrogenic cord cells (red), the metanephric mesenchyme (MM). Reciprocal 
inductive interactions between UB and MM lead to repeated branching of UB and the formation of 
metanephric nephrons from MM (not shown). 
 
Reciprocal inductive interactions between the UB and MM are the key events of 
mammalian nephrogenesis (Fig. 2.3) and accompanied by the sequential activation of 
gene expression from several different gene families [6]. The MM induces a repetitive 
branching morphogenesis of the UB, which gives rise to the collecting system. 
Simultaneously, the invading UB induces a mesenchymal to epithelial transition (MET) 
of the MM, forming  metanephric nephrons in a stereotypic sequence of 
morphological stages (Fig. 2.3) [8].  
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2.3 Formation of the Nephron  
 The epithelial segments of the nephron, which comprises the glomerulum, 
proximal tubule, loop of Henle and the distal tubule (distal convoluted tubule and 
connecting tubule) arise from the metanephric mesenchymal blastema. Nephron 
development requires a series of events which is defined by morphological stages 
and can be divided into different steps: 1) condensation, 2) epithelialisation, 3) early 
morphogenesis and 4) tubule maturation [9]. Upon ureteric bud induction, cells of the 
MM start to condensate around the advancing UB, forming a 4-5-cell thick layer, the 
cap condensate (Fig. 2.3). A cluster of cap condensate cells near the UB ampulla and 
the adjacent branch starts to polarize as they undergo mesenchymal to epithelial 
transformation. These cells separate from the cap condensate and reorganize in a 
pretubular aggregate to form a renal vesicle. Pluripotent precursor cells within the 
renal vesicle give rise to all type of glomerular and tubular epithelial cells. Nephron 
segmentation into globular and tubular domains is induced by the formation of two 
clefts within the renal vesicle. Firstly, a comma-shaped body forms with the 
invagination of a lower cleft (vascular cleft). Thereafter, a second upper cleft builds up 
the S-shaped body, which is characterized by three segments or limbs. The upper 
limb gives rise to the LOH and distal tubule, the middle limb to the proximal 
convoluted tubule and the lower limb to the glomerulum. Angioblasts invade the 
vascular cleft of the S-shaped body and contribute to the glomerular capillary. Finally, 
the distal part (upper limb) of the S-shaped body fuses to the adjacent collecting 
duct, completing the formation of the nephron (detailed review by [10]). 
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Fig. 2.3 Sequential steps of mammalian kidney development, taken from [7, 10]. Induction of the 
metanephric mesenchyme by the ureteric bud promotes aggregation of mesenchymal cells to form a 
cap condensate around its tip. A cluster of cells separates from the cap condensate and forms a renal 
vesicle while they polarize and undergo mesenchymal to epithelial transformation (MET). Meanwhile, 
unpolarized stromal mesenchyme cells migrate into the interior of the developing organ. Thereby, they 
influence branching morphogenesis of the ureteric bud which continues to induce nephrogenesis. 
Individual renal vesicles fuse to the proliferating collecting ducts. By the S-shaped body stage, the 
nephron is already patterned along the proximal-distal axis. Invasion of the proximal cleft by 
endothelial cells starts the process of glomerulogenesis [7, 10].   
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2.4 Formation of the renal Collecting System       
 The renal collecting system comprises the cortical and medullary collecting 
ducts, the renal calyces, the renal pelvis and the ureter. It develops from the ureteric 
bud by a process called branching morphogenesis while it invades the MM. 
Repetitive dichotomous branching events result in several generations (~15) of UB 
branches, which ultimately differentiate into distinct parts of the renal collecting 
system. The number of UB branches elaborated is considered to be a major 
determinant of the final number of nephrons, since the UB branch tips (ampullae) 
reciprocally induce discrete subsets of MM cells to undergo nephrogenesis [10]. Thus, 
UB branching morphogenesis might also determine the later architecture of the 
mature kidney [11]. Ureteric branching is completed by weeks 20-22 of gestation in 
humans and at E15.5 in mouse [7, 10]. Thereafter, the collecting duct system 
undergoes morphologic changes that result in the patterning of cortical (peripheral) 
and medullary (central) domains. At this stage, distinct morphologic features emerge 
between the cortical and medullary collecting ducts (CDs) [12]. While cortical CDs 
continue to undergo branching and induction of MM, medullary CDs organize into 
elongated, relatively unbranched linear arrays [12]. The main trunk of the UB gives 
rise to the mature ureter, while the early branches undergo remodelling by increased 
growth and dilatation to form the renal calyces and pelvis [12, 13]. 
 
 
 
 
 
 
23 
 
2.5 Terminal Differentiation and Organization of the renal Collecting Duct 
System 
Intensive in vivo and in vitro studies revealed many factors and molecules 
involved in UB outgrowth, branching morphogenesis and induction of mesenchymal 
to epithelial transition [14]. However, regulatory mechanisms of terminal CD system 
differentiation and maturation are still largely unknown. During organ development 
the function of the embryonic collecting duct epithelium needs to transdifferentiate 
from an inductive to an excretory system [15]. The architecture of the mature renal 
CD system is unique as it is composed of distinct cell types with highly specialized 
functions (see Chapter 2.6 and 3.4). Hence, the process of terminal differentiation 
goes along with the acquisition of functional differentiation and requires cell cycle 
arrest [16]. Our knowledge of the genetic programs and signals that regulate 
functional differentiation of the kidney has only just begun. A small number of key 
regulators and pathways such as the p53 and Notch signalling cascade were 
proposed to determine segmental nephron identity and terminal epithelial 
differentiation fate. Within these pathways, some transcription factors and signalling 
molecules (i.e. Bdkrb2, Cp2l1, Dmbt1 (Hensin), Foxi1 and Klf4) are suggested critical 
for the regulated differentiation of individual CD cell types. However, their 
hierarchical positioning within the signalling network remains to be determined. The 
majority of these molecules was incidentally discovered in disease models or deduced 
from in vitro studies and will be described in more detail in chapters 2.7 and 5.2.1.  
 
The morphology of the mature renal collecting duct system in mammals is 
characterized by its functional, zonal and cellular heterogeneity, accounting for the 
functional demands of final urine processing [15]. At least three types of cells are 
identified based on ultrastructural features (i.e. distribution of intracellular organelles, 
organization of plasma membrane), molecular composition and function. Even 
though they are unequally distributed throughout the CD system, principal cells (PCs) 
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are the major cell type and responsible for water and electrolyte transport. 
Occasionally, the CDs are interspersed with two types of intercalated cells, type-A and 
type-B (A-IC, B-IC), which are involved in acid-base excretion and show a zonal 
distribution. In the mature mouse kidney, A-ICs are most frequently present within 
the outer medulla, while B-ICs are restricted to the renal cortex (Fig. 2.4) [17]. 
Furthermore, both types of intercalated cells are present in the late DCT and CNT [18-
21]. However, based on immunologic and morphologic criteria species specific 
intermediate forms of intercalated cells have been described (detailed description in 
chapter 2.6) [22-24]. In any case, it remains controversial, whether the different ICs are 
truly distinct cell types or represent several configurations of the same cell [18].  
 
 
 
Fig. 2.4 Zonal distribution of cell populations in mouse renal collecting duct system, identified 
by immunologic criteria. Within the mature renal CD system, principal cells (PCs, blue bar, left) are 
the major cell type. However their abundance increases from the cortex towards the inner medulla. 
Type A-ICs (grey bar, centre) are predominantly expressed within the outer medullary CDs, whereas 
type B-ICs (green bar, right) are exclusively found in the renal cortex.  
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However, good evidence for the simultaneous differentiation of ICs from 
undifferentiated precursor populations in separate foci of the kidney in rodents was 
found [18, 25-27]. In mice, immunohistochemical identification of ICs demonstrated 
their contemporary appearance in the fetal connecting tubule and medullary 
collecting duct (MCD), while cortical collecting ducts appeared still not differentiated 
(Fig. 2.5, top). Hence, ICs seem to develop from distinct precursor populations which 
are present in both, the metanephrogenic blastema and the ureteric bud. 
Nevertheless, it remains speculative, whether PCs and the distinct types of ICs derive 
from the same or from distinct precursor populations.  
 
In fetal rat kidneys immunologic marker identifying ICs are not detected before 
embryonic day 18 (E18) [18, 28]. In mice, renal IC specific proteins are detected the 
earliest at E13 and E14, respectively (Fig. 2.5) [25]. Consistently, cellular expression 
levels of transporters and other proteins adapt to the increasing functional demands. 
A sequential and segmental regulation of intercalated cell subtypes and differential 
expression of characteristic proteins (i.e. V-ATPase, CaII) were observed during tubule 
maturation (Fig. 2.5) [29, 30]. Soon after birth, the maturing renal tubule develops 
excretory and reabsorptive functionality and progressively achieves the morphology 
of the adult kidney by adaptive remodelling [31]. Hereby, ICs are gradually removed 
from the papillary surface epithelium and terminal MCDs, while their abundance 
increases erratically in the renal cortex and outer medulla, respectively (Fig. 2.5, 
bottom) [32]. Moreover, pendrin expressing B-ICs disappear completely from the 
entire mature MCDs and are restricted exclusively to the late DCT (DCT2), CNT, CCD, 
and early OMCD [21, 25-27, 31, 33]. Elimination of ICs from the developing rat MCD 
might involve two mechanisms. Type A-ICs seem to be extruded from the renal 
epithelium into the lumen, while type B-ICs become apoptotic and are phagocytosed 
by adjacent cells [32]. 
 
26 
 
In human fetal kidney immature or undifferentiated ICs are observed as early as 8 
weeks gestation, while characteristic AE1 expression is not detected before 14 weeks 
gestation. Moreover, Pendrin expression is observed only as late as 26 weeks 
gestation and solely restricted to the fetal renal cortex. Additionally and likewise in 
contrast to rodents, IC abundance in human fetal kidney increases progressively from 
the inner cortex to the inner medulla with type A-ICs being the predominant IC 
manifestation [27].  
 
In outlook of the mature collecting duct epithelium, a structural and functional 
plasticity of the relative IC distribution has been observed as well in adaptive 
responses to disturbances of the milieu interieur. These observations raised the 
concept on reversal of structural and functional polarity in intercalated cells, with a 
definite proof still pending (detailed description in chapter 5.2.1) [17]. 
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Fig. 2.5 Segmental distribution of acid-base transporters expressed in renal intercalated cells of 
the developing mouse, taken from [25]. E= embryonic kidney; P= postnatal kidney; RP= renal papilla; 
OC= outer cortex; IC= inner cortex; OS= outer stripe of outer medulla; IS= inner stripe of outer 
medulla; i= initial part of IMCD; t= terminal part of IMCD. It is of note, that H
+
-ATPase and pendrin 
expressing cells are already detected in the late distal convoluted tubule (DCT2) of mouse, rat and 
human kidney (not shown) [21]. 
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  2.6 Architecture and Characteristics of renal Collecting Duct Cells 
Intensive studies on the heterogeneous cytology of mammalian collecting 
ducts revealed numerous ultrastructural and molecular differences among cell types 
accounting for their distinct function. However, transitional changes of the structural 
appearances of each cell type are described all along the CD system, while molecular 
profiles and functional aspects remain rather constant. For the sake of simplicity, the 
present study focuses on the identification of principal cells and intercalated cells 
(type A and type B) by immunohistochemical markers. 
 
2.6.1 Principal Cells 
By light-microscopy, principal cells appear translucent while intercalated cells 
appear dark due to their high density of mitochondria. In higher magnification, the 
apical membrane of PCs consists of a prominent single cilium with few and short 
microvilli and microfoldings. The basal membrane forms infoldings (basal labyrinth), 
which appear as a characteristic basal rim, as it is devoid of any cell organelles. 
However, principal cells undergo gradual, from the deep cortex towards the upper 
third of the inner medulla, but species specific distinct morphological changes 
regarding the abundance of mitochondria, lysosomal organelles and basal infoldings. 
Subsequently, the cell size may increase drastically (rabbit, guinea pig) and the cell 
shape might change from polygonal to cuboidal or low columnar (rat, mouse) [17]. 
However, immunologically all variations of principal cells are identified by the luminal 
and sometimes basolateral expression of aquaporin 2 (Aqp2), (Fig. 2.6) [34, 35]. 
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2.6.2 Intercalated Cells 
As mentioned earlier, the renal CNTs and CDs are interspersed with distinct 
manifestations of intercalated cells. Among the diverse IC cell population, species 
specific differences regarding structural manifestations, protein expression profiles 
and cellular pattern, as well as axial changes in their zonal distribution along the CNT 
and CD system have been described [26, 36-39]. All these subtypes share some 
common features and are involved in potassium and chloride reabsorption and acid-
base homeostasis [40]. The apical membrane of ICs is usually more rounded, 
compared to the polygonal architecture of adjacent PCs. Intercalated cells appear 
darker by light microscopy because of their densed cytoplasm, which contains 
numerous mitochondria, polysomes and tubulovesicular membrane structures. 
Moreover, the luminal membrane carries elaborate microfolds or microprojections 
and lacks the single cilium [17]. Immunologically, intercalated cells are characterized 
by their expression of cytosolic carbonic anhydrase II (CaII) and a vacuolar type H+-
ATPase (V-ATPase) (Fig. 2.6) [41, 42]. However, two IC manifestations are 
predominant and distinguished as type A and type B.  
 
2.6.2.1 Type A-Intercalated cells 
The apical cell pole of type A-ICs is usually broad and covered with elaborate 
microfolds and characteristic tubulovesicular structures. The apical and vesicular 
membrane domain is densely covered with studs. Type A-ICs are equipped with 
numerous mitochondria, which often arrange along the apical membrane and the 
nucleus shifted to the basolateral side [42]. Many microtubules and clathrin-coated 
vesicles are located between the tubulovesicular profile and mitochondria [17, 43]. 
Correspondingly, high abundance of the V-ATPase in the apical pole and membrane 
was demonstrated and is usually evident of type A-ICs [22, 24, 44]. The basolateral 
membrane of A-ICs is uncoated and devoid of V-ATPase. A kidney specific isoform of 
the Cl-/HCO3
- exchanger Ae1 (anion exchanger 1, band3, Slc4a1) is exclusively 
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expressed in the basolateral membrane of type A-ICs and serves as an immunologic 
marker (Fig. 2.6) [43, 45]. Thus, A-ICs are considered as acid secretory cells and show 
marked hypertrophy and hyperplasia under conditions of metabolic and respiratory 
acidosis and potassium depletion [17]. 
 
2.6.2.2 Type B-Intercalated cells 
In many respects type B-ICs are structurally and functionally opposite to type 
A-ICs (as summarized in detail by [17]). Compared with type A-ICs, the apical cell pole 
of B-ICs is usually narrow, with few and short microvilli, while the basal pole is broad 
with tightly arranged deep infoldings of the membrane. B-ICs exhibit a characteristic 
homogeneous belt of dense vesicle-free cytoplasm, containing filamentous 
compounds, just below the apical membrane [42]. Thus, mitochondria usually align 
along the lateral membrane and vesicles are distributed throughout the remaining 
cytoplasm. Type B-ICs contain a large Golgi-Complex with abundant smooth 
endoplasmic reticulum, exhibiting clathrin-coated heads. Polyribosomes, 
microtubules, lysosomes and phagolysosomes are much more frequently present in 
B-ICs than A-ICs [17]. In contrast to type A-ICs, B-ICs usually lack apical V-ATPase 
expression and correspondingly apical vesicles and studs. Instead, V-ATPase and 
coated studs are abundant in the basolateral membrane domain [17, 42]. Lectin-
immunoreactivity of the luminal membrane to peanut agglutinin (PNA) identifies B-
ICs. However, a member of the Slc26 family, pendrin (Pds, Slc26a4) was finally 
identified as the long missing exclusive Cl-/HCO3
- exchanger on the luminal 
membrane of B-ICs [46, 47]. Thus, B-ICs serve as bicarbonate secreting cells, mirroring 
the action of A-ICs, allowing the fine tuning of urinary acid-base excretion [33]. 
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2.6.2.3 Intermediate forms of Intercalated Cells 
Based on morphologic criteria, intermediate variants of ICs, which cannot be 
attributed to type A-ICs nor type B-ICs, have been observed [17]. One manifestation 
of these intermediates is frequently observed in rat and mouse renal CNT and CCD 
and is referred to as non-A/non-B intercalated cells (non-A/non-B-IC), as they display 
features of both, type A-ICs and B-ICs. The non-A/non-B cells are characterized by 
the luminal presence of both, V-ATPase and Pds, as well as the absence of basolateral 
Ae1 (Fig. 2.6) [42, 46, 48]. Functionally, the equilateral expression of V-ATPase and Pds 
would result in the parallel secretion of H+ and HCO3
- in the exchange for luminal Cl-. 
However, it remains controversial, whether non-A/non-B cells represent a distinct cell 
type or a specific activity state of B-ICs [33]. 
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Fig. 2.6 Schematic representation of molecular collecting duct marker.  
Immunohistochemically, principal cells along the CNT and CD are identified by the luminal presence of 
aquaporin 2 (Aqp2). Type A-intercalated cells are characterized by the luminal expression of V-ATPase 
(H
+
-ATPase) and basolateral expression of anion exchanger 1 (Ae1). In type B-intercalated cells the V-
ATPase is expressed on the basolateral membrane, while pendrin (Pds) is found on the apical side. 
Type non-A/non-B intercalated cells share features of both, type A-IC and type B-IC, with luminal 
coexpression of V-ATPase and Pds in the absence of basolateral Ae1. Moreover, some type non-
A/non-B-ICs express the V-ATPase on the apical and basolateral membrane simultaneously. All types 
of intercalated cells express high levels of cytosolic carbonic anhydrase II (CaII). 
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2.7 Disturbances of terminal renal Collecting Duct Differentiation 
 Even though the pathways and modulators of late embryonic renal CD 
differentiation are largely unknown, a variety of distinct molecules were discovered 
and suggested to play a role in mouse CD differentiation and adaptive plasticity of 
the mature nephron. Among them are receptors, signalling molecules, transcription 
factors, enzymes and transport proteins [49]. Strong evidence for most of the 
regulatory molecules and pathways comes from mouse disease models and in vitro 
experiments. However, developmental studies of other model organisms, such as 
zebrafish (pronephros and epidermis) and Xenopus laevis (larval skin), are of great 
support, as they share structure-function similarities and conserved regulatory 
mechanisms with the mammalian renal CD system (Fig. 2.7) [50-53]. 
 The differentiation of ionocytes (proton-secreting cells, PSC) in the larval 
epidermis of Xenopus laevis is probably the best available model, resembling 
mammalian renal intercalated cells. It has been shown recently, that two types of 
ionocytes are present and distributed in a “salt and pepper” fashion in the Xenopus 
larval skin. Similar to mammalian renal ICs, Xenopus type alpha-ionocytes (A-INCs) 
are characterized by the basolateral expression of ae1 and apical v-ATPase, while type 
beta-ionocytes (B-INCs) express apical pendrin and basolateral v-ATPase [51]. 
Moreover, differentiation of the ionocyte subtypes is regulated by notch activity and 
the downstream targets upstream binding protein 1 (ubp1) and foxi1 (Fig. 2.7) [51]. 
 Xenopus ubp1 belongs to the family of grainyhead transcription factors (chapter 
2.7.4) and shares close sequence similarities with the leader binding protein 1a 
(Lbp1a) of mouse and men. However, direct orthologues of ubp1 in mouse and men 
were not reported [51]. Additionally, based on its proposed functional role, Xenopus 
ubp1 rather resembles an orthologue of mammalian Cp2l1 (chapter 2.7.4) [51].  
 
34 
 
However, in Xenopus larval skin, expression of foxi1 was found in both types of 
ionocytes, whereas ubp1 seems to localize specifically with pendrin expressing B-
INCs. Interestingly, notch activity might mediate the regulation of ubp1 and foxi1 in a 
dose dependent manner. Strikingly, the notch signalling pathway, as well as the 
transcription factors Foxi1 and Cp2l1 (mammalian orthologue of ubp1) are suggested 
critical determinants of mammalian renal IC differentiation. 
 
 
 
Fig. 2.7 Suggested model of Xenopus laevis epidermal ionocyte differentiation. The schematic 
model is based on the findings of [51]. A) Overexpression of activated notch leads to suppression of 
ionocyte (INC) formation, probably by inactivating ubp1 and foxi1. B) Inhibition of notch leads to the 
formation of ionocytes, presumably by activation of ubp1 and foxi1. However, B-INCs (type beta-
ionocytes) are favoured over A-INCs (type alpha-ionocytes), most likely by ubp1 mediated repression 
of foxi1. C) Dose dependent effect of notch. While inactivated notch abolishes INC formation (A), little 
amounts of activated notch lead to the formation of INCs, favouring A-INCs over B-INCs. 
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 Similar observations were made regarding the differentiation of distinct 
ionocyte populations and keratinocytes in the epidermis of zebrafish embryos and 
larvae [52]. Cell lineage tracing experiments revealed the development of ionocytes 
and keratinocytes from the same precursor cell pool [54]. At least two types of 
ionocytes are distinguished, Na+,K+-ATPase-rich (NaR) cells and H+-ATPase-rich (HR) 
cells. Apparently, members of the fox transcription factor family (foxi1 and foxi3) are 
essential in ionocyte specification [54-56]. Furthermore, the delta-notch signalling is 
required to inhibit ionocyte formation of neighbouring cells, thus inducing the 
keratinocyte phenotype by lateral inhibition. Recently, the grhl1 (grainyhead-like 1) 
transcription factor was discovered to play some role in ionocyte and non-
keratinocyte formation, probably by negative autoregulation (Fig. 2.8) [57].  
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Fig. 2.8 Predicted model of epidermal cell differentiation in zebrafish larvae, modified after [56, 
57]. A common pool of epidermal precursor cells (expressing p63, bmp7) give rise to distinct cell types. 
Hereby, foxi1 mediated activation of delta C seems to determine the cell fate of neighbouring cells. 
While delta C mediated induction of foxi3 gives rise to the ionocyte lineage (Na
+
,K
+
-ATPase-rich cells, 
NaR; H
+
-ATPase-rich cells, HR), the activation of the delta/notch signalling pathway promotes the 
development of keratinocyte (KC) precursor cells by lateral inhibition. Furthermore, the induction of 
foxi3 and the negative autoregulation of grhl1 within the ionocyte precursor might result in the 
terminal differentiation of NaR and HR. In addition, the activation of grhl1 alone may lead to the 
development of distinct non-keratinocytes (non-KC). 
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2.7.1 The p53 gene family 
 Terminal cell differentiation inversely correlates with proliferation and thus 
requires cell cycle arrest and activation of a functional gene expression in the cell [16]. 
The tumor suppressor protein TP53 (p53) is a master regulator of transcription and 
central to the activation of cell cycle arrest, senescence, apoptosis, tumorogenesis, 
embryo development and differentiation [58, 59]. Consistently, p53 expression and 
activity is crucially regulated during embryonic kidney development and plays a role 
in transcriptional regulation of renal functional genes (RFGs) [60-62]. Briefly, in the 
fetal rat kidney p53 expression was detected in the differentiated zone with the onset 
of tubular differentiation, while it was absent in the immature nephrogenic zone [61]. 
The spatiotemporal distribution pattern and posttranslational modifications of p53 
correlate with the expression of RFGs (i.e. Bdkrb2, Aqp2, Na+/K+-ATPase α1, AT1A) and 
thus differentiated renal epithelial cells [63]. Consistently, p53 was shown to control 
the expression of these RFGs in distinct in vivo and in vitro models [61, 63, 64]. In 
addition, transcription factors (i.e. Klf4, Foxi1) involved in epithelial differentiation 
might be controlled directly by p53 or signalling molecules within the p53 pathway 
[65-67]. Interestingly, p53 deficient newborn mice exhibit severe renal cysts and 
hyperplasia, while p53 overexpression results in renal hypoplasia [61]. Among the p53 
responsive genes the bradykinin receptor type B2 (Bdkrb2, B2R) was identified and 
their relationship was investigated in more detail. The bradykinin receptors are 
thought to mediate paracrine actions of the renal kallikrein-kinin-system (KKS), which 
comprises cellular growth, inflammatory response, modulation of renal blood flow 
and urinary sodium excretion [68, 69]. Indeed, salt stressed Bdkrb2 deficient mouse 
embryos develop renal CD dysplasia and die early after birth [70]. The observed renal 
dysgenesis might be a result of p53 mediated apoptosis of nephron progenitors and 
repression of terminal differentiation [71, 72]. Moreover, a combinatorial model 
involving the transcription factors p53, cAMP response-element binding protein 
(CREB), Krüppel-like factor 4 (Klf4), and the transcriptional coactivator CREB-binding 
protein (CBP) is proposed to cooperatively activate Bdkrb2 transcription in the 
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process of terminal nephron differentiation (Fig. 2.9) [13, 65, 66]. Accordingly, p53 
performs a dual role in terminal epithelial differentiation by controlling cell cycle 
arrest and activating the transcription of renal function genes. However, whether a 
multi-protein complex is also required for the transcriptional regulation of other p53 
targets such as Aqp2 or Na+/K+-ATPase is still unknown. 
In addition, p73, another member of the p53 family and close homologue, was 
identified to control the expression of Aqp2 and Bdkrb2, independently of p53 [73]. 
Furthermore, p73 and p63, but not p53, might activate the Notch signalling pathway 
and thus influence developmental cell fate decisions [74].  
All together, genes of the p53 family might promote terminal differentiation of renal 
epithelial cells in the CD system and eventually initiate segment-specific transcription 
factors and cofactors ensuring segmental identity rather than specifying a cell lineage 
or cell fate [66].  
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Fig. 2.9 Suggested role of p53 family in terminal nephron differentiation, taken from [66]. A) 
Terminal nephron differentiation requires p53 stabilization and enhanced DNA binding activity. In the 
nephrogenic zone Pax-2 represses transcription of p53. In the differentiation zone high levels of p53 
suppress transcription of PCNA and induces KLF4 transcription, which in turn activates p21 expression 
and sustains cell cycle arrest [66]. B) Activation of the AT1R by angiotensin II mediates phosphorylation 
of CREB, which allows interaction of CREB with p53 and the coactivator CBP, thus enhancing Bdkrb2 
(B2R) transcription. CBP serves as a bridging molecule for the basal transcription machinery and as a 
histone acetyltransferase [66]. C) p53 and its homologue p73 are able to bind the promoters and 
activate the expression of renal function genes. However, the transcriptional activation requires 
additional transcription factors like KLF-4 or Foxi1 [66].  
Pax-2 (paired box gene 2); PCNA (proliferating cell nuclear antigen); KLF4 (Krüppel-like factor 4); AT1R 
(angiotensin II receptor type 1); CREB (cAMP response-element binding protein); CBP (CREB-binding 
protein); Foxi1 (Forkhead box protein I1) 
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2.7.2 Notch signalling pathway 
 The Notch signalling pathway is an evolutionary well conserved mechanism of 
intercellular crosstalk and a master regulator of development, cell fate determination, 
cell differentiation, tissue patterning, homeostasis and repair. The different actions of 
the Notch pathway can be broadly subdivided into three categories, which are 1) 
lateral inhibition, 2) lineage decisions, and 3) boundaries/inductive signalling [75]. 
Recent studies suggest Notch as a key regulator in renal development by establishing 
proximal epithelial fate during nephron segmentation and differentiation of principal 
cells in the renal CD system (Fig. 2.10) [76, 77].  
This has been nicely demonstrated in a study by Jeong and colleagues [77]. In detail, 
the Notch signalling pathway was selectively disrupted in the renal CD system by a 
conditional KO of mind bomb 1 (Mib 1). Mib 1 is an E3 ubiquitin ligase that is 
necessary for endocytotic removal of Notch ligands and thus initiating Notch 
signalling [78]. However, inactivation of the Notch signalling pathway in the renal CD 
system, leads to nephrogenic diabetes insipidus due to reduced abundance of Aqp2 
positive principal cells and their concomitant replacement by V-ATPase positive 
intercalated cells (Fig. 2.10 A) [77]. Interestingly, Foxi1 mRNA abundance (see Chapter 
2.7.3) was markedly increased in kidneys with inactivated Notch signalling. 
Intriguingly, constitutive activation of Notch signalling completely reverses the renal 
CD phenotype by restoring Aqp2 positive principal cells, virtually replacing all types 
of V-ATPase positive intercalated cells (Fig. 2.10 B). The constitutive activation of 
Notch was achieved by the introduction of the Notch intracellular domain (NCID) into 
the conditional Mib 1 deficiency phenotype [77]. Thus, Notch signalling critically 
influences the cellular heterogeneity of the mouse renal CD system.  
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Consistently, the Notch signalling pathway controls the mosaic pattern of multi-cilia 
cells and principal cells in the zebrafish pronephros by lateral inhibition [76, 79]. 
Furthermore, the Notch regulatory mechanism and members of the grainyhead 
family (see Chapter 2.7.4) most likely contribute to cell lineage determination of PSCs 
(proton-secreting cells) in Xenopus laevis and zebrafish larval skin, acting upstream of 
foxi1 (Fig. 2.7, 2.8) [51].   
 
 
Fig. 2.10 The Notch signalling pathway determines terminal differentiation of cells in the 
mammalian renal collecting duct system (after [77]). A) Disruption of the Notch signalling pathway 
goes along with increased Foxi1 mRNA expression and favours the abundance of V-ATPase positive 
intercalated cells (ICs) on the expense of Aqp2 positive principal cells (PCs). B) Constitutive activation 
of the Notch signalling pathway is accompanied by downregulation of Foxi1 mRNA and results in the 
presence of Aqp2 positive PCs with a complete loss of V-ATPase positive ICs.  
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2.7.3 Foxi1 deficiency 
 Transcription factors are essential regulatory proteins in embryogenesis and 
organ development. There is a large family of forkhead box (FOX) transcription 
factors identified, which share homology in the forkhead box domain, a well 
conserved DNA binding motif of 80-100 amino acids, also known as the winged helix 
domain. At present, 50 FOX genes in the human genome and 44 Fox gene 
orthologues in mouse are identified and distinguished in 19 clades [80]. Based on 
phylogenetic criteria, a common nomenclature using alphabetic letters for distinct 
Fox classes (FOXA – FOXS) is agreed. The FOX transcription factors play important 
roles in embryo and organ development, cell cycle control, growth, differentiation, 
longevity and cancerogenesis in a variety of distinct species [81].  
At least two Fox genes are involved in early kidney development, Foxd1 and Foxc1 
[10]. Another member Foxi1 was found to be expressed in distal tubules of fetal 
kidneys of later developmental stages and in the adult kidney [82], particularly in ICs 
of the renal CDs [83]. Furthermore, Foxi1 expression was detected in the mouse inner 
ear and epididymis [84-86]. Analysis of the Foxi1 consensus binding sequence 
identified potential target genes expressed in the renal distal tubule, among them are 
Pds, Ae1, Ae4 and the a4 and B1 subunits of the V-ATPase [82, 83, 85, 87]. 
Consistently, mice deficient for Foxi1 develop distal renal tubular acidosis (dRTA), 
most evidently due to the loss of acid-base regulating proteins in renal ICs, such as 
Pds, Ae1, Ae4 and the B1 subunit of the V-ATPase [83]. Interestingly, renal collecting 
ducts of Foxi1 KO mice are composed of only a single cell type that is equally positive 
for the PC marker Aqp2 and the IC marker CaII, instead of distinct populations of ICs 
and PCs (Fig. 2.11).  Likewise, ultrastructural analysis of the CD system confirmed a 
lack of normal ICs in Foxi1 null mutants. Instead of, a cell type neither displaying clear 
features of ICs nor strictly PC characteristics was found. Hence, all these data suggest 
Foxi1 as a critical factor regulating the correct and functional patterning of the renal 
CD epithelium. Whether Foxi1 is a direct or indirect regulator is still not known.  
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Fig. 2.11 Relationship of Foxi1 and terminal differentiation of mouse renal collecting duct cells 
(after [83]). A) The renal collecting duct (CD) of healthy mice consists of principal cells (PCs) and types 
of intercalated cells (ICs). B) However, PCs and ICs are absent in the renal CD system of Foxi1 deficient 
mice and replaced by a chimeric cell (ChiC) type, coexpressing aquaporin 2 (Aqp2) and carbonic 
anhydrase II (CaII). 
 
2.7.4 Cp2l1 deficiency 
 The family of LSF (late SV40 factor), also referred to as CP2 (CCAAT-binding 
protein 2 on α-globin) related proteins comprises an ancient and evolutionary well 
conserved family of transcription factors which are rather ubiquitously expressed and 
usually transcriptional activators [88]. The LSF family consists of two branches, the 
LSF/CP2 subfamily and the grainyhead (GRH) subfamily. In the human and mouse 
genome three LSF-subfamily genes are identified, of which one is LBP-9/CRTR-1 
(Leader binding protein 9, CP2-related transcriptional repressor-1) also known as 
TCFCP2L1/CP2L1 (Transcription factor CP2-like1). CP2L1 is exceptional among the 
LSF-subfamily, as it is rather expressed in specific tissue and acts as a general 
repressor instead of activator [89]. In general, members of the grainyhead gene family 
play fundamental roles in the development and morphogenesis of epithelial tissues in 
a wide variety of species. Murine Cp2l1 is characteristically expressed in the 
developing duct epithelium of exocrine glands including the salivary glands and in 
kidney [89, 90]. In detail, spatio-temporal Cp2l1 expression in the fetal mouse kidney 
is differentially regulated in both, the nephrogenic and ureteric bud derived epithelia 
(Fig. 2.12). However, in the postnatal maturing kidney, Cp2l1 expression becomes 
restricted to the DCT, CNT, CCD and OMCD. 
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Fig. 2.12 Differential expression of 
Cp2l1 in the developing mouse kidney, 
taken from [90]. 
 
 
 
 
Developmental maturation of functional salivary gland and renal distal tubule 
epithelium was defective in Cp2l1 deficient mouse embryos [90]. In particular, Cp2l1 
depleted kidneys lack the expression of Clcnkb, Gk-6 and Fxyd2c, genes which are 
characteristically present in the TAL, CNT and DCT, respectively. Moreover, mRNA 
expression of Atp6v1b1, Ae1 and Pds was completely absent in Cp2l1 deficient 
kidneys (Fig. 2.13). Unfortunately, more detailed characterization of the renal CD 
morphology is missing, as well as data assessing the acid-base homeostasis in these 
mice, despite the observation of a mild urinary concentrating defect. Anyhow, Cp2l1 
deficiency in mice correlates with incomplete renal CD differentiation, strongly 
affecting the characteristic structure and function of ICs. However, regulatory 
pathways and mechanisms involving transcriptional control of Cp2l1 are still missing.  
 
Fig. 2.13 Correlation of Cp2l1 deficiency with the expression of 
genes usually present in mouse renal collecting duct cells (after 
[90]). Loss of Cp2l1 in kidneys of mice does not alter the mRNA 
expression of aquaporin 2 (Aqp2), a marker for principal cells (PCs). 
However, Cp2l1 deficiency goes along with the absence of Atp6v1B1, 
Ae1 and Pds mRNA, usually expressed by types of intercalated cells 
(ICs).  
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2.7.5 Dmbt1 (Hensin) deficiency 
 Besides the importance of regulatory transcription factors and signalling 
molecules, another group of proteins, namely integrins and extracellular matrix (ECM) 
proteins, play a role in terminal differentiation of renal epithelial cells. Initially 
discovered in cultured epithelial cells derived from rabbit kidney, the ECM protein 
hensin is proposed crucial for terminal differentiation of renal intercalated cells and 
the hypothesized transdifferentiation of types of ICs upon acid-base disturbances 
(chapter 5.2) [91-93]. Hensin is expressed during embryonic development and with 
species differences in the expression levels in pancreas, intestine, gallbladder, salivary 
glands and nasal/olfactory/vomeronasal epithelium [94]. It has been described 
previously by different investigators and thus is known, beside other names, also as 
Dmbt1 (deleted in malignant brain tumors 1) or muclin (mucin-like glycoprotein). 
However, it has been reported, that hensin is synthesized and secreted to the 
extracellular matrix as a monomer or polymer. The polymerization of hensin seems to 
mediate interconversion of type B-ICs to type A-ICs and requires the presence of at 
least 3 additional proteins (galectin 3, cis-trans peptidyl prolyl isomerase and integrin 
αvβ1) [95-98].  
Recently, a mouse model with conditional deletion of hensin from renal intercalated 
cells was investigated [99]. The mice were reported to lack renal type A-ICs all along 
the CD system and consequently develop complete dRTA due to renal bicarbonate 
wasting. Essentially, type B-ICs were preserved in the renal cortex of the mutant mice, 
while a novel IC phenotype was discovered in the inner medulla. Here, the authors 
found an uncertain type of ICs, which displays the ultrastructural characteristics of 
type B-ICs but lacks pendrin expresssion. This novel cell type is suggested to be the 
progenitor of medullary type A-ICs. In the same study, another mouse model with a 
conditional deletion of integrin β1 from renal ICs was compared, since integrin β1 was 
suggested critical for hensin polymerization and deposition to the ECM. Accordingly, 
a phenotype similar to that of hensin deficient mice was observed. However, despite 
intensive studies, a putative molecular mechanism of hensin mediating renal IC 
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differentiation has never been suggested. Nevertheless, hensin was very recently 
integrated into an oversimplified schematic model of intercalated cell differentiation 
(Fig. 2.14) [100]. 
 
 
 
 
Fig. 2.14 Proposed model for renal intercalated cell differentiation, taken from [100]. 
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2.7.6 Carbonic anhydrase II deficiency 
 Besides transcription factors and signalling molecules the presence of the 
enzyme carbonic anhydrase II (CaII) was found to be a critical determinant of terminal 
IC differentiation. Renal ICs express high levels of the cytosolic enzyme CaII which 
catalyzes the rapid conversion of CO2 and water to H2CO3. CaII deficiency in mouse 
and men is known to cause distal renal tubular acidosis (dRTA). Moreover, ICs of the 
CCD and particularly MCD are severely reduced and replaced by PCs in kidneys of 
CaII deficient mice (Fig. 2.15) [101, 102]. Another study showed that the phenomenon 
of IC depletion in CaII deficient mice develops during late postnatal maturation of the 
kidney [103]. In detail, a remodelling of the MCD favouring PC abundance on the 
expense of ICs was only detectable after 3 weeks of life. These observations suggest 
that the presence or absence of CaII directly influences the cell type diversity in the 
renal CD.  
 
Fig. 2.15 Carbonic anhydrase II (CaII) 
deficiency leads to depletion of 
intercalated cells (ICs) in mouse 
kidney (after [101-103]). Detailed 
description in text.  
 
Notably, chronic pharmacologic inhibition of CaII with acetazolamide in rats was 
shown to induce distinct remodelling of the renal CD system [104]. Here, type A-IC 
abundance in the renal CCD was increased with a corresponding decrease in type B-
ICs, without affecting the ratio of total IC to PC. Furthermore, the relative number of 
type A-ICs in the outer medulla was increased on the expense of PCs. In addition, the 
size of ICs in CCD and OMCD was markedly increased. In contrast, A-ICs were 
strongly reduced in the inner medulla of acetazolamide treated rats, but not 
completely absent as it was reported for CaII deficient mice. These data are consistent 
with the concept of adaptive nephron plasticity (see Chapter 5.2.1). 
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3. RENAL ACID-BASE TRANSPORT 
The kidneys ability to produce acidic urine is an important mechanism to adapt 
to intermediate and chronic imbalances in systemic acid-base homeostasis. Renal 
excretion of acids is enabled by three regulatory pathways along the nephron: 1) 
reabsorption of filtered HCO3
- in the proximal tubule, 2) ammoniagenesis and 
excretion of ammonia and titratable acids, and 3) excretion of excess protons in the 
distal nephron. 
 
3.1 Renal bicarbonate handling 
  Bicarbonate in the blood is freely filtered in the renal glomerulum and thus 
needs to be recovered from the renal tubular lumen to prevent loss into the urine. 
The proximal tubule is the main site of renal HCO3
- reabsorption, accounting for 80% 
[105, 106]. As illustrated in Fig. 3.1, luminal HCO3
- and H+ are converted to CO2 and 
H2O by the action of the membrane bound carbonic anhydrase IV (CAIV). Carbon 
dioxide enters the proximal tubule cell rapidly by diffusion where it is once more 
combined with H2O to form HCO3
- and H+. This intracellular hydration is catalyzed by 
carbonic anhydrase II (CAII), which is a soluble isoform. While the H+ exits the cell to 
the luminal site, mostly in exchange for Na+, via the Na+/H+ exchanger NHE3, the 
formed HCO3
- is cotransported together with Na+ to the blood by the basolateral 
Na+/ HCO3
- cotransporter NBCe1.   
The remaining 20 % of luminal HCO3
- are finally reabsorbed in the thick ascending 
limb of the loop of Henle [107] and the distal tubule [108]. 
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Fig. 3.1 Bicarbonate reabsorption in proximal tubule (adapted after [1]), detailed description in text. 
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3.2 Ammoniagenesis 
Beside the recovery of bicarbonate from the urine, the kidneys are able to 
generate new bicarbonate from the synthesis of ammonium (NH4
+). Ammonium is 
primarily produced from glutamine in mitochondria of the proximal tubule (Fig. 3.1) 
[109]. Glutamine, provided by the liver due to amino acid break down, enters the 
proximal tubule cells mostly by the Na+ coupled cotransporter SNAT3 [110]. Inside 
the mitochondria, glutamine is cleaved to glutamate and ammonium (NH4
+) by 
glutaminase. Glutamate is then further converted to α-ketoglutarate and a second 
NH4
+ by glutamate dehydrogenase (GDH). Ammonium inside the cell dissociates into 
H+ and gaseous NH3, which diffuses into the tubular lumen, where it binds again to 
H+ and is trapped as NH4
+. The protons are consumed to form glucose from α-
ketoglutarate, thus generating bicarbonate. Ammonium might also be secreted into 
the lumen by the apical Na+/H+ exchanger NHE3, replacing the H+ as the preferred 
substrate. Along the different parts of the loop of Henle (LOH), ammonium is 
secreted and primarily reabsorbed in the thick ascending limb (TAL). This leads to the 
accumulation of NH4
+ in the interstitium of the outer medulla, partially favouring 
non-ionic diffusion of NH3 into the lumen of the medullary collecting ducts, where it 
is excreted to the final urine along with H+. 
As recently discovered, ammonia secretion in the inner medullary collecting duct, is 
not only passive, but mediated by the Na+/K+-ATPase and the Rhesus glycoproteins 
RhBG and RhCG [111-114]. These specialized transporters are predominantly present 
in principal cells and type-A intercalated cells of the collecting ducts [112] (Fig. 3.2). 
Mice deficient for Rhcg display an incomplete form of distal renal tubular acidosis 
(dRTA), due to insufficient NH3 excretion to the urine, indicating its relevance (see 
chapter 7.1.2) [114]. 
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Fig. 3.2 Ammonia excretion in type-A intercalated cell of renal collecting duct (adapted after 
[109]), detailed description in text. 
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3.3 Renal use of titratable acids 
Protons excreted with the urine are not only bound as NH4
+, but are also 
bound to other buffers, the so called titratable acids (TA). By definition, titratable 
acidity describes the amount of acid required to titrate the urine buffers from the 
plasma pH to urine pH [115]. The most important urinary titratable acids are 
phosphate (Fig. 3.1) and creatinine. However, other organic salts such as sulfate, 
citrate, lactate, pyruvate and urate also contribute to urinary buffering and thus, 
titratable acidity. The term net acid excretion (NAE) describes the sum of titratable 
acids and NH4
+ minus the urinary HCO3
- concentration in the urine (Eqn. 3) [1]. 
 
Eqn. 3  NAE = (TA + NH4
+) - HCO3
- 
 
3.4 Acid-base transport in the distal nephron 
While the proximal tubule plays a major role in the de novo generation and 
reabsorption of bicarbonate, the distal tubule and the collecting ducts are the site of 
urinary fine tuning and final acidification [116]. Today, the distal convoluted tubule 
(DCT), the connecting tubule (CNT) and the initial collecting tubule (ICT) are taken 
together as the classical distal tubule, even though they display significant cell 
heterogeneity.  The collecting ducts (CD) are distinguished in cortical collecting ducts 
(CCD), outer medullary collecting ducts (OMCD) and inner medullary collecting ducts 
(IMCD). As already described, the collecting ducts are comprised of at least three 
different cell types, principal cells, type-A and type-B intercalated cells. The principal 
cells are responsible for salt and water homeostasis. Type-A intercalated cells are acid 
secretory cells, since they secrete protons into the urine and transport bicarbonate 
into the blood. A-ICs are characterized by the luminal expression of the V-ATPase and 
basolateral expression of the Cl-/HCO3
- exchanger AE1 (SLC4A1, Band 3) (Fig. 2.6, 3.3).  
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Fig. 3.3 Model of type-A intercalated cell (A-IC) without NH3/NH4
+
 pathway, adapted from  [116], 
detailed description in text. 
 
Type-B intercalated cells (B-ICs) are bicarbonate secreting cells and show opposite 
features of type A-ICs with the luminal expression of the Cl-/HCO3
- exchanger pendrin 
(SLC26A4, PDS) and the basolateral presence of V-ATPase (Fig. 2.6, 3.4).  
 
 
Fig. 3.4 Model of type-B intercalated cell (B-IC), adapted from [116], detailed description in text. 
 
However, proton and bicarbonate excretion by the collecting ducts is strongly 
dependent on the presence of NH3 and titratable acids in the urine and is influenced 
by different factors, such as systemic acid-base and electrolyte status, several 
hormones and nutrition [116, 117].  
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4. DISTURBANCES OF ACID-BASE HOMEOSTASIS 
Systemic and renal acid-base regulation is influenced by a multitude of 
physiologic and pathophysiologic factors including respiration, nutrition and physical 
activity, as well as medication and various epithelial transporter disorders. Clinically, 
acidosis defines a blood pH lower than 7.35, while alkalosis exists with a blood pH 
higher than 7.45. Typically, four basal pH disturbances of different origin (Tab. 4.1) are 
distinguished: 1) respiratory acidosis, 2) respiratory alkalosis, 3) metabolic acidosis, 
and 4) metabolic alkalosis. In general, respiratory derived acid-base disturbances are 
primarily caused by alterations in blood pCO2 due to inappropriate pulmonary 
ventilation.  In contrast, metabolically derived pH imbalances are usually caused by 
accumulation or loss of non-volatile acids and therefore changes in blood HCO3
- 
concentration. Furthermore, metabolically derived pH disturbances may be 
distinguished in extrarenal and renal origin. Extrarenal metabolic pH disturbances 
might be caused by nutrition (i.e. high protein content), diarrhoea and excessive 
sports.  However, systemic pH imbalances might also arise because of renal tubular 
dysfunction. In any case, the body tries to restore systemic pH as close to normal by 
acute and long-term regulatory mechanisms.  
 
Tab. 4.1 Clinical types of acid-base disturbances, modified after [1] 
Disturbance Symptom Response 
Respiratory acidosis  pCO2  HCO3
- 
Respiratory alkalosis  pCO2  HCO3
- 
Metabolic acidosis  HCO3
-  pCO2 
Metabolic alkalosis  HCO3
-  pCO2 
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Clinically, determination of the serum anion gap helps to identify the cause of 
metabolic acidosis [118]. The anion gap is a calculated value, given by subtraction of 
the major anions [HCO3
-] and [Cl-] from the major cation [Na+] (Eqn. 4).   
 
Eqn. 4  Anion Gap = [Na+] – ([HCO3
-] + [Cl-]) 
 
Thus, the anion gap is usually a positive value (12 ± 4 meq/l), reflecting the quantity 
of anions which are not balanced by cations [119]. The result of the anion gap is 
classified as high or normal and allows the following interpretations. A high anion 
gap acidosis may be observed in the presence of additional metabolic acids 
consuming bicarbonate (i.e. lactic acidosis, ketoacids) or in renal failure, when the 
kidneys do not sufficiently reabsorb bicarbonate or secrete acids. Normal anion gap 
acidosis, also called hyperchloremic acidosis, goes along with the loss of bicarbonate 
compensated by an equivalent increase in serum chloride concentration. This form is 
usually caused by renal tubular acidosis, diarrhoea and ingestion of 
ammoniumchloride or hydrochloric acid. 
 
4.1 Respiratory acidosis 
Respiratory acidosis occurs during insufficient alveolar ventilation 
(hypoventilation) and leads to increased arterial pCO2 levels (hypercapnia) which is 
initially corrected by HCO3
- buffering from the extracellular fluid. On the long term, 
the kidneys need to correct the distorted blood [HCO3
-/CO2] by reabsorbing all 
filtered HCO3
- and enhancing the generation and secretion of all available acids by 
upregulating renal acid-base transporters [120, 121]. 
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4.2 Respiratory alkalosis 
Hypocapnia describes a state of low arterial pCO2 levels caused by alveolar 
hyperventilation. This leads to respiratory alkalosis and fall in plasma [HCO3
-]. Chronic 
hypocapnia further decreases extracellular fluid [HCO3
-] as a result of reduced renal 
net acid excretion [120, 121]. 
 
4.3 Metabolic acidosis 
Metabolic acidosis is a severe acid-base imbalance that may be caused by 
numerous factors, such as starvation, diarrhoea, intoxication or disease complications 
like diabetic ketoacidosis. Acute metabolic acidosis, lasting up to several days, is 
much more common than chronic forms [122]. However, the immediate 
compensatory response to metabolic acidosis is an increase in alveolar ventilation, 
thus exhaling more CO2. This is usually achieved by enhancing the respiratory tidal 
volume and frequency. However, the final correction of plasma [HCO3
-/CO2] needs to 
be established by the kidney. Thus, renal excretion of H+ and HCO3
- reabsorption is 
maximally upregulated. Additionally, ammoniagenesis and final excretion of NH4
+ 
increases markedly and becomes the main H+ extrusion pathway. Detailed adaptive 
responses of the kidney to acid loads will be discussed later on (chapter 5).  
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4.4 Metabolic alkalosis 
Two conditions may lead to metabolic alkalosis, namely the loss of hydrogen 
ions (i.e. by vomiting) or the inappropriate increase in plasma [HCO3
-] (i.e. abuse of 
steroids and diuretics). Likewise to metabolic acidosis, the respiratory system 
responds and adapts immediately to metabolically derived alkalosis. Here, the 
respiratory frequency slows down significantly, leading to the accumulation of pCO2 
in the blood. Again, the kidney is responsible for the final and persistent correction. 
During metabolic alkalosis, acid secretion and bicarbonate reabsorption by the kidney 
is markedly reduced. Moreover, type B-ICs of the renal cortical collecting ducts may 
even switch from net H+ secretion to HCO3
- secretion [1, 123].  
 
4.5 Renal tubular acidosis 
Impaired renal acidification leads to renal tubular acidosis (RTA), a form of 
metabolic acidosis with hyperchloremic anion gap in the setting of normal glomerular 
filtration [124]. Generally, acquired or inherited RTA may develop either because of 
insufficient proximal bicarbonate reabsorption or due to inadequate distal urinary 
acidification. However, based on the clinical symptoms and the underlying functional 
defect, four different types of RTA are distinguished: type 1 classic distal (dRTA), type 
2 proximal (pRTA), type 3 combined proximal and distal RTA, and type 4 distal-like 
hypoaldosteronism (hyperkalemic dRTA) [125, 126].  
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4.5.1 Type 1 RTA 
 Distal renal tubular acidosis (dRTA) is characterised by the renal inability to 
acidify the urine, leading to metabolic acidosis with variable severity of accompanying 
hypokalemia, hypercalciuria and hypocitraturia. The underlying defect is usually an 
acquired or inherited form of impaired acid secretion by type A-ICs of the renal 
collecting ducts. The impact of inadequate urine acidification might result in 
spontaneous systemic metabolic acidosis (complete dRTA) or metabolic acidosis after 
an imposed acid load (incomplete dRTA) [127]. Therapeutically, adequate bicarbonate 
supplementation is sufficient to restore plasma bicarbonate to near normal levels. The 
oral application of potassium citrate is favoured over sodium bicarbonate, as it 
simultaneously treats the accompanying and often life-threatening hypokalemia 
[128]. 
Primary familial dRTA is caused by mutations of epithelial transporters essentially 
expressed in renal type A-ICs. In dependence of the mutation and the affected 
transporter respectively, autosomal- dominant and –recessive forms of dRTA are 
known (Tab. 4.2) [126, 127]. Most commonly, loss of function mutations of the Cl-
/HCO3
- exchanger AE1 or the V-ATPase were identified in patients with primary 
familial dRTA [129-134].  
However, dRTA frequently also develops as a secondary disorder, often in 
consequence of autoimmune diseases such as Sjögren`s syndrome [135-138].  
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Tab. 4.2 Subtypes and features of inherited dRTA, adapted from [126]. 
dRTA 
Inheritance 
Age at 
Presentation 
Clinical Features Transporter 
Dominant Adulthood mild/compensated Metabolic 
Acidosis 
Hypokalemia (variable) 
Hypercalciuria 
Hypocitraturia 
Nephrolithiasis 
Nephrocalcinosis 
sometimes Rickets/ 
Osteomalacia 
Secondary Erythrocytosis 
AE1 (SLC4A1) 
Recessive Childhood Metabolic acidosis with 
Hemolytic Anemia 
AE1 (SLC4A1) 
Recessive Infancy/ Childhood early onset bilateral 
sensorineural hearing loss 
Metabolic Acidosis 
early Nephrocalcinosis 
growth retardation 
Rickets 
B1 subunit of 
V-ATPase 
(ATP6V1B1) 
Recessive Infancy/ Childhood as above with later onset of 
hearing loss or no deafness 
a4 subunit of 
V-ATPase 
(ATP6V0A4) 
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4.5.2 Type 2 RTA 
Proximal renal tubular acidosis (pRTA) is usually caused by defective proximal 
tubule bicarbonate reabsorption with intact distal acidification. This leads to excessive 
loss of bicarbonate by the kidney and subsequent metabolic acidosis with 
hypokalemia [139]. Primary isolated pRTA is a rare disorder and associated with 
dominant and recessive inherited mutations in the Na+/HCO3
- cotransporter NBCe1 
(SLC4A4) (Fig. 3.1). Since NBCe1 is also expressed in the eye, pRTA might come along 
with ocular abnormalities [140]. 
 
4.5.3 Type 3 RTA 
Type 3 RTA is caused by carbonic anhydrase II (CAII) deficiency and combines 
proximal and distal RTA features. It is characterized by reduced proximal bicarbonate 
reabsorption and distal inability to acidify the urine despite systemic acidosis [141]. 
CAII plays an important role in bone and central nervous system (CNS) metabolism. 
Therefore, CAII malfunction frequently leads to osteopetrosis, cerebral calcification, 
and mental retardation [142, 143].  
 
4.5.4 Type 4 RTA 
Type 4 RTA is actually a primary disorder in renal electrolyte handling with 
secondary normal anion gap acidosis. In general, renal aldosterone deficiency or 
resistance are thought to be the underlying defect. Thus, hyperkalemia and 
hyperchloremia are unique characteristics of type 4 RTA. The mild metabolic acidosis 
develops secondary to the hyperkalemia, which induces an intracellular alkalosis 
impairing renal proximal NH4
+ generation and excretion [144]. 
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5. RENAL ADAPTATION TO SYSTEMIC ACIDOSIS 
Systemic acidosis requires compensatory responses of the kidney function 
increasing the capacity of acid-base and electrolyte handling with cellular 
reorganization and even remodelling of the nephron [145-148]. Furthermore, the 
body has other mechanisms that contribute to renal compensatory regulation of 
acid-base imbalance, such as increase of glomerular filtration rate (GFR) [1], 
hormones that directly stimulate kidney function (angiotensin II, endothelin) [149, 
150] and hormones (i.e. parathyroid hormone, vitamin D) affecting bone resorption 
and thus recruitment of additional non-carbonate buffers [151, 152].  
 
5.1 Adaptation of proximal renal tubule 
In response to metabolic acidosis the renal proximal tubule undergoes a set of 
adaptations to maximally recover filtered bicarbonate [153] and generate new 
bicarbonate to buffer excess systemic acids. Increased acid loads enhance the 
capacity of proximal bicarbonate reabsorption by modulating the activity and/or 
abundance of apical and basolateral transport mechanisms [154]. The apically located 
Na+/H+ exchanger NHE3 plays a crucial role in transcellular bicarbonate reabsorption 
(Fig. 3.1) and enhanced transport activity, as well as increase in its abundance in the 
proximal tubule and TAL during metabolic acidosis have been demonstrated [154-
157]. Furthermore, the V-ATPase is an important apical H+ extrusion pathway, 
accounting for up to 40% of sodium independent bicarbonate transport, which is 
rapidly regulated by pCO2 and pH [158, 159]. Moreover, acidic pH modulates 
basolateral Na+/HCO3
- cotransport mediated by NBCe1 and increases the abundance 
of transporter at the cell membrane [160-163]. In turn, mutations of NBCe1 lead to 
proximal renal tubular acidosis (chapter 4.5.2) [164, 165]. 
 
 
62 
 
However, effective renal acid buffering requires de novo generation of 
additional bicarbonate by the synthesis and excretion of ammonium and excess acids. 
Ammonium is enzymatically generated from the amino acid glutamine in renal 
proximal tubule cells (Fig. 3.1). During metabolic acidosis, the excretion and synthesis 
of ammonium is highly upregulated [166] involving the supply and uptake of 
glutamine into renal tubular cells [167].  
 Additionally, the kidney increases the excretion of titratable acids, mainly 
phosphate (Fig. 3.1). In the proximal tubule, two unrelated gene families (SLC20 and 
SLC34) of phosphate transporters are expressed [168, 169]. Transport activity and 
abundance of members of the SLC34 family were found to be regulated upon acid-
base disturbances [170]. In response to metabolic acidosis elevated levels of 
phosphate are excreted into the urine, where it combines with excess protons acting 
as a titratable acid. Since elevated circulating phosphate is partially released from 
bone mass, chronic systemic acidosis may lead to osteoamalacia or osteopetrosis, as 
well as nephrocalcinosis and nephrolithiasis [171].   
 
5.2 Adaptation of distal renal tubule 
 The renal response to metabolic acidosis does not only require adaptations of 
the proximal tubule, but also of the distal nephron. The importance of the final 
urinary acidification and fine tuning by the distal nephron is also highlighted by the 
dysfunction of numerous transporters leading to dRTA. Within the collecting duct, the 
vacuolar type H+-ATPase (V-ATPase) is the major protein responsible for H+ secretion 
into urine. It is differentially expressed in all types of intercalated cells and thus 
involved in mediating renal net H+ secretion and HCO3
- generation or H+ 
reabsorption and net HCO3
- secretion (Fig. 2.6) [133]. The V-ATPase is a 
heteromultimeric complex, consisting of 13 different subunits which are assembled in 
two domains (Fig. 5.1) [172]. Some of the identified subunits are almost exclusively 
expressed in the kidney among them are the a4 (ATP6V0A4) and B1 (ATP6V1B1) 
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subunits. As indicated in Fig. 2.6, 3.3 and 3.4, the plasma membrane location of the V-
ATPase in intercalated cells (IC) is strongly dependent on the type of IC. Interestingly, 
acid-base disturbances do not seem to alter the mRNA or protein expression levels of 
renal V-ATPases, but trigger its redistribution within the cell [40]. While acidosis 
promotes the insertion of the proton pump into the cell membrane from a subplasma 
membrane pool of V-ATPase vesicles, alkalosis drives the retrieval of V-ATPase from 
the membrane into the submembrane vesicular pool [147]. In addition, acid-base 
disturbances regulate the protein abundance of the Cl-/HCO3
- exchangers Ae1 and 
Pds (Fig. 2.6). Acid-loads were shown to increase the protein abundance of Ae1 and 
decreases Pds, whereas alkali-loads decrease Ae1 abundance and increase Pds [173]. 
 
 
 
Fig. 5.1 Structural model of vacuolar type H
+
-ATPase (V-ATPase), taken from [172]. 
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5.2.1 Adaptive plasticity of distal renal tubule 
 In addition to acid-base related changes of the cellular protein composition 
and localization, acute and especially long-term acid-base imbalances are 
accompanied by changes in the relative number and axial distribution of renal type 
A-ICs and B-ICs [104, 145, 146]. It has been observed that the relative number of type 
A-ICs increases dramatically in rodents receiving chronic oral acid loads. Strikingly, 
the relative number of type B-ICs decreases at the same time, while the ratio of total 
ICs to PCs is not changed [173, 174]. The opposite phenomenon is true for rodents 
receiving chronic alkali loads, since the relative number of type B-ICs increases on the 
expense of type A-ICs. These empiric data raised several hypotheses, which are: 
 1) IC progenitors might exist in the CD epithelium and become activated upon acid-
base perturbations [175-177]. 
2) Terminally differentiated ICs proliferate or become apoptotic upon prolonged 
functional request [138, 146, 178, 179]. 
3) The concept of the plasticity of functional epithelial polarity was raised, a process 
where type B-ICs might convert into type A-ICs or vice versa. Moreover, type B-ICs 
are postulated precursors of type A-ICs [91, 174, 180]. 
Since then, several studies have been performed testing either idea. Accordingly, 
circulating (i.e. haematopoietic stem and progenitor cells, HSPCs) or tissue specific 
residual progenitor cells giving rise to new differentiated renal epithelial cells seem 
rather important for postinjury repair. Furthermore, the notion of proliferation or 
apoptosis of terminally differentiated cells upon exogenous stimuli (i.e. acid-base or 
electrolyte disturbances) is more tempting than the concept of adaptational reversal 
of functional epithelial polarity. In fact, the latter theory was never proofed 
convincingly. 
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5.2.2 Gdf15 is involved in early adaptive proliferation of renal type A-IC 
 Recently, the growth differentiation factor 15 (Gdf15), a member of the 
transforming growth factor-β (TGF-β) superfamily was found to be involved in the 
proliferation of type A-ICs during early adaptation of the kidney to metabolic acidosis 
[146]. The murine orthologue Gdf15 is also designated as macrophage inhibitory 
cytokine-1 (MIC-1), prostate-derived factor (PDF), placental TGF-β (PTGF-β), placental 
bone morphogenetic protein (PLAB) and non-steroidal anti inflammatory drug-
activated gene-1 (NAG-1), reflecting its pleiotropic functions [181]. As typically 
reported for TGF-β superfamily members, Gdf15 is a multifunctional acting factor and 
involved in the control of embryonic development and pregnancy, osteogenic and 
haematopoietic development, cellular responses to stress stimuli, inflammation and 
tissue repair after acute injury.  
During protein synthesis, Gdf15 undergoes extensive peptide processing leading to 
several manifestations, such as signal-peptide, propeptide, and mature peptide, 
which are associated with distinct molecular mechanisms (Fig. 5.2) [181]. The 
biological active mature protein is a secreted dimer, serving multiple autocrine and 
paracrine actions upon a multitude of stimuli (detailed review by [181]).  
In the mature mouse kidney, low mRNA expression levels all along the nephron were 
reported under basal conditions [146]. However, Gdf15 mRNA levels increased readily 
with induction of metabolic acidosis in the CNT, CCD and mostly OMCD. After 3 days 
of acid load, Gdf15 mRNA was maximally increased and declined with prolonged 
acidosis. Strikingly, the time-course of Gdf15 mRNA regulation upon acid loading 
matched the relative proliferation rates of type A-ICs. Moreover, acidotic Gdf15 
deficient mice showed a reduced and delayed proliferation rate of type A-ICs [146]. 
Interestingly, the early proliferation of type A-ICs of acidotic mice was shown to be 
dependent on the regulation of the cell-cycle regulatory protein Cyclin D1, which is a 
downstream target of the phosphatidylinositol-3 kinase (PI3K)/Akt/mammalian target 
of rapamycin (mTOR) signalling pathway. Consistently, the cell-cycle regulatory 
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proteins p53 and cyclin D1/D3 were abnormally regulated in Gdf15 KO mice. The 
molecular action of Gdf15 in renal CD differentiation remains uncertain. However, a 
putative role in controlling the orientation of the mitotic spindle by Gdf15 is 
suggested. Hence, this study [146] demonstrated nicely, that metabolic acidosis 
induces the proliferation of terminally differentiated type A-IC population in the renal 
OMCD of mice. Notably, proliferation markers were rarely detected in PCs or type B-
ICs. In addition, the data indicate that p53, Gdf15 and the PI3K/Akt/mTOR regulatory 
pathway are required for the acute proliferation event. However, detailed 
investigation of the interactive mechanisms is needed.  
 
 
Fig. 5.2 Illustration of cellular processing, secretion and storage of Mic-1 (Gdf15), taken from 
[181]. The biologically active mature Mic-1 protein is a secreted dimer and induces distinct autocrine 
and paracrine actions upon various stimuli. 
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6. BICARBONATE TRANSPORTER 
At present, two evolutionary unrelated gene families encoding for bicarbonate 
transporting proteins were identified in humans, the SLC4 (solute carrier 4) family of 
anion exchangers (AE) and the SLC26 family of sulfate permease anion transporters 
[182]. The gene products of either family display distinct phylogenetic relationships 
with differences in their tissue and subcellular distribution, as well as substrate 
preference, transport mode and regulatory mechanisms. Deficiencies in some of the 
members of both families lead to hereditary diseases affecting different organ 
functions and thus display characteristic phenotypes [127]. 
 
6.1 The SLC4 Family 
In humans, the SLC4 (solute carrier 4) family of Cl-/HCO3
- exchangers consists 
of ten members with distinct phylogenetic relationships. They are distinguished by 
their transport mechanism and preferred substrate and thus belong to at least three 
different major clades (Fig. 6.1) [183]. The Na+-independent and electroneutral Cl-
/HCO3
- exchangers SLC4A1 (AE1), SLC4A2 (AE2), and SLC4A3 (AE3). The Na+-
dependent electrogenic HCO3
- cotransporter SLC4A4 (NBCe1) and SLC4A5 (NBCe2), 
and the Na+-dependent electroneutral HCO3
- cotransporter SLC4A7 (NBCn1) and 
SLC4A10 (NBCn2), as well as the Na+/ HCO3
-/Cl- exchanger SLC4A8 (NDCBE). SLC4A9 
(AE4) does also belong to the Na+ dependent clade but its transport function and 
substrate preference are still unresolved. SLC4A11 (BTR1) belongs to the third major 
clade, since it shares similarities with borate transporters of plants, and fungi. 
However, its transport mechanism and anion preferences remain elusive. 
SLC4 homologues were identified in genomes of many different organisms, such as 
marine bacteria, plants, fungi, marine invertebrates, insects, and a variety of 
vertebrate and mammalian species [183]. 
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Fig. 6.1 Phylogenetic tree of human SLC4 family, taken from [183]. 
 
Members of the SLC4 family are crucial for several physiologic processes in mammals, 
such as the carriage of CO2 from tissue to lungs, epithelial secretion and reabsorption 
of acid-base equivalents (e.g. in the kidney, stomach and pancreas), reabsorption of 
NaCl (e.g. ileum and proximal colon) as well as regulation of cell volume and 
intracellular pH in almost every cell of the body [183]. 
All SLC4 polypeptides share three common structural domains and features. They 
have a remarkably long intracellular hydrophilic N-terminal domain consisting of 400-
700 amino acids, followed by a polytopic transmembrane domain of ~500 amino 
acids, which spans the membrane 10-14 times, and a short cytoplasmic C-terminal 
domain of 30-100 amino acids [184]. The predicted topology and structure of SLC4 
transporters is mostly derived from studies of the highly abundant human erythroid 
AE1 protein (Fig. 6.2). Almost all SLC4 genes express 5’- variant transcripts from 
alternate promoters, thus generating different polypeptide isoforms with distinct N-
terminal domains.  
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6.1.1 Electroneutral Anion Exchangers 
 Among the SLC4 family, three members (AE1, AE2 and AE3) belong to the 
clade of electroneutral and Na+-independent Cl-/HCO3
- exchangers. As they mediate 
the 1:1 exchange of monovalent anions from opposing sites of the plasma 
membrane, they are also referred to as anion exchangers (AEs). Their preferred 
substrates are Cl- and HCO3
-, but they can also transport OH-.  In addition, AE1 was 
shown to mediate the exchange of SO4
2- and H+ for Cl- at very low rates [185]. Since 
the anion exchange mechanism is driven by substrate gradients, AEs can mediate 
influx and efflux of HCO3
- by reversing the transport mode, but only erythroidal AE1 is 
known to work reversibly under physiological conditions [186]. Pharmacologically, all 
AEs are inhibited by the disulfonic stilbenes SITS and DIDS. However, the oxonol dye 
diBA5(C4) was shown to be a more potent inhibitor of AE1 than AE2, whereas 
polyaminosterols were found to inhibit AE2 more potently than AE1 [187].  
The structure of the three AEs is highly conserved, especially within the 
transmembrane (TM) domains, as they share up to 56% of amino acid identity [183]. 
However, they are distinct in their regulation and transport activity.  Interestingly, in a 
physiological range, AE1 activity is not modulated by pH, whereas AE2 and AE3 
activity is highly sensitive to changes in pH [182, 188].  Additionally, AE2, but not AE1, 
was shown to be activated by hypertonicity and contributes to cell volume regulation 
when expressed in Xenopus laevis oocytes [182]. 
Furthermore, AE1 has a single N-glycosylation site, of yet unknown function, at the 
fourth extracellular loop, while AE2 and AE3 are N-glycosylated at the third 
extracellular TM domain [184]. However, the N-glycosylation of AE2 and AE3 had only 
little effects on transport activity or membrane expression [189].  
The present study focuses on the relevance of Ae1 in the kidney. Notably, renal 
deficiency of Ae1 does not seem to induce compensatory regulation of other AEs in 
mouse kidney [190]. 
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6.1.2 The Anion exchanger 1 
In mammals, the anion exchanger 1 (AE1) is predominantly expressed in the 
plasma membrane of red blood cells (RBCs) and the basolateral membrane of renal 
type A-ICs (Fig. 3.3). Lower expression levels of AE1 are also present in the heart, 
distal colon, glomerular podocytes and other tissues [191, 192]. Homologous of 
mammalian AE1 were also identified in insects and amphibians [51, 193, 194]. The 
AE1 gene encodes two polypeptide variants, the longer erythroid AE1 (eAE1, red cell 
band 3) and the shorter kidney AE1 (kAE1). In humans, kAE1 initiates at Met66 
(methionine 66), while it initiates at Met79 in mice [184]. Numerous mutations of the 
SLC4A1 gene have been identified in humans, but also cattle and zebrafish, which 
either affect the structure and function of RBCs or the kidney (Fig. 6.2) [184].  
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Fig. 6.2 Predicted topology model for human AE1 polypeptide, after Zhu et al. [195] taken from 
[184]. Polymorphisms encoding blood group antigens are highlighted in blue. Mutations (missense, 
nonsense, splicing and deletion) associated with hereditary spherocytic anemia and ovalocytosis (HS) 
are highlighted in orange, missense mutations leading to hereditary stomatocytosis (Hst) and 
xerocytosis are shown in red. Mutations identified in dominant and recessive distal renal tubular 
acidosis (dRTA) are labeled in green and terminal truncations are in lighter orange and green. 
 
In the RBC, eAE1 is the most abundant integral membrane protein and serves, 
together with the action of the metalloenzyme carbonic anhydrase II (CAII), to 
increase the CO2 carriage capacity of the blood and thus its removal by the lungs (Fig. 
6.3). CAII was suggested to interact with the short C-terminus of eAE1 forming a pH 
dependent functional transport metabolon that accelerates transmembrane 
bicarbonate transport [196, 197].  
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Fig. 6.3 Role of AE1 in erythroid CO2 carriage (Jacobs-Stewart Cycle), modified from [183]. In the 
capillaries, CO2 enters the erythrocyte mostly by transmembrane diffusion and probably via the water 
channel aquaporin 1.  Soluble CA II (carbonic anhydrase II) catalyzes the rapid formation of HCO3
-
 from 
intracellular CO2 and H2O. Deoxygenated hemoglobin buffers excess H
+
 (Hb-H), while eAE1 releases 
newly generated HCO3
-
 into the blood plasma in the exchange for extracellular Cl
-
 (“Hamburger”-Shift). 
The cycle is reversed in the lungs with oxygenation of hemoglobin (Hb-O2). 
 
Furthermore, the presence of eAE1 dimers or tetramers in the RBC membrane is 
known to be crucial for the stability and integrity of the membrane as it is a central 
part of a cytoskeletal macrocomplex (Fig. 6.4) [186]. In the RBC, the N-terminal 
domain of eAE1 anchors the spectrin based cytoskeleton to the plasma membrane 
via interaction with ankyrin. Moreover, eAE1 was shown to interact with protein 4.1 
and 4.2, hemoglobin, glycolytic enzymes (aldolase, GAPDH, protein tyrosine kinase) 
and rhesus glycoprotein complexes [198, 199]. 
However, possible interactions of kAE1 with other proteins in the renal type A-ICs are 
less well understood and most likely different, since the kAE1 N-terminal domain 
lacks the first 65 amino acids in humans or 78 amino acids in mouse and therefore 
the ability of, for example ankyrin binding. Additionally, mutations of AE1 affecting 
both organs simultaneously, RBCs and kidney, are rarely seen. 
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Fig. 6.4 AE1 macrocomplex in the erythroidal membrane, taken from [186]. In the RBC membrane, 
eAE1 (indicated as band 3) is present as dimers or tetramers, which interact with other cytoskeletal 
proteins forming a macrocomplex. Dimers of eAE1 bind to glycophorin A (GPA), while tetrameric eAE1 
is further interacting with the rhesus glycoprotein RhAG and the cytoskeletal complex protein 4.2, 
ankyrin-1 and α- and β- spectrin.  
 
Several mutations of human AE1 are identified and indicated in Fig. 6.2. They 
give rise to erythrocyte malformation and malfunction with haemolytic anaemia in 
dominant hereditary spherocytosis (HS) or stomatocytosis (Hst) with overhydrated 
cation-leak syndrome, or affect the kidney function leading to primary dRTA [200]. 
Notably, mutations leading to HS are distributed throughout the whole transporter, 
while Hst mutations are restricted to the first part of the second half of the TM 
domain and dRTA associated mutations are spread within the TM domain and the C-
terminal tail. Since the SLC4A1 gene generates at least two tissue specific products, 
mutations affecting both organs simultaneously are rarely seen. However, dominantly 
inherited mutations affecting the RBCs might be recessively inherited for renal 
defects [186] and  dominantly inherited RBC mutants are associated with 50% 
expression of the wildtype allele, which seems to be sufficient for normal renal 
function [200]. Additionally, some dRTA associated AE1 mutations are rescued by 
chaperones like glycophorin A (GPA), which are expressed in RBCs or heterologous 
expression systems, but not in kidney [201-203].  
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In the kidney, kAE1 is abundantly expressed at the basolateral membrane of 
type A-ICs Fig. 2.6, 3.2, 3.3). Together with apical H+ secretion, kAE1 is required for 
the acidification of the final urine, as it is the major basolateral bicarbonate extruder. 
Deficiency for kAE1 in man, mouse and cattle leads to dominant or recessive forms of 
dRTA. Among humans, mutations such as kAE1 R589 (H, C, S), S613F and R901X were 
identified in dominant dRTA, while G701D, S773P and S667F cause recessive forms. 
Several in vitro studies of dRTA associated AE1 mutants try to explain their 
pathogenicity and give rise to possible mechanisms involved in renal AE1 
biosynthesis and targeting. Interestingly, the dominant negative kAE1 R901X 
mutation was shown to be mistargeted to the apical membrane or retained 
intracellularly in MDCK cells [204, 205]. Similarly, expression of dominant negative 
kAE1 R589H and S613F in polarized MDCK cells showed the retention of the protein 
within the ER (endoplasmatic reticulum) as well, where it can dimerize with the wild-
type kAE1 and thus prevent its trafficking to the surface [206]. However, when 
expressed in Xenopus oocytes, kAE1 R589H retains partial activity and surface 
expression [207], which might be due to incubation with lower temperature 
(temperature-sensitive folding mutation), or the presence of different trafficking, 
signalling and folding chaperones in Xenopus  derived cells [200]. Anyhow, in a renal 
biopsy from a patient with dominant kAE1 R589H associated dRTA and superimposed 
pyelonephritis and nephrocalcinosis, a reduced  number of intercalated cells was 
observed, with preserved expression of V-ATPase, but absence of detectable kAE1 
[208]. In contrast, analysis of a renal biopsy from a patient with the dominant kAE1 
S613F mutation, showed reduced number and size of ICs, with an exclusively cytosolic 
expression of kAE1 [138].  
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6.2 The SLC26 Family 
 The SLC26 family of anion exchangers consists of ten members that play 
critical roles in a variety of physiological processes, such as skeletal development, 
synthesis of thyroid hormone, transepithelial Na+-Cl- transport, renal bicarbonate 
excretion and pancreatic bicarbonate secretion [209]. Accordingly, SLC26 transporters 
are very distinct in their expression pattern. Moreover, they transport a variety of 
monovalent and divalent anions, including sulfate, chloride, iodide, formate, oxalate, 
hydroxyl ion, and bicarbonate with variable transport specificity [209].  
Within the kidney, several SLC26 members are expressed along the renal tubule (i.e. 
SLC26A1, SLC26A4, SLC26A7) [209-211]. However, the present study focuses 
exclusively on the Cl-/HCO3
- exchanger Pendrin (SLC26A4).  
 
6.2.1 Pendrin 
 Pendrin (PDS, SLC26A4) is expressed in the inner ear, thyroid gland, and the 
kidney and transports chloride, bicarbonate, and iodide [33, 209]. In humans, 
mutations of PDS are associated with Pendred Syndrome, which is clinically 
characterized by hypothyroidism and goiter, as well as sensorineural deafness [33]. In 
the kidney, Pds is exclusively expressed on the luminal membrane of bicarbonate 
secreting type B-ICs and type non-A/non-B ICs of the CD system (chapter 3.4, Fig. 2.6 
and 3.4). As described in chapter 2.5, Pds expressing cells are restricted to the renal 
cortex of adult kidneys (Fig. 2.4, 2.5). However, during renal development Pds 
expressing cells derive from both, the MM and UB pool of progenitor cells (Fig. 2.5).  
The expression of Pds in mouse kidney and inner ear was shown to depend on the 
transcriptional activation by the forkhead box protein Foxi1 (chapter 2.7.3). In adult 
rodent kidneys Pds expression is highly regulated by systemic acid-base status 
(chapter 4.4, 5.2, and 5.2.1) and systemic chloride levels (for review see [33]). 
However, humans and mice with genetic disruption of Pds have normal acid-base 
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balance under basal conditions [33, 212]. Nevertheless, two independent Pds 
deficient mouse models show a reduced urinary pH due to a reduced urinary 
buffering of H+ by secreted HCO3
- [212, 213]. Interestingly, the abundance of type 
non-A ICs, but not A-ICs, was shown to be reduced in the renal cortex of Pds KO mice 
[212]. Moreover, type B-ICs in Pds deficient kidneys were markedly reduced in size 
and their ultrastructural appearance was altered [212]. Concomitantly, a reduction of 
transporters involved in renal H+/OH- handling (i.e. V-ATPase, NBC3, Rhbg) was 
noted, probably attenuating a rise in intracellular and systemic pH due to the loss of 
Pds [212]. 
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7. MOUSE MODELS USED IN THIS STUDY 
 In the present study, distinct mouse models were used to answer the question 
whether an acid-base disturbance per se or the absence of renal Ae1 would introduce 
the observed abnormal presence of IC marker in Ae1 deficient mice. 
 
7.1 Mouse models with primary dRTA 
 As already described in detail, renal Ae1 deficiency leads to distal renal tubular 
acidosis (dRTA) in mouse and men. Furthermore, loss of function mutations or 
absence of Atp6v1b1 and Rhcg in mice was also shown to reduce the kidneys ability 
of maximal urinary acidification and therefore the removal of systemic excess acid. 
Hence, a genetic defect in one of the three proteins impairs renal IC mediated acid-
base handling and thus causes primary dRTA. Therefore, Atp6v1b1 and Rhcg deficient 
mice serve as alternative models to investigate a possible impact of inherited dRTA 
on the differentiation of ICs, respectively. 
 
 7.1.1 Atp6v1b1 deficient mice 
 Deficiency of the B1 subunit of the V-ATPase (ATP6V1B1) leads to spontaneous 
dRTA in humans [214]. Nevertheless, the phenotype is different in mice, as a 
homozygous deficiency of the B1 subunit of the V-ATPase (Atp6v1b1) leads to 
incomplete dRTA [215]. Briefly, under standardized laboratory conditions and feeding 
with normal rodent chow B1 KO mice did not show a detectable renal acid-base 
disturbance. Consistently an increased abundance of the alternative B subunit (B2) of 
V-ATPase was detected, which might partially compensate for B1 deficiency. Anyhow, 
after an oral acid load these animals develop systemic acidosis, due to an insufficient 
urinary acidification. It seems reasonable, that the strong alkali load provided by the 
standard rodent chow, might help to compensate insufficient urinary acidification 
under basal conditions [215]. 
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7.1.2 Rhcg deficient mice 
 Distal urinary acidification is a complex process, involving the coordinated 
secretion of protons by luminal V-ATPase and the recovery of bicarbonate to the 
blood by basolateral Cl-/HCO3
- exchanger. As already discussed, this process is 
limited and thus additional alternate acid extrusion pathways like titratable acids and 
essentially ammonium are required. Recently, the rhesus glycoprotein Rhcg was 
identified as an ammonia transporter in mice, rats and humans [109]. Similar to 
murine B1 deficiency, mice lacking Rhcg display incomplete dRTA, as unravelled by 
oral acid load test [114]. Again, animals under basal conditions were raised with 
standard rodent chow, implicating large alkali loads that may compensate for renal 
insufficiency. Two independently generated Rhcg KO mice are available (Marini AM, 
Bruxelles [114] and TIGM, USA (Bourgeois, Bounoure, Christensen, Devuyst, Wagner, 
unpublished data)). However, both mouse models develop incomplete dRTA with 
minor differences under basal conditions. 
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7.2 Induced chronic metabolic acidosis model 
 As reported above, B1 and Rhcg deficient mice are prone to develop dRTA 
under forced acid-base disturbances. However, Ae1 KO mice and patients with 
dominant mutations of kAE1 suffer chronically from complete dRTA. Experimentally 
induced acute and particularly chronic acid-base disturbances in rodents were 
observed to alter the renal CD morphology (chapter 5.2, 5.2.1 5.2.2). Thus, the 
observed dysregulation of CD cell markers in Ae1 deficient subjects might be a result 
from the chronic acid-base disturbance or from the loss of Ae1 protein in the kidney. 
The oral application of NH4Cl to the food or drinking water of rodents is a common 
experimental approach to induce metabolic acidosis [155, 216, 217]. Even though a 
more than 7 days lasting treatment with NH4Cl is already considered a chronic acid-
base disturbance and sufficient to cause adaptive responses in renal CD morphology, 
the period of time does not compare with the lifelong deteriorating dRTA in Ae1 
deficient subjects. Furthermore, an altered differentiation of CD markers was initially 
observed in adult (P84) Ae1 KO mice. Therefore, metabolic acidosis in C57/Bl6 
wildtype mice was induced for a total of 8 weeks, starting right away after weaning at 
3 to 4 weeks of life. Based on recent studies, the supplementation of equivalent 
amounts of NH4Cl to the food was favoured over the addition of 0.28M NH4Cl to the 
drinking water to avoid unwanted side effects by chronic dehydration of the animals 
[218, 219].  
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8. AIM OF THE STUDY 
 Similar to humans, Ae1 deficiency in mice is correlated with the development 
of complete dRTA and nephrocalcinosis, as well as dysmorphology and 
malfunctionality of erythrocytes [190, 200, 220]. Furthermore, a severe urinary 
concentrating defect associated with dysregulated renal expression and localization 
of the water channel Aqp2 was observed in Ae1 deficient mice [190]. Additionally, 
unpublished observations indicated an abnormal distribution of intercalated cell 
marker proteins within the renal CD system of Ae1 deficient mice. Moreover, in renal 
biopsies of patients carrying dRTA associated AE1 mutations (AE1R589H and 
AE1S613F) aberrancies of V-ATPase expressing cells in the renal CDs have been 
reported [138, 208]. 
Therefore, the major aim was to examine the role of Ae1 in collecting duct cell 
differentiation by addressing the following subaims: 
1) Characterization and quantification of possible abnormal expression pattern of 
renal IC marker by immunofluorescence (IF) in Ae1 deficient mice at different 
developmental and mature time points of life. 
2) Investigation of a possible impact of acid-base disturbance on IC 
differentiation, by comparing the abnormal IC marker expression in Ae1 
deficient mice with expression profiles in distinct mouse models for 
incomplete dRTA and chronically induced metabolic acidosis (chapter 5.2.1). 
3) Immunologic comparison of IC marker expression in Ae1 deficient mice and 
patients carrying AE1 mutations associated with dRTA. 
4) Investigation of the possible impact of candidate molecules (transcription 
factors, signalling molecules, receptors), which have been reported to play a 
role in IC development and differentiation (chapter 2.7 to 2.7.6, 5.2.2), on the 
abnormal IC differentiation observed in Ae1 deficient mice, by IF, qRT-PCR and 
immunoblot. 
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9. MATERIAL AND METHODS 
9.1 Animal experiments 
 Animal experiments were performed in the ZIHP (Zurich Center for Integrative 
Human Physiology) Core facility for Rodent physiology (ZIRP) according to the rules 
and guidelines of the Swiss animal welfare law and approved by the Veterinäramt 
Kanton Zürich, Switzerland. 
 Ae1 deficient mice were obtained from Luanne Petersen and Seth Alper, 
Boston, Massachusetts, USA [220]. B1 deficient mice were obtained from Richard P. 
Lifton, New Haven, Connecticut, USA [215]. Rhcg deficient mice were obtained from 
TIGM (Texas A&M Institute for Genomic Medicine). All transgenic strains were bred in 
heterozygous pairs in the in-house animal facility of the University of Zurich.  
 Where appropriate, time of gestation was assessed by monitoring vaginal 
mating plugs. Adult mice or embryos and pups were euthanized by cervical 
dislocation or decapitation for organ collection. Both kidneys were subsequently 
removed, freed from the renal capsule, cut into halves, snap frozen in liquid nitrogen 
(N2) and stored at -80°C until further analysis. 
 C57/Bl6 male mice were obtained from Institute of Veterinary Sciences, 
Fuellinsdorf, Switzerland at the age of 3 to 4 weeks and exposed to an oral acid load 
for 8 weeks to induce chronic metabolic acidosis. The animals were housed in normal 
cages with tab water ad libitum and fed standard rodent powder chow (GLP 3433, 
Kliba Nafag, Switzerland). Supplementation of 2 g NH4Cl/100 g powdered food 
(equivalent to 0.28 M NH4Cl in the drinking water) for 8 weeks was given to induce 
chronic metabolic acidosis [170, 219]. The bodyweight of all animals was assessed 
weekly and the health status (indicated by the appearance of the fur and activity) was 
determined at least every 2 days. At the end of the experimental period, the animals 
were placed in metabolic cages (Tecniplast, Italy). The mice were allowed to adapt to 
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the new environment for 3 days before assessing metabolic parameters and 
collection of 24 hours urine samples under mineral oil for another 2 days. 
Finally, mice were anesthetized with 1.5% Isoflurane/pressurized air and 500 l 
venous blood was taken with a heparinised syringe from the V. cava caudalis for 
subsequent blood gas analysis (ABL505, Radiometer, Copenhagen). The remaining 
blood was centrifuged at 5,000 rpm (4°C) for 5 minutes and the obtained plasma was 
snap frozen in liquid N2 for further analysis. Finishing blood sampling, 5 animals per 
group were perfused with phosphate buffered saline (PBS, pH 7.4) through the left 
ventricle to allow wash-out of residual blood. Both kidneys were subsequently 
removed, freed from the capsule, cut into halves and snap frozen in liquid N2 for 
further analysis. Another 5 animals per group were processed for organ fixation as 
described in 9.2.  
 
9.2 Fixation and cryopreservation of whole organs 
 Adult and juvenile mice were anesthetized with 1.5 % Isoflurane/pressurized air 
and perfused through the left ventricle with 10 ml preperfusate consisting of 10,000 
IU Heparin-Na Solution (BBraun), 2 ml Rapidocain 1 % (Ratiopharm), 2 ml CaCl2 16 %, 
2 ml 0.9 % NaCl and 2 ml Aqua destillata. Subsequently, the animal was perfusion 
fixed with 3 % Paraformaldehyde (PFA) in 0.1 M Na-cacodylate buffer. After 5 minutes 
the kidneys were removed and postfixed for an additional hour on ice in the above 
fixative solution. Embryos and pups were euthanized by decapitation and kidneys 
were subsequently removed and immersion fixed in 3 % PFA/0.1 M Na-cacodylate 
buffer for 1 hour at 4°C. Following fixation, the kidneys were stored at 4°C in 1% 
PFA/0.1 M Na-cacodylate buffer. Cryoprotection was assured by immersion in 30% 
Sucrose/PBS. The kidneys were then embedded in Tissue-Tek Cryomolds (VVR) and 
Neg-50 frozen section medium (Richard-Allan Scientifics) with liquid propane and 
stored at -80°C.  
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9.3 Immunofluorescence 
 Paraffin embedded human kidney biopsy sections (kind gifts of Robert Unwin, 
University College London, UK and Seth Alper, Beth Israel Deaconess Medical Center, 
Boston, MA) were dewaxed in a series of 2 x 10 min 100 % Xylol, 3 x 3 min 100 % 
ethanol (EtOH),  3 x 3 min 96 % EtOH, and 1 x 30 min 75 % EtOH before rehydration 
in PBS. Cryopreserved mouse kidneys were cut into 3-5 m thin slices (Cryostat 
CM1850, Leica) and rehydrated in PBS for at least 60 minutes. Different antigen 
retrievals were carried out, where necessary. Paraffinized tissue sections were treated 
by microwaving for 4 minutes in 10 mM citric acid pH 6.0 and 1 % sodium dodecyl 
sulfate (SDS) in PBS for 5 minutes. Cryopreserved tissue sections were either treated 
with 1 % SDS/PBS for 5 minutes, 0.3 % Triton X/PBS for 15 minutes or by 
microwaving. Following antigen retrieval, the sections were washed in PBS for 3 x 5 
minutes. Unspecific binding of antibodies was impeded by 15 minutes incubation 
with 1 % bovine serum albumin (BSA) in PBS. Antibodies were diluted in 0.02 % Na-
azide/PBS and stored at 4°C. Primary antibodies were incubated for overnight at 4°C 
in a moist chamber followed by two washes with hypertonic PBS (18 g/l NaCl/PBS) 
and 1 x wash with PBS. Secondary antibodies containing 4',6-diamidino-2-
phenylindole (DAPI) were incubated in the dark for 120 minutes at room temperature 
(RT) in a moist chamber followed by previously described washing-steps. The stained 
sections were finally embedded with Glycergel (DakoCytomation) and kept at 4°C in 
the dark until microscopic analysis. Photomicrographs were taken using an upright 
DM 5500 fluorescence microscope with AF 6000 System (Leica) including the 
objectives HC PL FLUOTAR 10.0x0.30 DRY, HCX PL APO 40.0X1.25 OIL and HCX PL 
FUOTAR 100.0X1.30 OIL. Fluorescent specimens were pictured using a DFC 360 FX 
monochrome camera (Leica) and chromogenic specimens were pictured by bright-
field microscopy using the digital colour camera DFC 295 (Leica). Images were further 
analyzed and processed using the LAS AF Lite Software (Leica), Corel PHOTO-PAINT 
X5 and the open-source software Image J (National Institute of Health). 
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The following combinations of primary antibodies detecting different marker proteins 
were used in distinct colocalization studies to distinguish principal cells, variations of 
ICs, type A-ICs and type B-ICs (Tab. 9.1). 
 
Tab. 9.1 Marker combinations in immunofluorescent colocalization studies 
Species: Mouse 
1) Aqp2 Pds Calb1 
2) Aqp2 Ae1 Calb1 
3) Aqp2 a4 Calb1 
4) Aqp2 B1 Calb1 
5) Aqp2 CaII Calb1 
 
Species: Human 
1) AQP2 PDS AE1 
2) AQP2 PDS a4 
3) AQP2 PDS B1 
4) AQP2 PDS CAII 
 
9.5 Quantification of cells 
 Immunofluorescently labelled cells from at least one kidney cross section per 
animal and each set of antibody combination was counted (Tab. 9.1). Principal cells 
were identified by luminal aquaporin 2 expression. Intercalated cells were either 
labelled for the a4 or B1 subunit of the V-ATPase. Type B-ICs were identified by the 
apical presence of Pds and type A-ICs by the basolateral presence of Ae1, where 
appropriate. The cellular affiliation to distinct renal tubule segments was taken into 
account. The renal CNT, CCD, OMCD and IMCD were primarily distinguished based 
on morphologic criteria. Immunologic presence of cytosolic calbindin D28K (Calb1) 
was further used to discriminate between the CNT and CCD segment [21]. 
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Tab. 9.2 List of Antibodies (AB) used for immunofluorescence 
1° AB Antigen/Catalog No. 
dilution 
(mouse) 
dilution 
(human) 
Source 
rabbit-anti-mouse Ae1 
DCFIYEDQIRPQDREELLRA
LLLK 
1:1,000 1:500 
Own 
(Pineda) 
guinea pig-anti-mouse Ae1 
DCFIYEDQIRPQDREELLRA
LLLK 
1:500 
 
Own 
(Pineda) 
rabbit-anti-mouse Pendrin 
CKDPLDLMEAEMNAEELD
VQDEAMRRLAS 
1:1,000 
 
Own 
 (Pineda) 
guinea pig-anti-mouse Pendrin 
CKDPLDLMEAEMNAEELD
VQDEAMRRLAS 
1:1,000 1:250 
Own 
 (Pineda) 
rabbit-anti-a4 CKFSPFSFKHILDGTAEE 1:1,500 1:500 
Own 
(Pineda) 
rabbit-anti-B1 CAQQDPASDTAL 1:1,000 1:250 
Own 
(Pineda) 
guinea pig-anti-B1 CAQQDPASDTAL 1:500 
 
Own 
(Pineda) 
rabbit-anti-CaII AB1828 1:1,500 1:500 
Chemicon 
Int. 
goat-anti-Aqp2 sc9882 1:2,000 1:200 Santa Cruz 
mouse-anti-Calbindin D28K McAB 300 1:20,000 
 
Swant 
goat-anti-Foxi1 TSGVLYPREGTEV 1:200 
 
abcam 
rabbit-anti-Cp2l1 
MLFWHTQPEHYNQHNSG
SC 
1:1,500 
 
[90] 
     
2° AB Antigen/Catalog No. 
dilution 
(mouse) 
dilution 
(human) 
Source 
donkey-anti-goat IgG  
Alexa 647 
A21447 1:1,000 1:500 Invitrogen 
donkey-anti-goat IgG  
Alexa 488 
A11055 1:1,000 
 
Invitrogen 
donkey-anti-rabbit IgG Alexa488 A21206 1:1,000 1:1,000 Invitrogen 
donkey-anti-rabbit IgG Alexa594 A21207 1:1,000 
 
Invitrogen 
donkey-anti-guinea pig IgG Cy2 706-226-148 1:500 
 
dianova 
donkey-anti-guinea pig IgG Cy3 706-165-148 1:500 1:500 dianova 
donkey-anti-guinea pig IgG 
Dylight 649 
706-496-148 1:500 
 
Jackson 
Immuno 
Lab 
donkey-anti-mouse IgG  
Dylight 649 
715-496-151 1:500 
 
Jackson 
Immuno 
Lab 
donkey-anti-mouse IgG Alexa594 A21203 1:1,000 
 
Invitrogen 
donkey-anti-mouse IgG Alexa488 A21202 1:1,000 
 
Invitrogen 
4´,6-diamidino-2-phenylindole, 
dilactate (DAPI, dilactate) 
D3571 1:1,000 1:1,000 Invitrogen 
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9.6 RNA Isolation and qRT-PCR 
 Total RNA was isolated from half a kidney of adult mice (P30 and P84) using 
the RNEasy mini Kit (Qiagen). Total RNA from one kidney of mouse embryos (E18) or 
newborn mice (P3) was isolated using the RNEasy micro Kit (Qiagen). RNA isolation 
and on-column DNA digestion was performed according to the manufacturer`s 
protocols. Total RNA quantity was measured using a ND-1000 UV/Vis-
Spectrophotometer (NanoDrop Technologies). Reverse transcription of total RNA 
(300 ng) was carried out using the TaqMan Reverse Transcription Kit (Applied 
Biosystems). Quantitative real-time PCR (qRT-PCR) was performed with an ABI PRISM 
7700 sequence detection system (Applied Biosystems) using TaqMan Universal PCR 
Master Mix (Applied Biosystems). Specific primers for the genes of interest were 
designed using the online-tool Primer3 (http://frodo.wi.mit.edu/primer3/) and tested 
by conventional PCR to generate the expected amplification products. 
Oligonucleotide probes conjugated to the reporter dye FAM at the 5’ end and the 
quencher TAMRA at the 3’ end were obtained from Microsynth, Switzerland. The 
mRNA expression levels of genes of interest were firstly normalized to the expression 
levels of the housekeeping gene hypoxanthine-guanine-phosphoribosyltransferase 
(Hprt). Secondly, the normalized values were calculated in percentage and statistical 
analysis was performed, respectively. 
 
 
 
 
Reverse Transcription       Real Time RT-PCR
Step Temperature time Step Temperature time cycle
1 25°C 10 min 1 50°C 2 min
2 40°C 30 min 2 95°C 10 min
3 95°C 5 min 3 95°C 15 sec 40
4 4°C hold 4 60°C 1 min
5 4°C hold
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Tab. 9.3 List of primer and Taqman probes used for qRT-PCR 
Gene Accession No. forward primer 
Hprt NM_013556 5'- TTATCAGACTGAAGAGCTACTGTAATGATC -3' 
Aqp2 NM_009699 5'- TGGTGCTGTGCATCTTTGCCT -3' 
Slc4a1 (Ae1) NM_011403 5'- AGGACCTGGTGTTGCCAGAG -3' 
Slc26a4 (Pds) NM_011867 5'- GCCTTTGGGATAAGCAACGTC -3' 
Cp2l1 NM_023755 5'- ATGCTGTTCTGGCACACGCAGC -3' 
Foxi1 NM_023907 5'- AAGAAGGTGCCCCGAGATG -3' 
Klf4 NM_010637 5'- CTGCCAGACCAGATGCAGT -3' 
Bdkrb2 NM_009747 5'- ATGCCCTGCTCCTGGAAGCTACT -3' 
Gdf15 NM_011819 5'- AGAGGACTCGAACTCAGAACCAAG -3' 
Rhcg NM_019799 5'- GTTGGAGAAGAAGCGCAAGAA -3' 
Atp6v1b1 (B1) NM_134157 5'- AGGACAGTGTGCAGCGTCAAT -3' 
Hensin (Dmbt1) NM_007769.2 5'- GCTCTTTCACCTCAACATCCA -3' 
   
Gene Accession No. reverse primer 
Hprt NM_013556 5'- TTACCAGTGTCAATTATATCTTCAACAATC -3' 
Aqp2 NM_009699 5'- ACTTGCCAGTGACAACTGCTG -3' 
Slc4a1 (Ae1) NM_011403 5'- CGGTTATGCGCCATGGA -3' 
Slc26a4 (Pds) NM_011867 5'- CAACGATGGCAACATCACA -3' 
Cp2l1 NM_023755 5'- TCTCAGGAGATAGCTGCGGCTC -3' 
Foxi1 NM_023907 5'- TCTTCTCACAGTTAGGGTCCAGAGT -3' 
Klf4 NM_010637 5'- TGGTATAGGTTTTGCCACAGC -3' 
Bdkrb2 NM_009747 5'- AGATCTCGGCCACAGTGCAGCTG -3' 
Gdf15 NM_011819 5'- TTGACGCGGAGTAGCAGCTGGC -3' 
Rhcg NM_019799 5'- CGAAGACCATGGCGTGTACA -3' 
Atp6v1b1 (B1) NM_134157 5'- CCTGAACAATGGCCTTGGTC -3' 
Hensin (Dmbt1) NM_007769.2 5'- GCTGGCTTGCATGTGATTT -3' 
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Gene Accession No. oligonucleotide (Taqman probe) 
Hprt NM_013556 5'-TGAGAGATCATCTCCACCAATAACTTTTATGTCCC -3' 
Aqp2 NM_009699 5'- ACCTCCTTGGGATCTATTTCACCG -3' 
Slc4a1 (Ae1) NM_011403 5'- ACCTGAGGCTCCGCATGTCGACTATACC -3' 
Slc26a4 (Pds) NM_011867 5'- TGGATTTTTCTCCTGTTTTGTGGCTACCACT -3' 
Cp2l1 NM_023755 5'- TGGCAGCTACTTGCGTGATGTGCTGGC -3' 
Foxi1 NM_023907 5'- ACGACCCAGGCAAAGGGAATTACTG -3' 
Klf4 NM_010637 5'- TCTCTCCATTATCAAGAGCTCATGCCA -3' 
Bdkrb2 NM_009747 5'- GCCTCCTTTGGCATCGAAATGTTC -3' 
Gdf15 NM_011819 5'- TGTCCGGATACTCAGTCCAGAGGTGAGA -3' 
Rhcg NM_019799 5'- TTACTATCGCTACCCGAGCTTCCAG -3' 
Atp6v1b1 (B1) NM_134157 5'- CCCAGTATGCTGAGATTGTCAACTTTACCCTCC -3' 
Hensin (Dmbt1) NM_007769.2 5'- TGACAATAACACCACCAATCTCCCTTTGTGAGT -3' 
 
 
9.7 Protein Isolation 
 Crude membrane and cytosolic proteins were extracted from half a kidney of 
adult mice (P30 and P84). In detail, the organ was minced on ice and homogenized in 
200 l of ice cold resuspension buffer (200 mM Mannitol, 80 mM Hepes, 41 mM KOH, 
pH 7.5 supplemented with 1 tablet/10 ml Complete Mini Protease Inhibitor Cocktail, 
Roche) using a Polytron homogenizer (0.5 mm diameter at 20,000 rpm for 1 minute 
at 4°C). The homogenate was further sonicated on ice before centrifugation at 2,000 
rpm for 20 minutes at 4°C. The resulting supernatant was transferred into a prechilled 
tube and further centrifuged at 41,000 rpm for 1 hour at 4°C. After ultracentrifugation 
the supernatant (cytosolic proteins) was transferred into a fresh prechilled tube, while 
the pellet (crude membrane proteins) was resuspended in 50 l of ice cold 
resuspension buffer. Protein concentration was measured using the Bio-Rad DC 
Protein Assay according to manufacturer recommendations.  
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 In order to obtain total cell lysates, confluent cell monolayers, grown on 6 well 
plates (Nunclon Surface, nunc), were washed with ice-cold PBS (without Ca++, Mg++, 
Gibco) at 4°C and scraped into a prechilled 1.5 ml Eppendorf tube. The cell 
suspension was centrifuged at 2,000 rpm for 5 minutes at 4°C and the supernatant 
was removed. Subsequently, the densed cell pellet was lysed by addition of 50 l 
RIPA buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% 
NP-40, 1% Na-deoxycholate, supplemented with 1 x Protease inhibitor cocktail 
(Sigma) and 2 mM PMSF) and vigorous pipetting. The crude cell lysate was 
centrifuged at 10,000 rpm for 10 minutes at 4°C and the supernatant (total cell lysate) 
was transferred into a fresh tube. Protein concentration was measured using the Bio-
Rad Protein Assay following manufacturer recommendations. 
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9.8 Nuclear protein extraction 
 
Buffer A (hypotonic lysis buffer) 
10 mM Tris-Cl, pH 8.0 
150 mM NaCl 
10 mM MgCl2 
 
Homogenization buffer (HB) 
0.27 M Sucrose 
in 1x Buffer A 
2 mM EDTA, pH 8.0 
0.1 % NP-40 
1 mM PMSF 
0.5 mM DTT 
Protease Inhibitor Cocktail  
(1 tablet/10 ml, Sigma) 
 
Nuclear extraction buffer (NEB) 
10 mM Tris-Cl, pH 8.0 
1 mM EDTA, pH 8.0 
400 mM NaCl 
1 mM DTT 
1 mM PMSF 
 
Sucrose Cushion (SC) 
30 % w/v Sucrose 
 
in 1x Buffer A 
2 mM EDTA, pH 8.0 
 
 Nuclear proteins were extracted from half a kidney of adult mice (P30 and 
P84). The tissue was minced and subsequently homogenized on ice in 2 ml of ice cold 
homogenization buffer (HB) using a Polytron homogenizer (0.5 mm diameter at 
20,000 rpm) for 1 minute. Prior to homogenization, a 3 ml layer of sucrose cushion 
(SC) was prepared in a 15 ml Sarstedt tube on ice. The homogenate was smoothly 
transferred to the 15 ml tube overlaying the SC and centrifuged at 2,000 rpm for 15 
minutes at 4°C. Subsequently, the supernatant was removed and the densed pellet of 
nuclei was washed with ice cold PBS and centrifuged again. Following removal of PBS, 
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the pelleted nuclei were resuspended in 1 volume of ice cold nuclear extraction buffer 
(NEB) transferred to a prechilled tube and incubated for 15 minutes on ice while 
vortexing every 5 minutes. Afterwards the samples were centrifuged at 13,200 rpm at 
4°C for 15 minutes and the supernatant (nuclear extracts) was transferred into a fresh 
prechilled tube. Protein concentration was determined using the Bio-Rad Protein 
Assay according to manufacturer recommendations.  
 
9.9 Immunoblotting 
 For immunoblotting 20 g of crude membrane, or cytosolic protein extracts, or 
total cell lysate, or 5 g of nuclear protein extracts were solubilized in Laemmli buffer, 
seperated by SDS-PAGE and stained with Coomassie Blue or blotted on a PVDF 
membrane (Immobilon-P, Millipore). Washing steps were carried out using TBS-T (Tris 
buffered saline, 0.1 % Tween 20) and unspecific binding of the antibodies was 
impaired using 5 % non-fat dry milk/TBS-T. Antibodies were diluted according to Tab. 
9.4 in 1 % non-fat dry milk/TBS-T. Primary antibodies were incubated overnight at 
4°C, while secondary antibodies were incubated for 2 hours at RT. Immunoreactive 
signals were detected by chemiluminescence (Immobilon Western Substrates, 
Millipore) using a DIANA III-chemiluminescence detection system (Raytest). 
Densitometry of the respective signals was quantified using the AIDA software 
(Advanced Image Data Analyzer, Raytest) and normalized to β-actin intensity or 
Coomassie Blue staining as indicated.  
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Tab. 9.4 List of Antibodies (AB) used for immunoblotting 
1° AB Antigen/Catalog No. dilution Source 
guinea pig-anti-Ae1 DCFIYEDQIRPQDREELLRALLLK 1:500 
Own 
(Pineda) 
rabbit-anti-pendrin CKDPLDLMEAEMNAEELDVQDEAMRRLAS 1:1,000 
Own 
(Pineda) 
rabbit-anti-B1 CAQQDPASDTAL 1:1,000 
Own 
(Pineda) 
rabbit-anti-AQP2 AQP2 C-term 1:3,000 Loffing, J. 
goat-anti-Foxi1 TSGVLYPREGTEV 1:250 abcam 
goat-anti-Gdf15 sc46248 1:1,500 Santa Cruz 
mouse-anti-β actin A5441 1:10,000 Sigma 
 
2° AB Antigen/Catalog No. dilution Source 
anti-rabbit IgG, AP S3731 1:5,000 Promega 
anti-rabbit IgG, HRP NA9341 1:10,000 Amersham 
anti-guinea pig IgG, AP A5062 1:5,000 Sigma 
anti-mouse IgG, AP S3721 1:5,000 Promega 
anti-mouse IgG, HRP NA931 1:10,000 Amersham 
donkey-anti-goat IgG, AP V1151 1:5,000 Promega 
 
 
9.10 Blood and Urine Analysis 
 Blood pH, blood gas (pCO2, pO2), and blood electrolyte concentrations (Na
+, 
K+, Cl-, Ca++) were analyzed using an ABL 505 blood gas analysator (Radiometer, 
Kopenhagen) and  performed on heparinised venous blood as described earlier 
(chapter 9.1). Creatinine in urine was measured according to Jaffe`s method [221]. 
Urinary ammonium was measured following Berthelot`s protocol [222]. Plasma and 
urinary Urea levels were measured using diacetyl monoxime [223] and inorganic 
phosphate was determined using acid ammonium molybdate [224]. The urinary 
electrolytes were normalized to urinary creatinine and represented as mean ± SEM 
(standard error of the mean).  
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9.11 Cell culture and transient transfection 
 Hek293T cells (P8-10) were grown on 75 cm2 flask (Greiner) in complete 
growth medium (DMEM with L-Glutamine (PAA), supplemented with 1 mM L-
Glutamine (Lonza), 1 mM NEAA (Non-Essential-Amino-Acids (Lonza), and 10% FCS 
(fetal calf serum, Gibco)) at 37°C with 5% CO2 atmosphere. Cells were passaged when 
they reached 80% confluency and split in a 1:15 ratio for general maintenance. Prior 
to trypsinization with 0.1 mM Trypsin-EDTA (Sigma), the monolayer was washed twice 
with prewarmed PBS (without Ca++, Mg++, Gibco). Trypsinization was stopped by 
addition of complete growth medium and cell suspension was centrifuged at 1,000 
rpm for 1 minute. The supernatant was removed and the cell pellet was gently 
resuspended in complete growth medium. Transient transfections were carried out 
using Lipofectamine 2000 (Invitrogen) following manufacturer recommendations. 
Briefly, 26 cells/well were seeded on Poly-L-Lysine (Sigma) coated (15 minutes at RT) 6 
well plates (Greiner) in complete growth medium. After 24 hours the growth medium 
was replaced by serum-free reduced medium (Opti-Mem, Gibco) and cells were 
transfected with 1 g Foxi1 plasmid DNA (ImaGenes  IRAVp968C0115D, Acc.No. 
BC007475). In case of untransfected cells, the plasmid DNA was replaced by 
equivalent amounts of sterile distilled water. Cells were harvested 48 hours after 
transfection and total cell lysates were prepared as described in chapter 9.7. Plasmid 
DNA was purified from a liquid bacteria culture using the Fast Plasmid Kit 
(Eppendorf).  
 
9.12 Statistical Analysis 
 All data are presented as mean ± SEM (standard error of the mean). Statistical 
Analysis was performed with GraphPad Prism Software 5.0 and the unpaired t-test or 
one way ANOVA with Tukey post-test were done where appropriate. Only results with 
p≤0.05 were considered statistically significant. 
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10. RESULTS 
 As already mentioned, a urinary concentrating defect correlating with Aqp2 
dysregulation was observed in adult Ae1 deficient mice, in addition to erythroidal 
defects and severe dRTA [190]. Furthermore, preliminary unpublished observations 
indicated the abnormal expression of renal IC marker proteins involved in acid-base 
homeostasis. Therefore, colocalization studies using specific antibodies targeting the 
a4 and B1 subunits of the V-ATPase, Pds, Ae1, CaII and Aqp2 were performed. As 
described earlier, carbonic anhydrase II is strongly expressed in renal ICs and 
therefore commonly used as a general marker [41, 42]. However, in the present study 
a strong CaII expression was additionally found in Aqp2 positive cells of the CNT and 
early CCD in kidneys of murine and human origin (data not shown). Hence, CaII did 
not proof a specific marker for renal ICs in general and these data will not be further 
considered. Therefore, as shown in Fig. 2.6 renal principal cells were identified by the 
presence of Aqp2 (Aqp2+), while V-ATPase (B1+, a4+, V-ATPase+) labelling identified 
types of intercalated cells in general. Furthermore, Ae1 (Ae1+) expression specified 
type A-ICs, where appropriate, while Pds (Pds+) labelling determined type B-ICs. The 
number of cells positive or negative for either marker was assessed and statistically 
analyzed with respect to the segmental distribution. Within the CD system four 
different segments (CNT, CCD, OMCD and IMCD) were primarily distinguished based 
on morphologic criteria. Moreover, simultaneous immunologic localization of the 
Calcium binding protein Calbindin D28K (Calb1) helped to discriminate between the 
CNT and CCD segments. No further information was gathered by Calb1 staining and 
therefore these data will not be presented.  
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10.1 Intercalated cells of the mature Ae1 deficient mouse kidney are 
abnormally differentiated 
 Investigation of the mature kidney of juvenile (P30) and adult (P84) Ae1 
deficient mice revealed unusual expression of pendrin in inner medullary collecting 
ducts. Moreover, mRNA expression levels as well as protein abundance and 
expression pattern of candidate regulatory molecules involved in terminal 
differentiation of the renal collecting duct were found to be abnormally regulated in 
kidneys of P30 and P84 Ae1 KO mice. However, kidney development and maturation 
seemed unaffected in Ae1 deficient animals. 
 
10.1.1 Pendrin is abnormally expressed in the inner medulla of adult Ae1 
deficient mouse kidney 
 In the healthy adult kidney, pendrin expression identifies type B-ICs and is 
usually restricted to the renal cortex, (Fig. 10.1). In contrast to wild-type (WT), Pds 
expression was still present in the renal inner medulla of adult (P84, postnatal day 84) 
Ae1 knock-out (KO) mice (Fig. 10.2). Moreover, Pds in the inner medulla was 
unusually coexpressed with the PC marker Aqp2. Interestingly, Pds expression in the 
renal cortex (CNT and CCD) of adult Ae1 KO mice appeared normal, indicating a 
cortical preservation of the type B-IC phenotype. Nevertheless, quantification of 
individually labelled cells revealed an altered cellular distribution in distinct renal 
segments of Ae1 KO mice compared to WT (Fig. 10.3). The marker combination used 
in this colocalization study distinguishes only between principal cells (Aqp2+) and 
type B-ICs (Pds+), thus other variations of ICs are represented in the population of 
unlabelled (none) cells. Consistent with the chronic dRTA, the relative number of Pds+ 
cells is significantly reduced in the CNT and CCD of Ae1 KO mice with a concomitant 
increase in Aqp2+ cells (Fig. 10.3A, B). Furthermore, unusually Aqp2+/Pds+ colabelled 
cells were detected in the renal OMCD (Fig. 10.3C), probably at the expense of 
unlabelled (none) cells. Moreover, the relative abundance of both, Pds+ and 
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Aqp2+/Pds+ cells respectively, is significantly increased in IMCDs of Ae1 deficient 
mice, with a simultaneous reduction of unlabeled cells (Fig. 10.3D). 
 
 
Fig. 10.1 Immunologic localization of Pds in adult (P84) Ae1
+/+
 mouse kidney. A-C) 
Representative photomicrographs from renal cortex (CCD). D-F) Representative photomicrographs 
from renal inner medulla (IMCD). A, D) Individual Aqp2 (aquaporin 2) expression in renal CCD and 
IMCD identifies principal cells. B) In the CCD, Pds (pendrin) localizes to the luminal membrane of Aqp2 
negative cells, identifying B-ICs. E) In adult WT mouse kidney, Pds is absent from the inner medulla. C, 
F) merge. Magnification 400x. 
 
Aqp2 Pds merge
Ae1 +/+ Ae1 +/+ Ae1 +/+A B C
D E F
Aqp2 Pds merge
Ae1 +/+ Ae1 +/+ Ae1 +/+
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Fig. 10.2 Immunologic localization of Aqp2 and Pds in adult (P84) Ae1
-/-
 mouse kidney. A-C) 
Representative photomicrographs from renal cortex (CCD). D-F) Representative photomicrographs 
from renal inner medulla (IMCD). A, D) Individual Aqp2 (aquaporin 2) expression in renal CCD and 
IMCD identifies principal cells. B) In the CCD, Pds (pendrin) localizes to the luminal membrane of Aqp2 
negative cells, identifying B-ICs. C) merge. E) In adult Ae1 deficient mouse kidney, Pds expression is 
occasionally still present on the luminal membrane of IMCD cells and even coexpressed with luminal 
Aqp2 expression (F, arrowheads). Magnification 400x. 
 
Aqp2 Pds merge
Ae1 -/- Ae1 -/- Ae1 -/-A B C
D E F
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Ae1 -/- Ae1 -/- Ae1 -/-
<
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Fig. 10.3 Relative distribution of Aqp2 and Pds in adult (P84) WT and Ae1 KO mouse kidney. A-
D) Summary of cell counts assessing the relative abundance of Aqp2 (aquaporin 2) and Pds (pendrin) 
positive cells in the renal CNT, CCD, OMCD and IMCD of adult (P84) Ae1 WT and KO mice. In total, 
9,676 cells were counted in WT kidneys (n=7) and 5,533 cells in KO kidneys (n=4). Statistical analysis 
using Student`s t-test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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10.1.2 Intercalated cells in the mature kidney of juvenile (P30) Ae1 deficient 
mice are abnormally differentiated 
 Similar to adult (P84) Ae1 deficient mice, an unusual presence of Pds in 
cells of the mature inner medulla was observed in juvenile (P30) Ae1 KO mouse 
kidneys (Fig. 10.4 to 10.7).  Consistently, renal medullary Pds expression was still 
present in Ae1 KO kidneys and in addition unusually coexpressed with Aqp2 in the 
IMCD (Fig. 10.6C, 10.7F, 10.8C, D). However, the relative distribution of labelled cells 
within the renal distal tubule was slightly different in P30 compared to P84 Ae1 KO 
kidney, possibly reflecting the impact of prolonged dRTA. In detail, Aqp2+ cells were 
less abundant in the renal CNT of P30 WT and Ae1 KO mice compared to P84 CNT, 
while unlabelled cells were more abundant (Fig. 10.8A). Interestingly, the relative 
abundance of Pds+ cells in the renal CNT was comparable at both ages. Furthermore 
and in contrast to P84 kidneys, there was no difference in the relative abundance of 
Aqp2+, Pds+ or unlabelled cells in the CNT of P30 Ae1 WT and KO kidneys. Moreover, 
Pds+ cells in the renal CCD of P30 Ae1 KO mice were increased compared to P30 WT, 
while the relative abundance of unlabelled cells was reduced and Aqp2+ cells were 
not altered (Fig. 10.8B). In contrast, Pds+ cells in the renal CCD of P84 Ae1 KO animals 
were significantly reduced, while unlabelled cells were not altered and Aqp2+ cells 
were increased compared to P84 WT kidneys (Fig. 10.3B). Similar to the renal CCD of 
P30 animals, the relative abundance of Pds+ cells in P30 Ae1 KO OMCD was increased 
when compared to P30 WT OMCD and the relative numbers of unlabelled cells were 
decreased (Fig. 10.8C). In contrast, OMCDs of P84 Ae1 KO mice displayed unusual 
presence of Aqp2+/Pds+ cells compared to P84 WT, probably on the expense of 
unlabelled cells (Fig. 10.3C). Finally, in the renal IMCD of P30 Ae1 KO increased 
abundances of Pds+ and Aqp2+/Pds+ cells were found compared to P30 WT, with an 
adequate reduction of Aqp2+ cells (Fig. 10.8D). Likewise, Pds+ and Aqp2+/Pds+ cells 
were increased in Ae1 KO IMCD of P84 mice compared to WT IMCD, but here the 
relative number of Aqp2+ was not altered (Fig. 10.3D). The inappropriate increases in 
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Pds+ and Aqp2+/Pds+ cells might rather be explained by the modestly reduced 
presence of unlabelled cells in P84 Ae1 KO kidneys compared to WT. 
 
 
Fig. 10.4 Zonal distribution of Aqp2 and Pds expressing cells in kidney of juvenile (P30) Ae1 
+/+
 
mouse. A) Aqp 2 (aquaporin 2) is expressed along cortical and medullary collecting ducts. B) Pds 
(pendrin) expression is restricted to the renal cortex in mature kidney. C) merge, blue dashed line 
indicating cortico-medullary boundary, orange dashed line indicating medullary-papillary boundary. 
Magnification 400x, Tile Scan. 
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Fig. 10.5 Zonal distribution of Aqp2 and Pds expressing cells in kidney of juvenile (P30) Ae1 
+/+
 
mouse. Aqp2 (aquaporin 2) is expressed along cortical (A) and medullary (D) collecting ducts. Pds 
(pendrin) expressing cells are frequently present in the renal cortex (B) and absent from the medullary 
collecting ducts (E). C, F) merge. Nucleic acid stained with DAPI (blue). § Pds positive cell; # Aqp2 
positive cell; * Aqp2/Pds negative cell. Magnification 400x. 
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Fig. 10.6 Zonal distribution of Aqp2 and Pds expressing cells in kidney of juvenile (P30) Ae1 
-/-
 
mouse. A) Aqp 2 (aquaporin 2) is expressed along cortical and medullary collecting ducts. B) Pds 
(pendrin) expression is present in the cortex and inner medulla of the mature kidney. C) merge, blue 
dashed line indicating cortico-medullary boundary, orange dashed line indicating medullary-papillary 
boundary. Magnification 400x, Tile Scan.
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Fig. 10.7 Zonal distribution of Aqp2 and Pds expressing cells in kidney of juvenile (P30) Ae1 
-/-
 
mouse. Aqp2 (aquaporin 2) is expressed along cortical (A) and medullary (D) collecting ducts. Pds 
(pendrin) expressing cells are frequently present in the cortical (B) and medullary collecting ducts (E). 
C, F) merge. Nucleic acid stained with DAPI (blue). § Pds positive cell; # Aqp2 positive cell; arrowhead: 
Aqp2/Pds positive cell. Magnification 400x. 
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Fig. 10.8 Relative distribution of Aqp2 and Pds expressing cells in kidneys of juvenile (P30) Ae1 
WT and KO mice. Summary of cell counts assessing the relative abundance of Aqp2 (aquaporin 2) and 
Pds (pendrin) positive cells in the renal CNT, CCD, OMCD and IMCD of juvenile (P30) Ae1 WT and KO 
mice. In total, 5,214 cells were counted in WT kidneys (n=5) and 5,335 cells in KO kidneys (n=5). 
Statistical analysis using Student`s t-test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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 In order to investigate the distribution and appearance of Pds negative ICs of 
P30 Ae1 KO kidneys, co-immunostainings using the a4 and B1 subunits of the V-
ATPase, indicating the presence of manifestations of ICs other than type B-ICs, were 
performed and quantified (Fig. 10.9 and 10.10). No significant differences in the 
relative abundance and distribution of the kidney-specific a4 subunit of V-ATPase 
(a4+) cells were found in P30 Ae1 KO kidneys compared to WT (Fig. 10.9). However, 
co-staining of Aqp2 and the IC-specific B1 subunit of V-ATPase gave another 
impression. Here, renal inner medullary collecting ducts of P30 Ae1 KO mice showed 
a significant increased abundance for Aqp2+/B1+ cells with a concomitant reduction 
in Aqp2+ cells compared to WT (Fig. 10.10D). Although alterations of B1+ cell 
expression in the other segments did not reach significant difference, a similar trend 
was observed. In the renal CNT of P30 Ae1 KO mice a modest increase in Aqp2+/B1+ 
cells (p-value 0.0590) and reduction in unlabelled cells became apparent, while the 
increase in Aqp2+/B1+ cells of the CCD (p-value 0.0621) and OMCD (p-value 0.0798) 
was accompanied by a reduction in Aqp2+ cells (Fig. 10.10A-C).  
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Fig. 10.9 Relative distribution of Aqp2 and a4 expressing cells in kidneys of juvenile (P30) Ae1 
WT and KO mice. Summary of cell counts assessing the relative abundance of Aqp2 (aquaporin 2) and 
a4 (a4 subunit of V-ATPase, Atp6v0a4) positive cells in the renal CNT, CCD, OMCD and IMCD of 
juvenile (P30) Ae1 WT and KO mice. In total, 4,930 cells were counted in WT kidneys (n=5) and 5,094 
cells in KO kidneys (n=5). Statistical analysis using Student`s t-test. * p ≤ 0.05, ** p ≤ 0.01,                  
*** p ≤ 0.001.  
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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Fig. 10.10 Relative distribution of Aqp2 and B1 subunit of V-ATPase (Atp6v1b1) expressing cells 
in kidneys of juvenile (P30) Ae1 WT and KO mice. Summary of cell counts assessing the relative 
abundance of Aqp2 (aquaporin 2) and B1 (B1 subunit of V-ATPase, Atp6v1b1) positive cells in the renal 
CNT, CCD, OMCD and IMCD of juvenile (P30) Ae1 WT and KO mice. In total, 5,619 cells were counted 
in WT kidneys (n=5) and 4,638 cells in KO kidneys (n=5). Statistical analysis using Student`s t-test.  
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.  
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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 As described in chapter 2.7, some molecules and transcription factors have 
been identified as critical in terminal differentiation of renal CD specific cells. Among 
them are the transcription factors Foxi1 and Cp2l1. Even though both transcription 
factors were localized in renal tubular structures a detailed localization concerning 
their putative presence in the CD epithelium is missing. Therefore, the expression 
patterns of both transcription factors were investigated in more detail and 
preliminary results were compared between Ae1 WT and KO.  
 The Foxi1 protein was occasionally detected in nuclei of CD cells in P30 WT 
mouse kidney. Co-labelling with the B1 subunit of V-ATPase (Fig. 10.11, 10.13) and 
Aqp2 (Fig. 10.14, 10.16) revealed predominant expression of Foxi1 in intercalated cells 
and less in principal cells of the CNT, CCD, OMCD and IMCD. Quantification of cell 
counts showed that the majority of Foxi1+ nuclei corresponded with B1+ cells (Fig. 
10.13, 10.16). Results obtained from cell counts suggest a relative equal distribution 
of Foxi1+/B1+ cells among the CNT (23.69%), CCD (26.33%) and OMCD (21.70%) 
segments of P30 WT mouse kidney with a similar trend in Ae1 KO animals (Fig. 10.13). 
However, in Ae1 WT kidney the relative abundance of Foxi1+/B1+ cells in the IMCD 
(15.19%) is significantly lower compared to CCD (26.33%, p-value <0.05), reflecting 
the expected reduced presence of ICs in the renal inner medulla compared to cortex. 
Similarly, in Ae1 WT kidney the presence of Foxi1+ cells in the staining series with 
Aqp2 (Fig. 10.16) declines significantly from CNT (24.08%), CCD (18.64%), OMCD 
(14.72%) to IMCD (8.19%), indicating again the expected reduction of ICs along the 
CD system towards the papilla. Anyhow, comparing the relative distribution of Foxi1 
expression in Ae1 WT and KO kidneys of P30 mice showed some small but significant 
differences. Individually labelled Foxi1+ cells in the staining series with the B1 subunit 
of V-ATPase were significantly increased in IMCDs of Ae1 KO kidneys when compared 
to WT (Fig. 10.13D). In addition, a simultaneous but statistically not significant 
increase in Foxi1+/Aqp2+ cells was observed in IMCDs of Ae1 KO kidneys (Fig. 
10.16D). Furthermore, individually Foxi1+ and unlabelled (none) cells were 
significantly reduced in the CCD of P30 Ae1 KO kidneys, while Aqp2+/Foxi1+ 
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coexpressing cells increased concomitantly (Fig. 10.16B). Hence, loss of Ae1 in kidneys 
of P30 mice alters the relative segmental distribution of Foxi1 in the CCD and OMCD, 
favouring its coexpression with the principal cell marker Aqp2. 
 
 
Fig. 10.11 Expression pattern of Foxi1 and B1 expressing cells in kidney of juvenile (P30) Ae1 
+/+
 
mouse. A-C, G) Renal cortex. D-F, H) Renal inner medulla. B1 (B1 subunit of V-ATPase, Atp6v1b1) 
expressing intercalated cells were frequently present in the renal cortical (A) and medullary (D) 
collecting ducts. Nuclear expression pattern of Foxi1 protein was detected in cortical (B) and medullary 
(E) tubular structures. Overlay reveals expression of Foxi1 in B1 positive and less frequently in B1 
negative cells along the renal collecting ducts (C, F, G, H). Nucleic acid stained with DAPI (blue). # B1 
negative/Foxi1 positive cell; arrowhead: B1/Foxi1 positive cell. A-F) Magnification 400x. G,H) 
Magnification 1,000x. 
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Fig. 10.12 Expression pattern of Foxi1 and B1 expressing cells in kidney of juvenile (P30) Ae1 
-/-
 
mouse. A-C, G) Renal cortex. D-F, H) Renal inner medulla. B1 (B1 subunit of V-ATPase, Atp6v1b1) 
expressing intercalated cells were frequently present in the renal cortical (A) and medullary (D) 
collecting ducts. Nuclear expression pattern of Foxi1 protein was detected in cortical (B) and medullary 
(E) tubular structures. Overlay reveals expression of Foxi1 in B1 positive and less frequently in B1 
negative cells along the renal collecting ducts (C, F, G, H). Nucleic acid stained with DAPI (blue). 
arrowhead: B1/Foxi1 positive cell. A-F) Magnification 400x. G,H) Magnification 1,000x. 
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Fig. 10.13 Relative distribution of Foxi1 and B1 subunit of V-ATPase (Atp6v1b1) expressing cells 
in kidneys of juvenile (P30) Ae1 WT and KO mice. Summary of cell counts assessing the relative 
abundance of Foxi1 and B1 (B1 subunit of V-ATPase, Atp6v1b1) positive cells in the renal CNT, CCD, 
OMCD and IMCD of juvenile (P30) Ae1 WT and KO mice. In total, 2,680 cells were counted in WT 
kidneys (n=4) and 3,489 cells in KO kidneys (n=5). Statistical analysis using Student`s t-test. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.001.  
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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Fig. 10.14 Expression pattern of Foxi1 and Aqp2 expressing cells in kidney of juvenile (P30)   
Ae1 
+/+
 mouse. A-C, G) Renal cortex. D-F, H) Renal inner medulla. Principal cells expressing luminal 
Aqp2 (aquaporin 2) in renal cortical (A) and medullary (D) collecting ducts. Nuclear expression pattern 
of Foxi1 protein was detected in cortical (B) and medullary (E) tubular structures. Overlay reveals 
predominant expression of Foxi1 in Aqp2 negative and less frequently in Aqp2 positive cells along the 
renal collecting ducts (C, F, G, H). Nucleic acid stained with DAPI (blue). # Aqp2 negative/Foxi1 
positive cell; arrowhead: Aqp2/Foxi1 positive cell. A-F) Magnification 400x. G, H) Magnification 1,000x. 
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Fig. 10.15 Expression pattern of Foxi1 and Aqp2 expressing cells in kidney of juvenile (P30)   
Ae1 
-/-
 mouse. A-C, G) Renal cortex. D-F, H) Renal inner medulla. Principal cells expressing luminal 
Aqp2 (aquaporin 2) in renal cortical (A) and medullary (D) collecting ducts. Nuclear expression pattern 
of Foxi1 protein was detected in cortical (B) and medullary (E) tubular structures. Overlay reveals 
predominant expression of Foxi1 in Aqp2 negative and less frequently in Aqp2 positive cells along the 
renal collecting ducts (C, F, G, H). Nucleic acid stained with DAPI (blue). #: Aqp2 negative/Foxi1 
positive cell. arrowhead: Aqp2/Foxi1 positive cell. A-F) Magnification 400x. G, H) Magnification 1,000x. 
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Fig. 10.16 Relative distribution of Foxi1 and Aqp2 expressing cells in kidneys of juvenile (P30) 
Ae1 WT and KO mice. Summary of cell counts assessing the relative abundance of Foxi1 and Aqp2 
(aquaporin 2) positive cells in the renal CNT, CCD, OMCD and IMCD of juvenile (P30) Ae1 WT and KO 
mice. In total, 4,403 cells were counted in WT kidneys (n=5) and 5,243 cells in KO kidneys (n=5). 
Statistical analysis using Student`s t-test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.  
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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 The expression of Cp2l1 was reported to change in accordance with the 
maturation of the developing nephron and CD system (Fig. 2.12) [90]. In adult mouse 
kidney, Cp2l1 expression was reported in parts of the DCT, CNT, CCD, and OMCD 
(Fig. 2.12). However, the cell types expressing Cp2l1 were not further characterized in 
this study [90]. In the present study, Cp2l1 expression was assessed in P30 kidneys 
and consistent with previous reports occassionally detected in cells of the DCT, CNT, 
CCD, and OMCD. Additionally, Cp2l1 was present in cells of the TAL and IMCD. In 
order to determine the cell type harbouring nucleic Cp2l1, coimmunostainings using 
the principal cell marker Aqp2 were performed. Interestingly, Cp2l1 was occasionally 
expressed in Aqp2 positive tubules of the renal cortex and medulla of P30 Ae1 WT 
(Fig. 10.17) and KO (Fig. 10.18). Moreover, Cp2l1 expression was detected in principal 
cells (Aqp2+) and manifestations of intercalated cells (Aqp2-) along the distal tubule. 
Strikingly, Cp2l1 was found to be present in virtually all nuclei of the IMCD in P30 WT 
kidneys (Fig. 10.17E, F, H), whereas the nuclear localization was completely absent in 
IMCDs of P30 Ae1 KO kidney (Fig. 10.18E, F, H). Moreover, instead of the expected 
nuclear pattern, the signal for Cp2l1 was now detected on the luminal cell membrane 
of certain cells, but not in all. However, detailed quantification using distinct CD 
markers are necessary to further analyze the expression pattern of Cp2l1. 
Furthermore, while analyzing the immunofluorescent images of Cp2l1, the relative 
signal intensity for Cp2l1, particularly in the renal cortex, appeared stronger in Ae1 
deficient kidneys compared to WT (Fig. 10.17B, 10.18B). However, at present 
immunoblotting of Cp2l1 to assess the relative protein abundance was not successful 
due to technical reasons. 
 
 
 
116 
 
 
Fig. 10.17 Expression pattern of Cp2l1 and Aqp2 expressing cells in kidney of juvenile (P30)   
Ae1 
+/+
 mouse. A-C, G) Renal cortex. D-F, H) Renal inner medulla. Principal cells expressing luminal 
Aqp2 (aquaporin 2) in renal cortical (A) and medullary (D) collecting ducts. Nuclear expression pattern 
of Cp2l1 protein was detected in cortical (B) and predominantly medullary (E) tubular structures. 
Overlay reveals expression of Cp2l1 in Aqp2 positive and negative cells along the renal collecting ducts 
(C, F, G, H). Nucleic acid stained with DAPI (blue). # Aqp2 negative/Cp2l1 positive cell; arrowhead: 
Aqp2/Cp2l1 positive cell. A-F) Magnification 400x. G, H) Magnification 1,000x. 
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Fig. 10.18 Expression pattern of Cp2l1 and Aqp2 expressing cells in kidney of juvenile (P30)   
Ae1 
-/-
 mouse. A-C, G) Renal cortex. D-F, H) Renal inner medulla. Principal cells expressing luminal 
Aqp2 (aquaporin 2) in renal cortical (A) and medullary (D) collecting ducts. Nuclear expression pattern 
of Cp2l1 protein was detected in cortical tubular structures (B), while a cell membrane associated and 
exclusively extranuclear signal for Cp2l1 was detected in inner medullary tubules (E). Overlay reveals 
expression of Cp2l1 in Aqp2 positive and negative cells along the renal collecting ducts (C, F, G, H). 
Nucleic acid stained with DAPI (blue). # Aqp2 negative/Cp2l1 positive cell; arrowhead: Aqp2/Cp2l1 
positive cell. A-F) Magnification 400x. G, H) Magnification 1,000x. 
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10.1.3 Pendrin is normally expressed in embryonic Ae1 deficient kidney 
 Kidney sections of 18 days old Ae1 WT and KO embryos were costained with 
Aqp2 and pendrin (Fig. 10.19), as well as Aqp2 and the a4 and B1 subunits of V-
ATPase (data not shown). Despite the intriguing abnormal presence of pendrin in the 
inner medulla of mature (P30 and P84) Ae1 deficient kidneys (Fig. 10.2 and 10.7), 
pendrin expression in embryonic kidneys (E18) appeared normal (Fig. 10.19). 
However, the analyzed tubules might be rather derived from the renal cortex, where 
normal Pds expression was also preserved in Ae1 deficient mature kidneys. Therefore, 
analysis of the embryonic inner medullary region seems inevitable. However, mRNA 
expression studies of Ae1 deficient kidneys at different time points of life suggest a 
late onset (after postnatal day 3, P3) of abnormal expression of acid-base related 
transporters and signalling molecules in Ae1 KO kidney (Fig. 10.20). 
 
 
Fig. 10.19 Expression pattern of Aqp2 and Pds expressing cells in embryonic kidney (E18) of  
Ae1 
-/-
 mouse. A) Principal cells are identified by luminal Aqp2 (aquaporin 2) expression. B) Pds 
(pendrin) expression identifies type B-intercalated cells. C) merge. Nucleic acid stained with DAPI 
(blue). # Aqp2 positive/Pds negative cell; § Aqp2 negative/Pds positive cell. Magnification 1,000x. 
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10.1.4 Ae1 deficiency causes late dysregulation of transcription factors 
 In order to address the question, whether Ae1 deficiency affects the proper 
expression of genes regulating CD differentiation, mRNA expression levels of 
candidate genes were compared at different time points of life (E18, P3, P30, P84) and 
between Ae1 +/+, Ae1 +/- and Ae1 -/- kidneys. According to chapter 2.7 and 5.2.2, 
Foxi1, Cp2l1, Klf4, Bdkrb2, and Gdf15 are implicated in terminal differentiation of 
renal CD epithelium. Furthermore, the renal expression of the acid-base regulatory 
transporters Ae1, Pds, Rhcg and B1 subunit of V-ATPase were investigated because of 
the known complication of dRTA in Ae1 deficiency. The results obtained by qRT-RT-
PCR are presented in Fig. 10.20. Interestingly, a difference in the mRNA levels of any 
gene tested between the Ae1 genotypes was not observed in embryonic kidneys. 
Moreover, dysregulation of mRNA expression of some candidate genes tested was 
observed only after postnatal day 3 (P3). As expected and in agreement with the 
development of dRTA, mRNA of Pds and B1 were significantly downregulated in adult 
Ae1 KO kidneys (P84). Surprisingly, there was no difference in mRNA abundance of 
Foxi1 or Cp2l1 in Ae1 deficient kidneys at any time point of life examined. However, it 
is of note, that mRNA levels of regulatory molecules involved in p53 mediated 
signalling pathways, namely Gdf15, Klf4 and Bdkrb2, were significantly upregulated in 
Ae1 KO kidneys after postnatal day 3 (P3).  
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Tab. 10.20 Summary of relative mRNA abundance of genes involved in renal collecting duct differentiation in Ae1 mutant kidney. The relative mRNA 
abundance of several target genes was assessed in male Ae1 mutant mice at four different time points of life. n= 4-8 animals per genotype and age. Gene 
expression levels were normalized to Hprt expression and calculated in percentage (chapter 9.6). E18: embryonic day 18, P3: postnatal day 3, P30: postnatal day 
30, P84: postnatal day 84. Statistical analysis using one way ANOVA and Tukey post-test. * indicating significant difference compared to Ae1
+/+
 ; # indicating 
significant difference compared to Ae1
+/-
. */# p ≤ 0.05, **/## p ≤ 0.01, ***/### p ≤ 0.001 
 
  
% Ae1 % Pds % Rhcg % B1 % Foxi % Cp2l1 % Gdf15 % Klf4 % Bdkrb2
Ae1 
+/+ 100.0 ± 33.6 100.0 ± 11.2 100.0 ± 6.8 100.0 ± 14.7 100.0 ± 7.1 100.0 ± 8.8 100.0 ± 16.8 100.0 ± 12.0 100.0 ± 11.6
E18 Ae1 
+/- 171.9 ± 17.8 94.0 ± 14.3 87.1 ± 11.5 81.0 ± 16.4 104.2 ± 7.4 98.0 ± 11.8  92.5 ± 25.9 100.8 ± 6.9 106.3 ± 28.9
Ae1 
-/- 1.4 ± 0.5 * ## 95.9 ± 14.2 93.2 ± 7.1 78.6 ± 14.2 114.8 ± 8.7 101.6 ± 11.8 112.3 ± 17.2 109.7 ± 6.8 157.7 ± 26.3
Ae1 
+/+ 100.0 ± 23.6 100.0 ± 40.6 100.0 ± 18.6 100.0 ± 6.8 100.0 ± 5.3 100.0 ± 8.1 100.0 ± 12.3 100.0 ± 3.7 100.0 ± 23.1
P3 Ae1 
+/- 54.6 ± 17.3 70.9 ± 10.5 125.2 ± 9.4  97.6 ± 6.7 98.7 ± 4.7 110.0 ± 6.1 107.7 ± 9.2 98.4 ± 8.9 140.8 ± 14.0
Ae1 
-/- 0.1 ± 0.0 * 28.1 ± 5.7 78.9 ± 20.9  90.2 ± 8.9 77.5 ± 13.5 82.0 ± 12.8 119.7 ± 18.6 144.5 ± 18.5 # 169.4 ± 24.5
Ae1 
+/+ 100.0 ± 22.6 100.0 ± 15.7 100.0 ± 23.2 100.0 ± 14.5 100.0 ± 23.0 100.0 ± 27.5 100.0 ± 9.5 100.0 ± 15.6 100.0 ± 24.4
P30 Ae1 
+/- 25.8 ± 1.7 ** 50.6 ± 3.7 ** 62.9 ± 3.1 71.5 ± 7.6 94.0 ± 12.8 74.6 ± 9.6 85.9 ± 7.2 83.5 ± 8.2 92.4 ± 24.4
Ae1 
-/- 0.3 ± 0.3 *** 78.7 ± 4.3 100.2 ± 15.9 110.8 ± 13.2 164.1 ± 54.5 123.8 ± 26.3 165.9 ± 23.3 * ## 270.1 ± 73.7 * # 309.2 ± 73.0 * #
Ae1 
+/+ 100.0 ± 16.6 100.0 ± 12.5 100.0 ± 8.9 100.0 ± 10.4 100.0 ± 13.3 100.0 ± 3.9 100.0 ± 11.7 100.0 ± 6.1 100.0 ± 11.9
P84 Ae1 
+/- 53.3 ± 8.5 * 127.8 ± 6.7 134.6 ± 4.1 105.9 ± 3.2 111.6 ± 5.3 106.9 ± 8.3 76.9 ± 4.8 86.1 ± 3.6 87.1 ± 13.7
Ae1 
-/- 0.6 ± 0.4 *** # 72.5 ± 3.5 ## 99.7 ± 20.4 71.5 ± 5.4 # 121.6 ± 9.7 112.1 ± 15.2 201.2 ± 17.6 *** ### 214.7 ± 25.7 *** ### 200.3 ± 54.7 #
121 
 
E18 P30 P84
Jej IMCD3Kid
Dmbt1
Hprt
 The extra-cellular matrix protein hensin (Dmbt1) was reported to be crucial for 
renal intercalated cell differentiation and interconversion (chapter 2.7.5). Since we 
observed an abnormal expression of Pds in the inner medulla of Ae1 deficient mice, 
we aimed to investigate mRNA expression levels of hensin. Surprisingly, we could not 
detect hensin mRNA in the mouse kidney at any time point of life (Fig. 10.21). 
Additionally, hensin was not detected in cDNA of the immortalized mouse inner 
medullary collecting duct cell line IMCD3. However, the primer pair used to detect 
hensin produced the expected product with cDNA obtained from mouse jejunum, 
confirming specificity and feasibility of the assay. Similar results were obtained using 
the Taqman gene expression assay from Applied Biosystems for mouse Dmbt1 
(Mm00455996_1m*) (data not shown). In order to test, whether mouse strain specific 
differences may lead to the unexpected absence of hensin in C57/Bl6 mouse kidney, 
total mRNA was extracted from 129SvEv wild-type mouse kidney and the cDNA 
synthesized was tested (data not shown). Again, we could not detect a RT-RT-PCR 
primer product for hensin. Since a lack of detectable mRNA certainly bears the 
absence of a related protein product, we have to conclude that hensin is not 
expressed in the kidneys of the mouse strains tested. This is in contrast to the recent 
report of [99], which was discussed in more detail in chapter 2.7.5. 
 
Fig. 10.21 Lack of detectable hensin 
(Dmbt1) mRNA in mouse kidney. Top) qRT-
PCR using hensin specific primer was 
performed on kidney cDNA from embryonic 
(E18), juvenile (P30) and adult (P84) mice, and 
cDNA obtained from mouse inner medullary 
collecting duct cell line (IMCD3). The PCR 
product was loaded on an Agarosegel and visualized under UV-light. Hensin is reported to be highly 
expressed in the intestine and consistently the expected PCR product was obtained in cDNA of mouse 
jejunum (Jej). Bottom) The housekeeping gene Hprt was used for additional control. 
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 Since Gdf15 mRNA was significantly upregulated in mature Ae1 KO mice (P30 
and P84) compared to WT, the protein abundance was assessed by immunoblotting 
(Fig. 10.22, 10.23). As illustrated in Fig. 5.2, the Gdf15 precursor peptide undergoes 
extensive cellular processing, resulting in the biologically active and secreted mature 
Gdf15 dimer, which is reported to migrate at approximately 30 kDa in electrophoretic 
SDS-PAGE [181, 225]. Immunoblotting for Gdf15 on cytosolic fractions of P30 and 
P84 kidneys revealed significant downregulation of the secreted mature Gdf15 dimer, 
in Ae1+/- kidney compared to Ae1+/+ (Fig. 10.22C, 10.23C), while a probably immature 
propeptide was not altered [225]. However, the mild decrease in Gdf15 protein 
abundance in Ae1-/- kidneys did not reach significant difference. Cytosolic fractions of 
mouse liver and placenta homogenates, respectively, were included for positive 
control (data not shown). Interestingly, the upper 50 kDa band of Gdf15 was 
exclusively present in the liver, while the lower 32 kDa band of Gdf15 was only 
detected in placenta samples (data not shown). Thus, a further proof of the molecular 
identity of the detected Gdf15 related bands in kidney derived samples is requested. 
In any case, the quality of the Gdf15 immunoblots is not satisfying and needs to be 
improved. 
 
 
123 
 
Ae1 +/+
250
150
100
75
50
37
25
20
15
kDa
Ae1 -/- Ae1 +/-
D
 
        Fig. 10.22 Protein abundance of 
Gdf15 in P84 Ae1 mutant kidneys. 
Representative western blot (A) for 
Gdf15 (growth differentiation factor 
15) in cytosolic fractions of P84 
Ae1
+/+
, Ae1
-/-
 and Ae1
+/-
 kidneys. Two 
Gdf15 related bands were detected, at 
50 kDa and 32 kDa, respectively, 
probably corresponding to immature 
propeptide and mature dimer. The 
relative protein abundance of β-actin was signifcantly higher in Ae1
-/-
 kidneys, despite loading of equal 
protein amounts and was therefore not considered for normalization. B, C) Densitometry of respective 
Gdf15 signal intensities, normalized to Coomassie Blue staining of duplicate SDS-PAGE gel (D). Statistic 
analysis using one way ANOVA and Tukey post-test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
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Fig. 10.23 Protein abundance of 
Gdf15 in P30 Ae1 mutant kidneys. 
Representative western blot (A) for 
Gdf15 (growth differentiation factor 
15) in cytosolic fractions of P30 
Ae1
+/+
, Ae1
-/-
 and Ae1
+/-
 kidneys. Two 
Gdf15 related bands were detected, at 
50 kDa and 32 kDa, respectively, 
probably corresponding to immature propeptide and mature dimer. The relative protein abundance of 
β-actin was signifcantly higher in Ae1
-/-
 kidneys, despite loading of equal protein amounts and was 
therefore not considered for normalization.  B, C) Densitometry of respective Gdf15 signal intensities, 
normalized to Coomassie Blue staining of duplicate SDS-PAGE gel (D). Statistic analysis using one way 
ANOVA and Tukey post-test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
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10.2 Renal adaptation to chronic metabolic acidosis 
10.2.1 Metabolic parameters 
 As described in chapter 5.2, acid-base disturbances are known to induce 
several adaptive responses in the kidney, including a cellular remodelling of the CD 
epithelium. Therefore, a possible impact on induced chronic metabolic acidosis, 
lasting for 8 weeks, was investigated and finally compared with observations in Ae1 
deficiency. Metabolic parameters of experimental mice (P84) are summarized in Tab. 
10.24 and confirmed the expected adaptation to metabolic acidosis induced by 
addition of NH4Cl to the food. The health status of the animals was tightly monitored 
during the experimental procedure by subjective observations (appearance of fur, 
eyes and activity). Furthermore, adolescence of the acidotic (NH4Cl) animals seemed 
normal, since the bodyweight was unaffected by the unusual diet. The daily water 
intake and respective urinary output was increased in acidotic animals as previously 
reported [219]. The increased blood plasma chloride levels as well as the increased 
secretion of urinary NH3/NH4
+ reflected the chronic oral uptake of NH4Cl with the 
food in acidotic mice. The increased renal secretion of acid equivalents to the urine, 
indicated by the lowered urinary pH and increased urinary NH3/NH4
+ excretion, 
completely compensated the induced metabolic acidosis. Therefore, blood pH, pCO2 
and HCO3
- concentrations, as well as the Anion Gap were normal in NH4Cl loaded 
mice compared to Control. 
 
 
 
 
 
 
126 
 
Tab. 10.24 Metabolic and urine parameters of Control and 8 weeks NH4Cl loaded C57/Bl6 (P84) 
mice. Statistical analysis using Student`s t-test (n = 10 per group).  
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
Control NH4Cl
Bodyweight (g) 26.16 ± 0.55 25.10 ± 0.36
H2O Intake (g/g BW) 0.18 ± 0.01 0.26 ± 0.01 ***
Food Intake (g/g BW) 0.17 ± 0.01 0.16 ± 0.01
Stool (g/g BW) 0.04 ± 0.00 0.04 ± 0.00
Urine (g/g BW) 0.04 ± 0.01 0.09 ± 0.01 ***
Blood
pH 7.35 ± 0.02 7.39 ± 0.07
pCO2 (mmHG) 45.86 ± 2.46 45.20 ± 2.91
pO2 (mmHG) 34.94 ± 0.88 41.63 ± 2.17
HCO3
- (mM) 24.52 ± 0.71 22.96 ± 1.54
Na+ (mM) 144.60 ± 0.98 146.20 ± 0.37
K+ (mM) 4.02 ± 0.21 3.98 ± 0.07
Cl- (mM) 107.00 ± 0.84 110.60 ± 1.25 *
Ca++ (mM) 1.15 ± 0.08 1.04 ± 0.06
Hematocrit (%) 45.26 ± 0.40 47.12 ± 1.61
Anion Gap 13.16 ± 1.41 12.60 ± 0.30
Urine
Creatinine (mg/dl) 32.08 ± 2.38 16.38 ± 1.08 ***
pH 5.83 ± 0.02 5.46 ± 0.01 ***
HCO3
- (mM)/Crea (mg/dl) 0.008 ± 0.0009 0.005 ± 0.0005 *
NH3/NH4
+ (mM)/Crea (mg/dl) 2.05 ± 0.14 26.98 ± 0.63 ***
 
 
 
 
 
 
 
127 
 
10.2.2 Renal expression pattern of acid-base transporters during chronic 
metabolic acidosis 
 The renal expression pattern of Pds, V-ATPase (represented by a4 and B1 
subunit) and Ae1 was assessed by immunofluorescence and the relative abundance 
of individually labelled cells of Control and NH4Cl treated mice were compared (Fig. 
10.25 to 10.28). Furthermore, the relative protein abundance of the afore-mentioned 
transporters, as well as Gdf15 and Foxi1, was determined by immunoblotting (Fig. 
10.29 to 10.34). Finally, the relative mRNA abundance of candidate genes expressed 
in kidneys was compared between Control and 8 weeks NH4Cl treated mice and Ae1 
mutant mice, respectively (Fig. 10.35, 10.36).  
The obtained results clearly show the renal compensation of the chronic oral acid 
load in treated C57/Bl6 mice. Moreover, the adaptive responses of the kidney to 
chronic metabolic acidosis are significantly different to the observations made in Ae1 
deficiency.   
 As expected and shown in Fig. 10.25, the relative abundance of Pds expressing 
type B-IC decreased significantly upon chronic oral acid loading. However, this 
adaptation was totally accounted by alterations of the relative cell number in the 
renal CCD, since the abundance of Pds expressing type B-ICs was not changed in the 
renal CNT, OMCD or IMCD of NH4Cl loaded mice compared to Control. The expected 
decrease of type B-ICs in the renal CCD of acidotic animals was accompanied by an 
increase of Aqp2 labelled principal cells (Fig. 10.25B). In the renal OMCD, the relative 
abundance of Aqp2+ cells was reduced in acidotic kidneys, while unlabelled (none) 
cells increased concomitantly (Fig. 10.25C). A similar, but not yet significantly different 
trend was observed in renal IMCD of acid loaded mice (Fig. 10.25D). As expected and 
importantly in contrast to Ae1 deficient mice, Pds expressing cells were not detected 
at all in the IMCD of chronic NH4Cl treated animals (Fig. 10.3D, 10.8D, 10.25D). 
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Fig. 10.25 Relative distribution of Aqp2 and Pds expressing cells in kidneys of Control and 8 
weeks NH4Cl treated mice (P84). Summary of cell counts assessing the relative abundance of Aqp2 
(aquaporin 2) and Pds (pendrin) positive cells in the renal CNT, CCD, OMCD and IMCD of Control and 
NH4Cl treated mice. In total, 7,882 cells were counted in Control kidneys (n=5) and 4,014 cells in NH4Cl 
treated kidneys (n=5). Statistical analysis using Student`s t-test. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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 Interestingly, the relative abundance of Ae1 positive (Ae1+) cells remained 
constant upon chronic NH4Cl loading (Fig. 10.26). However, similar to the 
observations made in the Pds staining series (Fig. 10.25B), a significant increase in 
Aqp2+ cells on the expense of unlabelled (none) cells was present in renal CCD of 
acid loaded mice (Fig. 10.26B). The unlabelled (none) cells of the Ae1 staining series 
comprise all types of ICs with the exception of type A-ICs as defined by the respective 
marker proteins. Therefore, the data suggest that principal cells in the renal CCD 
increase on the expense of type B-ICs upon chronic acid stimuli. Immunologic 
detection of the V-ATPase, a more general marker of renal ICs, confirmed the 
conclusion.   
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Fig. 10.26 Relative distribution of Aqp2 and Ae1 expressing cells in kidneys of Control and 8 
weeks NH4Cl treated mice (P84). Summary of cell counts assessing the relative abundance of Aqp2 
(aquaporin 2) and Ae1 (anion exchanger 1) positive cells in the renal CNT, CCD, OMCD and IMCD of 
Control and NH4Cl treated mice. In total, 3,926 cells were counted in Control kidneys (n=5) and 2,913 
cells in NH4Cl treated kidneys (n=5). Statistical analysis using Student`s t-test. * p ≤ 0.05, ** p ≤ 0.01, 
*** p ≤ 0.001. 
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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 The V-ATPase is composed of distinct subunits (Fig. 5.1) and ubiquitously 
expressed in different tissues. The a4 subunit of the V-ATPase is specifically expressed 
in the kidney, while the B1 subunit is only present in renal ICs of the CD system, thus 
representing a more specific molecular marker. The cellular localization of the V-
ATPase differs among renal ICs, matching their function in acid-base regulation. 
However, the subcellular localization of the V-ATPase within the renal ICs was not 
further included in the quantitative analysis of the immunologic staining series. Here, 
cells positive for the a4 (a4+) or B1 (B1+) subunit combine all manifestations of the 
cellular V-ATPase localization (i.e. apical, cytosolic, basolateral). Comparing the 
relative abundance of V-ATPase labelled cells in acidotic kidneys, it is of note, that the 
a4 and B1 subunit of V-ATPase are differentially regulated in distinct parts of the 
distal tubule (Fig. 10.27, 10.28). This phenomenon was already described during 
nephrogenesis by Jouret et al [29]. The relative abundance of cells positive for the a4 
subunit of V-ATPase increased in the renal OMCD of NH4Cl treated mice, while Aqp2
+ 
decreased (Fig. 10.27C). However, there were no significant differences observed 
between Control and acidotic kidneys regarding the a4+ or Aqp2+ cell abundance in 
other distal tubule segments (Fig. 10.27A, B, D). In contrast, the relative abundance of 
B1+ cells increased significantly in the renal CNT of acidotic mice, maybe to some 
extent on the expense of unlabelled (none) cells although the reduction did not reach 
statistical relevance (Fig. 10.28A). However, the renal CNT of mice is a segment, which 
consists of a variety of distinct and transitory cell types. Hence, it is likely that some 
less defined cell type expresses the B1 subunit of V-ATPase upon chronic metabolic 
acidosis. Consistent with observations of the Pds staining series (Fig. 10.25), the 
relative abundance of B1+ cells of acidotic CCD was decreased and accompanied by a 
respective increase in Aqp2+ cells (Fig. 10.28B). This observation confirms the 
previous conclusion that principal cells of the renal CCD increase in abundance, on 
the expense of type B-ICs upon chronic acid loading. Apart from that, the relative 
abundance of B1+ cells in OMCD and IMCD was similar in Control and NH4Cl treated 
animals (Fig. 10.28C, D). 
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 Notably and in contrast to Ae1 deficiency, Pds expressing cells remained 
absent in chronic metabolic acidosis. Furthermore, an interconversion of type A-ICs 
from type B-ICs upon chronic metabolic acidosis is not likely, as the relative 
abundance of type A-ICs did not change upon prolonged acid load. Instead of, an 
adaptive increase in PCs of the renal CCD was observed with a concomitant decrease 
in type B-ICs. However, whether this is a result of proliferation and apoptosis of the 
respective cell types or from cell type interconversion remains speculative.  
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Fig. 10.27 Relative distribution of Aqp2 and a4 expressing cells in kidneys of Control and 8 
weeks NH4Cl treated mice (P84). Summary of cell counts assessing the relative abundance of Aqp2 
(aquaporin 2) and a4 (a4 subunit of V-ATPase) positive cells in the renal CNT, CCD, OMCD and IMCD of 
Control and NH4Cl treated mice. In total, 5,482 cells were counted in Control kidneys (n=5) and 4,822 
cells in NH4Cl treated kidneys (n=5). Statistical analysis using Student`s t-test. * p ≤ 0.05, ** p ≤ 0.01, 
*** p ≤ 0.001. 
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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Fig. 10.28 Relative distribution of Aqp2 and B1 expressing cells in kidneys of Control and 8 
weeks NH4Cl treated mice (P84). Summary of cell counts assessing the relative abundance of Aqp2 
(aquaporin 2) and B1 (B1 subunit of V-ATPase) positive cells in the renal CNT, CCD, OMCD and IMCD 
of Control and NH4Cl treated mice. In total, 4,714 cells were counted in Control kidneys (n=5) and 
4,543 cells in NH4Cl treated kidneys (n=5). Statistical analysis using Student`s t-test. * p ≤ 0.05, ** p ≤ 
0.01, *** p ≤ 0.001. 
CNT: connecting tubule, CCD: cortical collecting duct, OMCD: outer medullary collecting duct, IMCD: 
inner medullary collecting duct 
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 Immunoblotting of total kidney membrane preparations confirmed the results 
obtained by immunofluorescent labelling. Again, Aqp2 protein abundance was 
increased in acidotic kidneys (Fig. 10.29), while Pds abundance was decreased (Fig. 
10.30). Moreover, the relative protein abundance of Ae1 and the B1 subunit of V-
ATPase did not change upon chronic metabolic acidosis (Fig. 10.31, 10.32). 
 
 
Fig. 10.29 Relative protein abundance of Aqp2 in kidneys of Control and 8 weeks NH4Cl treated 
mice (P84). A) Representative immunoblot of Aqp2 (aquaporin 2) on total kidney membrane 
preparation from Control and 8 weeks NH4Cl treated mice, β-actin served as loading control. B, C) 
Densitometry. Statistical analysis using Student`s t-test (n = 5 per group). * p ≤ 0.05, ** p ≤ 0.01, *** p 
≤ 0.001. 
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Fig. 10.30 Relative protein abundance of Pds in kidneys of Control and 8 weeks NH4Cl treated 
mice (P84). A) Representative immunoblot of Pds (pendrin) on total kidney membrane preparation 
from Control and 8 weeks NH4Cl treated mice, β-actin served as loading control. B, C) Densitometry. 
Statistical analysis using Student`s t-test (n = 5 per group). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
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Fig. 10.31 Relative protein abundance of Ae1 in kidneys of Control and 8 weeks NH4Cl treated 
mice (P84). A) Representative immunoblot of Ae1 (anion exchanger 1) on total kidney membrane 
preparation from Control and 8 weeks NH4Cl treated mice, β-actin served as loading control. B, C) 
Densitometry. Statistical analysis using Student`s t-test (n = 5 per group). * p ≤ 0.05, ** p ≤ 0.01, *** p 
≤ 0.001. 
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Fig. 10.32 Relative protein abundance of B1 subunit of V-ATPase in kidneys of Control and 8 
weeks NH4Cl treated mice (P84). A) Representative immunoblot of B1 subunit of V-ATPase 
(ATP6v1b1) on total kidney membrane preparation from Control and 8 weeks NH4Cl treated mice, β-
actin served as loading control. B) Densitometry. Statistical analysis using Student`s t-test (n = 5 per 
group). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
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 In addition to alterations of acid-base transporters, Gdf15 protein abundance 
was significantly regulated in chronic metabolic acidosis (Fig. 10.33). A supposingly 
immature propeptide was detected at 50 kDa and found to be significantly 
downregulated upon chronic acidosis. Consistently, the probably mature secreted 
dimer of Gdf15 at 32 kDa was significantly upregulated in acidotic kidneys, while 
Gdf15 mRNA was not changed (Fig. 10.35J). However, whether the regulated 
supposingly mature dimer is really present as a secreted signalling peptide of Gdf15 
circulating in the blood is not known, since serum levels of Gdf15 were not assessed 
in Control or acidotic mice. Furthermore, the function of Gdf15 in adaptive responses 
of the kidney during chronic metabolic acid-base disturbances is not yet resolved. In 
the early adaptive response of the kidney to metabolic acidosis, Gdf15 was suggested 
to be involved in the initiation of proliferation (chapter 5.2.2). However, this function 
seems unlikely in the case of chronic (8 weeks) acidosis, as the initial increase of the 
proliferation rate might be already terminated and sustained at low comparable rates 
of Control kidneys. Moreover, Gdf15 is involved in the regulation of cellular processes 
upon manifold stress stimuli [181]. Hence, a regulatory role of Gdf15 in the kidney of 
chronic acidotic mice might be rather involved in processes that reduce cellular stress.  
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Fig. 10.33 Relative protein abundance of Gdf15 in kidneys of Control and 8 weeks NH4Cl treated 
mice (P84). A) Representative immunoblot of Gdf15 (growth differentiation factor 15) on cytosolic 
fractions of total kidney homogenates extracted from Control and 8 weeks NH4Cl treated mice, β-actin 
served as loading control. B, C) Densitometry. Statistical analysis using Student`s t-test (n = 5 per 
group). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
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 In order to assess the relative protein abundance of Foxi1 in Control and 
acidotic kidneys, immunoblotting of nuclear protein extracts and cytosolic fractions 
from kidney homogenates were performed. Transiently Foxi1 transfected Hek293T 
cells served as a positive control for the pattern of Foxi1 protein and derivates in 
electrophoretic SDS-PAGE (Fig. 10.34C). Here, three Foxi1 related bands were 
detected by western blot, of which one matched the expected molecular weight of 
Foxi1 (41 kDa). The other two Foxi1 related bands were detected at higher molecular 
weights and are of unknown origin. However, in kidney nuclear extracts all three 
bands were detected and were found expressed at comparable levels in Control and 
NH4Cl treated animals (Fig. 10.34A). Interestingly, Foxi1 immunoblotting on kidney 
cytosolic fractions of total homogenate showed a distinct pattern (Fig. 10.34B). The 
lowest band, corresponding to the expected molecular weight was missing. Anyhow, 
the two higher Foxi1 related bands of unknown origin were present but not regulated 
upon acid-base disturbance. Future experiments are necessary to solve the character 
of the Foxi1 related bands detected by immunoblotting. Foxi1 was shown to be 
capable of remodelling chromatin structures and to remain bound to condensed 
chromatin during mitosis [226]. However, inactive or premature forms of Foxi1 might 
also be present outside the nucleus, as indicated by the detection of Foxi1 related 
proteins with higher molecular weight in the cytosolic fraction of kidney 
homogenates. 
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Fig. 10.34 Relative protein abundance of Foxi1 in kidneys of Control and 8 weeks NH4Cl treated 
mice (P84). A-C) Representative immunoblot of Foxi1 (forkheadbox protein 1). A) Nuclear protein 
extracts from total kidneys of Control and 8 weeks NH4Cl treated mice. B) Cytosolic fractions of total 
kidney homogenates from Control and 8 weeks NH4Cl treated mice with β-actin as loading control. C) 
Nuclear protein extracts from untransfected (Foxi1 -) and transiently transfected Hek293T cells      
(Foxi1 +) and total kidney (Kid) (P30). arrow: indicates expected molecular weight of Foxi1 (41 kDa), 
only detectable in nuclear protein extracts. 
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 Addressing the question whether chronic acidosis is capable of altering the 
differentiation of renal IC, total mRNA of Control and NH4Cl treated mouse kidney 
was extracted and qRT-PCR was performed for the above introduced candidate genes 
of acid-base transporters and transcription factors or signalling molecules. Finally, the 
results were compared with data obtained from Ae1 mutant mouse kidney. The 
relative mRNA expression levels are presented in bar graphs of Fig. 10.35A-J and a 
simplified tabular expression of the results is shown in Fig. 10.36. Consistent with the 
chronic acidosis, relative mRNA levels of Ae1 (Fig. 10.35A) were upregulated in NH4Cl 
loaded mice compared to Control, while Pds was downregulated (Fig. 10.35B). 
Similarly, relative mRNA expression of Pds was reduced in Ae1 KO mice. The relative 
abundance of the B1 subunit of V-ATPase was not altered in NH4Cl loaded animals 
compared to Control (Fig. 10.35C). However, the B1 subunit of V-ATPase was 
significantly downregulated in Ae1 KO kidneys. Furthermore, Rhcg mRNA levels were 
not changed significantly in chronic metabolic acidosis nor Ae1 related dRTA (Fig. 
10.35D). Interestingly, relative Foxi1 mRNA abundance was not different in NH4Cl 
treated mice compared to Control or Ae1 mutant mice (Fig. 10.35E). Strikingly, 
relative Cp2l1 mRNA abundance was upregulated in chronic metabolic acidosis but 
not in Ae1 KO (Fig. 10.35F). Moreover, relative mRNA levels of Bdkrb2, Klf4 and Gdf15 
were significantly upregulated in kidneys Ae1 KO mice compared to WT, but not in 
kidneys of NH4Cl loaded mice compared to Control (Fig. 10.35G-J).  
Hence, the investigated genes are differentially regulated during chronic metabolic 
acidosis and Ae1 related dRTA as also shown in the simplified table (Fig. 10.36).  
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Fig. 10.35 Relative renal mRNA abundance of target genes during chronic metabolic acidosis 
and dRTA. Left bar graph represents mRNA expression levels in C57/Bl6 Control and NH4Cl treated 
mice. Right bar graph shows renal mRNA expression levels of Ae1 mutant mice, respectively. Statistical 
analysis using Student`s t-test (n = 4-5 animals per group). * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001. 
   
 
 
Fig. 10.36 Summarized results from Fig. 10.35 representing relative changes in mRNA expression 
levels of NH4Cl treated mice relative to C57/Bl6 Control and Ae1 KO mice relative to Ae1 WT.  
indicating significant upregulation;  indicating significant downregulation;  indicating no difference 
compared to C57/Bl6 Control, or Ae1 WT respectively.  
Gdf15J
relative change in % mRNA abundance
gene Control vs NH4Cl Ae1 WT vs KO
Ae1 ↑ ↓↓
Pds ↓ ↔
Atp6v1b1 ↔ ↔
Rhcg ↔ ↔
Foxi1 ↔ ↔
Cp2l1 ↑↑ ↔
Gdf15 ↔ ↑↑
Klf4 ↔ ↑↑
Bdkrb2 ↔ ↔
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10.3 Pendrin expression pattern is normal despite incomplete dRTA 
 Renal Ae1 deficiency in mice and humans leads to distal renal tubular acidosis 
(dRTA). The previous results proofed that induction of chronic metabolic acid loads 
by oral application of NH4Cl is not sufficient to cause the abnormal expression of Pds 
observed in the inner medulla of Ae1 KO mice. However, possible negative effects on 
Pds expression in the inner medulla induced by Ae1 related dRTA cannot be excluded 
by this experimental model. Therefore, the expression pattern of Pds was investigated 
in mice deficient for the B1 subunit of V-ATPase (B1) or Rhcg. Both mouse models 
were reported to develop dRTA upon induced acid-base disturbances (chapter 7.1). 
In contrast to Ae1 deficient mice, representative photomicrographs of kidneys from 
B1 and Rhcg deficient mice did not show signs of abnormal Pds expression in cortex 
or medulla (Fig. 10.37). Hence, Pds expression pattern in the renal inner medulla is 
normal despite incomplete dRTA. Moreover, Ae1 and the a4 and B1 subunits of V-
ATPase were not differentially expressed in kidneys of B1 or Rhcg mutant mice 
compared to WT (data not shown). However, both mouse models were investigated 
under basal conditions, where acid-base homeostasis seems compensated despite 
their renal defects. 
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Fig. 10.37 Immunologic localization of Pds in adult (P84) B1
-/-
 and Rhcg
-/-
 mouse kidney. 
Representative merged photomicrographs from renal cortex (CCD) of B1
-/-
 (A) and Rhcg
-/-
 (C) mice. 
Representative merged photomicrographs from renal inner medulla (IMCD) of B1
-/-
 (B) and Rhcg
-/-
 (D) 
mice. Individual Aqp2 (aquaporin 2) expression in renal CCD and IMCD identifies principal cells. A, C) 
In the CCD, Pds (pendrin) localizes to the luminal membrane of Aqp2 negative cells, identifying B-ICs. 
B, D) Pds is absent from the mature inner medulla of B1
-/-
 and Rhcg
-/-
 mice (n = 3 per genotype). 
Nucleic acid is stained with DAPI. § indicating Pds positive cell; # indicating Aqp2 positive cell; * 
indicating Aqp2/Pds negative cell. Magnification 400x. 
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10.4 Expression of acid-base transporters in human Control kidney and a case of 
AE1 related dRTA 
In humans, several mutations of AE1 account for the development of primary dRTA 
(chapter 4.5.1, Tab. 4.2, chapter 6.1.2). However, these patients are rarely biopsied 
since diagnosis of disease is made from the clinical presentation and genetic analysis. 
A renal biopsy of a patient with the dominant negative AE1 S613F mutation (kind gift 
of Dr. R. Unwin, University College of London, UK) was investigated to search for signs 
of CD cell abnormalities using immunofluorescent markers. As discussed already in 
detail, under physiologic conditions luminal expression of PDS labels type B-ICs, 
whereas basolateral presence of AE1 marks type A-ICs (Fig. 10.38A). Similar to mouse 
and rat kidneys, AQP2 is expressed on the apical cell membrane of principal cells, 
while the a4 and B1 subunit of V-ATPase is expressed in intercalated cells (Fig. 10.38B, 
C). Consistent with observations in mouse kidney, human carbonic anhydrase II (CA II) 
expression was found in AQP2 positive and negative cells of the CNT in Control 
kidneys and is therefore not considered as a IC cell-specific marker (data not shown).  
In a renal biopsy of the above mentioned patient with the dominant negative AE1 
mutation S613F a reduced abundance of ICs with a concomitant increased presence 
of PCs was obvious. Variants of the IC type were detected using AE1, PDS and V-
ATPase markers (a4 and B1 subunit) and rarely seen. In contrast, PCs labelled with 
AQP2 seemed to be the major cell type of the collecting ducts. Furthermore, AE1 
immunoreactivity was absent in cells of the connecting tubule and collecting duct in 
the kidney with AE1 S613F mutation. However as expected, AE1 staining was 
preserved in erythrocytes (Fig. 10.39B). In addition, PDS positive cells were rarely 
detected in AE1 S613F renal tissue and PDS seemed to be expressed mostly in the 
cytosol instead of the apical membrane (Fig. 10.39C). Moreover, few cells coexpressed 
PDS along with AQP2. Notably, the medullary region was not present in this biopsy as 
usual. Similarly, the majority of a4 positive cells unusually coexpressed AQP2 (Fig. 
10.40). Additionally, B1 immunoreactivity appeared markedly reduced and B1 positive 
cells were hardly present (Fig. 10.41). However, because of the single case relative 
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abundance of the labelled cells was not assessed and quantification of relative 
protein abundance is not possible. 
 
 
Fig. 10.38 Expression pattern of collecting duct marker proteins in human Control kidney. A) 
AE1 (Anion Exchanger 1) and PDS (Pendrin) are expressed in distinct types of intercalated cells. 
Basolateral expression of AE1 indicates presence of type A-IC. Apical presence of PDS labels type B-IC 
(arrow). B, C) AQP2 (Aquaporin 2) is exclusively expressed in principal cells. The a4 subunit of V-
ATPase is expressed in intercalated cells of the renal collecting duct system and proximal parts of the 
nephron (B). The B1 subunit of V-ATPase is specifically expressed in renal IC (C). Colocalization of 
basolateral V-ATPase with luminal PDS confirms type B-IC identity (arrow) (B), while equilateral V-
ATPase and PDS expression indicate type non-A/non-B IC phenotype (arrow) (C). Magnification 400x. 
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Fig. 10.39 Renal expression pattern of PDS and AQP2 in a case of AE1 S613F. A) The majority of 
cells in the human renal cortex express luminal AQP2 (Aquaporin 2). B) Immunoreactivity for AE1 
(Anion Exchanger 1) was absent in renal cells of the collecting duct, but is conserved in erythrocytes. C) 
A rather cytosolic expression of PDS (Pendrin) was found in some cells of the renal collecting duct. D) 
merge. Some PDS positive cells remain negative for AQP2 (arrrow), while other PDS positive cells seem 
to coexpress AQP2 (dashed arrow). arrowhead indicates AQP2 positive/PDS negative cell. 
Magnification 1,000x. 
 
 
Fig. 10.40 Renal expression pattern of a4 subunit of V-ATPase and AQP2 in a case of AE1 S613F. 
A) Apical AQP2 (Aquaporin 2) is present in the majority of renal collecting duct cells. B) The a4 subunit 
of V-ATPase (a4, ATP6V0A4) is expressed in intercalated cells of the renal collecting ducts and in cells 
of the proximal nephron. C) merge. The majority of a4 positive cells are also positive for AQP2 (dashed 
arrow). Magnification 400x. 
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Fig. 10.41 Renal expression pattern of B1 subunit of V-ATPase and AQP2 in a case of AE1 S613F. 
A) Apical AQP2 (Aquaporin 2) is present in the majority of renal collecting duct cells. B) The B1 subunit 
of V-ATPase (B1, ATP6V1B1) is rarely expressed in intercalated cells of the renal collecting ducts. C) 
merge. B1 and AQP2 are expressed in distinct cell types of the renal collecting duct. Magnification 
400x. 
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 In another case of primary dRTA related to the dominant negative AE1 R589H 
mutation (kind gift of Dr. Alper, S.L., Harvard Medical School, Boston, USA) 
immunofluorescent analysis of the renal CD system failed due to a loss of the renal 
morphology. Here, chronic nephrocalcinosis and pyelonephritis destroyed the renal 
tubular structures which were replaced by amorphous fibrotic scars (Fig. 10.42). 
 
 
Fig. 10.42 Hematoxylin and Eosin staining of a renal biopsy of a case with AE1 R589H. The kidney 
morphology shows amorphous fibrotic remodelling and loss of tubular structures due to 
nephrocalcinosis and recurring pyelonephritis. # indicates fibrotic remains of a glomerulum. 
Magnification 100x. 
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11. DISCUSSION  
 The metanephric mammalian kidney originates from two different primordia, 
the nephrogenic mesenchymal blastema and the ureteric bud epithelium. The 
nephrogenic CNT joints the renal CD system to the upstream nephron. The mature 
renal CD system is the main site of final urinary acidification and according to its 
functional demands subdivided into the CCD, OMCD and IMCD. However, the renal 
CNT and CD system are comprised of at least three different cell types, which are 
unequally distributed (Fig. 2.4). The principal cells (PCs) are the major cell type and 
involved in systemic electrolyte and water homeostasis. They are interspersed with 
distinct types of intercalated cells (ICs), which regulate systemic acid-base 
homeostasis. The two major forms of ICs are the acid secretory type A-ICs and the 
bicarbonate secretory type B-ICs. In accordance with their function, cells of the renal 
CD can be distinguished by their ultrastructural appearance and specific marker 
proteins (Fig. 2.6). In the present study, PCs are identified by the immunologic 
presence of Aqp2, while both types of ICs are detected by their expression and 
subcellular localization of the a4 or B1 subunit of V-ATPase. Furthermore, the two 
major types of IC are distinguished by their expression of Ae1 (type A-ICs) or Pds 
(type B-ICs). 
 
 The Cl-/HCO3
- exchanger Ae1 is essentially expressed in erythrocytes and in the 
kidney exclusively on the basolateral membrane of type A-ICs. In humans, several 
mutations of the transporter were identified, which either disturb its function in the 
erythrocyte or the kidney. Consistent with the role of Ae1 in renal type A-ICs, 
disturbances of Ae1 expression and function in the kidney lead to distal renal tubular 
acidosis (dRTA), an inability to acidify the urine. However, data of the present study 
suggest an additional role for Ae1 in the terminal differentiation of the renal CD 
system, which is most likely beyond its Cl-/HCO3
- exchange. 
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11.1 Loss of Ae1 coincides with the unusual expression of Pds in the renal 
inner medulla 
 Despite intensive studies of the early events of nephrogenesis and 
characterization of the adult kidney, only very little is known about the cellular origin 
of the different cell types of the renal CD system. Studies of fetal mouse, rat and 
human kidneys suggest the development of PCs and subtypes of ICs from distinct 
pools of precursor cells in the renal CNT and MCD (chapter 2.5, Fig. 2.5). Interestingly, 
subtypes of ICs are not detected in the renal CCD before birth. However, with 
increasing functional demands of the maturing postnatal kidney, the CD system 
undergoes continuous remodelling resulting in a distinct segmental pattern. In the 
adult kidney, type B-ICs are exclusively present in the renal CNT and CCD, while the 
relative abundance of type A-ICs increases towards the inner medulla with a 
maximum in the outer medullary region (Fig. 2.4, 2.5).  
Surprisingly, immunofluorescent investigation of mature kidneys from juvenile (P30) 
and adult (P84) Ae1 deficient mice revealed an unusual expression of Pds in cells of 
the inner medulla (Fig. 10.2, 10.6, 10.7). Moreover, some cells coexpressed Pds along 
with the PC marker Aqp2. Interestingly, the later observation was confined to the 
inner medulla of mature Ae1 deficient kidneys, as a normal cellular Pds expression 
was detected in the mature cortex and in embryonic kidneys.  
Only the quantification of immunologically counter-labelled cells in juvenile and adult 
mouse kidneys revealed some differences concerning the cellular distribution among 
the genotypes. Consistent with chronic dRTA, the relative abundance of Pds+ cells in 
the renal CNT and CCD were significantly reduced, while Aqp2+ cells increased in 
adult (P84) Ae1 KO kidneys. However, in the renal OMCD of P84 Ae1 KO mice the 
relative abundance of Aqp2+/Pds+ coexpressing cells increased, probably on the 
expense of unlabelled cells. In addition, the relative abundance of Pds+ and 
Aqp2+/Pds+ coexpressing cells in the renal ICMD of P84 Ae1 KO mice increased with 
a modest decrease in unlabelled cells.  
156 
 
In contrast, Aqp2 and Pds expressing cells in the CNT of juvenile (P30) mouse kidneys 
were not altered between WT and Ae1 KO mice. Moreover, Pds+ cells increased in 
abundance on the expense of unlabelled cells in the CCD and OMCD of P30 Ae1 KO 
mice. Likewise, Pds+ and Aqp2+/Pds+ coexpressing cells in the renal ICMD of P30 Ae1 
KO mice increased, while unlabelled cells modestly decreased. Strikingly, the unusual 
expression of Pds in Ae1 deficient IMCDs is accompanied by a reduced relative 
abundance of Aqp2+ in P30 mice, while it is paralleled by a reduced abundance of 
unlabelled cells in P84 kidneys. 
The altered cellular expression pattern between P30 and P84 Ae1 KO mice might be a 
consequence of two circumstances. The juvenile mice just experienced a dietary 
switch from mother milk to rodent chow, which was shown to provide a strong net 
alkali load  [227]. Consistently, the urinary pH of juvenile mice after weaning from the 
mother milk was shown to be more alkaline [31]. Hence, the increased need to 
excrete excess base equivalents from the body might reflect the unexpected 
increased presence of Pds+ cells in the CCD and OMCD of P30 Ae1 KO kidney despite 
early dRTA. It remains speculative, whether this is due to a delayed apoptotic removal 
of Pds+ cells from the MCD or an increased proliferation rate of Pds+ cells. In addition, 
adult (P84) Ae1 KO mice suffered from chronic dRTA, which affects renal water 
handling [190, 218]. This might also be the reason for the reduced number of Aqp2+ 
in the renal CNT of juvenile (P30) WT mice compared to adult (P84) WT animals. 
Furthermore, an adaptive increase of Aqp2+ cells upon prolonged dRTA might mask 
the abnormal differentiation of Aqp2+ cells in the renal IMCD, or drive the abnormal 
differentiation of cells other than Aqp2+. However, in kidneys of juvenile Ae1 KO 
mice, which might have a less pronounced dRTA, the unusual expression of Pds in the 
IMCD seems to origin from the abnormal differentiation of cells retaining or acquiring 
Aqp2 expression. 
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 Consistent with the observations in Ae1 deficient mouse kidney, PDS 
expression seemed altered in a renal biopsy of a patient with primary dRTA due to 
the dominant negative AE1 S613F mutation (chapter 10.4). This mutation is known to 
exclusively affect the expression and functionality of AE1 in renal type A-ICs, but not 
in erythrocytes. In vitro experiments using polarized MDCK cells suggest that the AE1 
S613F mutant protein is retained in the ER and thus does not reach the basolateral 
cell membrane of type A-ICs. Since reticulocytes are not polarized and have different 
chaperones and trafficking mechanisms than renal epithelial cells, they might 
circumvent the dominant negative effect of the mutant and escape early ER 
degradation.  
However, a previous investigation of the patient’s renal biopsy documented a 
reduced number of renal ICs and a solely cytosolic expression of AE1 S613F, with a 
preserved expression in erythrocytes [138]. Similar results were obtained using 
immunofluorescent molecular CD cell markers in the present study. The abundance of 
renal ICs (identified by V-ATPase, PDS or AE1) was remarkably low and PCs (identified 
by AQP2) seemed to comprise the major cell type of the renal CD system. In the 
present study, AE1 immunoreactivity was only detected in erythrocytes but the 
accessibility of the renal epitope might have been lost over the years of storage, 
especially since the original work mentioned a rather weak AE1 signal intensity in 
renal epithelial cells [138]. Anyway, V-ATPase and PDS expression were detected only 
in very few cells of the renal CD system and PDS localization appeared to be mostly 
cytosolic. Notably, the CD section represented on the biopsy were exclusively from 
the CNT and CCD segment as assessed by the gross morphology of the surrounding 
tissue and given by the usual technique to take biopsies.   
Similarly, a reduced number of renal ICs from the CD system was reported for a case 
with the dominant negative AE1 R589H mutation [208].  
Hence, Ae1 deficiency in mouse and man seems to correlate with abnormal 
subcellular expression of pendrin and severely reduced number of ICs. 
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11.2 The type A-IC phenotype is preserved in Ae1 deficient kidneys 
 In order to further elucidate which CD cell type might be abnormally 
differentiated in Ae1 KO kidneys, the expression pattern of V-ATPase was examined in 
P30 mice. The expression pattern of the kidney specific a4 subunit of V-ATPase did 
not show any significant differences between the genotypes. However, the IC-specific 
B1 subunit of V-ATPase partially reflected the unusual presence of Pds in the renal 
MCDs of Ae1 deficient mice. Here, an increased abundance of B1+/Aqp2+ 
coexpressing cells was observed in Ae1 KO kidneys, which reached significant 
difference in the IMCD of P30 mice. In line with the previous observation, Aqp2+ cells 
of the Ae1 deficient IMCD were simultaneously decreased. Therefore, some Aqp2 
expressing cells of the IMCD of Ae1 KO mice might either coexpress Pds 
(Aqp2+/Pds+) or B1 (Aqp2+/B1+) or both (Aqp2+/Pds+/B1+), respectively. The 
unchanged expression pattern of individually B1+ cells in Ae1 deficient kidneys 
suggests a normal differentiation of the type A-IC phenotype, which certainly 
represents the major IC subtype in the pool of unlabelled cells. This observation 
implies that renal Ae1 deficiency does not necessarily result in a loss of type A-ICs, 
but rather a loss of a proper molecular marker. Unfortunately, no other unequivocal 
marker of type A-IC is available to date to further confirm maintenance of this cell 
type. However, the unusual expression pattern of Pds expressing cells in Ae1 KO 
kidneys might origin from the abnormal differentiation of PCs and affects the type B-
IC phenotype or the type non-A/non-B IC variant. However, further experiments are 
needed to answer this question.  
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11.3 Foxi1 expression is altered in Ae1 deficient kidneys 
 Transcription factors of the forkhead box family are involved in early 
nephrogenesis and terminal differentiation of the renal CD system (chapter 2.7.3). 
Foxi1 deficient mice were reported to lack molecular markers of renal ICs and 
consequently develop dRTA [83]. Moreover, the renal CD system of Foxi1 KO mice 
consists of a single cell type which coexpresses Aqp2 and CaII (Fig. 2.11). Similarly, 
Foxi1 homologues are required for epidermal ionocyte differentiation in larvae of 
Xenopus laevis and zebrafish (Fig. 2.7, 2.8) [51, 54, 56]. Therefore, the Foxi1 expression 
pattern was examined in Ae1 deficient kidneys by immunohistochemistry. Previous 
studies mentioned Foxi1 expression in the murine distal tubule and more precisely in 
type A-ICs and B-ICs, but not in PCs [82, 83]. However, the preliminary results of the 
present study reveal a nuclear expression of Foxi1 mainly in B1+ ICs, but also in few 
Aqp2+ PCs (Fig. 10.11-16). The contrary cellular localization of Foxi1 with previous 
reports might be due to the distinct experimental approach. Anyhow, quantification 
of the Foxi1 expression pattern in Ae1 WT and KO kidneys of juvenile mice revealed 
some interesting differences. The relative abundance of individual Foxi1+ cells was 
significantly increased in the renal IMCDs of Ae1 KO mice compared to WT. 
Moreover, a similar amount of Aqp2+/Foxi1+ cells was increased in IMCDs of Ae1 KO 
mice, even though it did not reach statistical significance. Furthermore, Aqp2+/Foxi1+ 
cells in the CCD of Ae1 deficient kidneys were significantly increased, while the 
relative abundance of Foxi1+ and unlabelled cells was simultaneously reduced. 
Similarly, Pds+ cells were increased in the CCD of Ae1 deficient kidneys on the 
expense of unlabelled cells, while the relative abundance of Aqp2+/B1+ tends to 
increase on the expense of Aqp2+ cells. Likewise, the increase of Pds+ and 
Aqp2+/Pds+ cells in the renal IMCD of Ae1 KO mice on the expense of Aqp2+ cells is 
paralleled by an increase in Foxi1+ cells. Although the percentage of Aqp2+/Foxi1+ 
cells is smaller than the number of cells with unusual Pds and B1 expression, their 
concomitant appearance is likely related to each other and thus caused by Ae1 
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deficiency. Moreover, Foxi1 is a known positive transcriptional regulator of the B1 
subunit of V-ATPase, Ae1 and Pds [83, 85, 87]. 
 
 Interestingly, mice with a conditionally disrupted Notch signalling pathway in 
the renal CD system suffer from nephrogenic diabetes insipidus based on the loss of 
Aqp2 expressing PCs (chapter 2.7.2) [77]. Additionally, an increased abundance of V-
ATPase expressing cells with a concomitant increased mRNA expression of V-ATPase, 
Ae1, Pds and Foxi1 was noted. Consistently, a mouse model with a constitutive 
activation of the Notch signalling pathway in the renal CD system was devoid of 
molecular markers for ICs and expressed only Apq2 positive PCs (Fig. 2.10). Hence, 
terminal differentiation of the renal CD cells is regulated by the Notch signalling 
pathway and Foxi1, but the definite interaction of these transcriptional regulators is 
not yet elucidated. Studying the expression of the molecular players of the Notch 
signalling pathway during collecting duct development in WT mice and its regulation 
in Ae1 KO kidneys would add further important information. 
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11.4 Cp2l1 expression is altered in Ae1 deficient kidneys 
 Similar to Foxi1 KO mice and those with disrupted Notch signalling pathway, 
animals deficient for the transcription factor Cp2l1 are devoid of IC marker in the 
renal CD system (chapter 2.7.4, Fig. 2.11) [90]. The role of Cp2l1 in the mammalian 
kidney is only poorly investigated, but studies of the epidermal development of 
ionocytes in Xenopus and zebrafish larvae suggest a regulatory role of Cp2l1 
homologues in a Pds expressing ionocyte subtype [51, 57]. Moreover, the 
transcriptional control of Cp2l1 involves the interaction with the Notch signalling 
pathway and Foxi transcription factors (Fig. 2.7, 2.8). However, whether this is also 
true for Cp2l1 in murine kidney cells is not known. Preliminary data from 
immunologic localization studies on P30 WT mouse kidneys show coexpression of 
nuclear Cp2l1 mainly with Aqp2 positive and less with Aqp2 negative cells along the 
renal CD system (Fig, 10.17, 10.18). Apparently, the abundance of Cp2l1 positive cells 
increases from the CNT towards the inner medulla, where Cp2l1 seems to be 
expressed in almost every cell. Similarly, the presence of Aqp2 expressing PCs 
increases from the CNT towards the inner medulla. In addition and in line with a 
previous report, nuclear Cp2l1 expression is detected in some tubuli of the DCT and 
TAL [90]. Even though detailed colocalization studies are not yet available, a striking 
difference in the expression of Cp2l1 was observed in Ae1 deficient kidneys 
compared to wildtype. The nuclear expression profile of Cp2l1 in inner medullary 
collecting duct cells was completely absent and moreover appeared to be shifted to 
the apical membrane in some cells. Whether the altered subcellular localization is 
related to different activity states of the transcription factor needs to be investigated. 
However, the loss of Cp2l1 from the nuclei of IMCD cells seems to coincide with the 
abnormal cell differentiation described upon renal Ae1 deficiency.  
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11.5 Late onset of Ae1 related abnormal differentiation of renal IMCD 
 Although Pds expressing cells in kidneys of Ae1 deficient embryos seemed to 
be preserved, an abnormal regulation of transporters and transcription factors 
involved in CD cell function and specificity cannot be ruled out. Therefore, mRNA 
expression levels were compared at different developmental ages in kidneys of Ae1 
mutant mice (Tab. 10.20). Interestingly, alterations of genes implicated in renal acid-
base handling (Ae1, Pds, B1 subunit of V-ATPase and Rhcg) were not altered before 
postnatal day 30 (P30). This result supports the afore mentioned impact of a dietary 
switch from mother milk to rodent chow on systemic acid-base homeostasis and the 
concomitant mutual reaction with Ae1 related dRTA. Alternatively, it may reflect the 
completion of postnatal maturation of the kidney which includes the removal of Pds+ 
cells from the medulla. Surprisingly, mRNA abundance of Foxi1 and Cp2l1 were not 
different between Ae1 WT and mutant mice at any time point of life investigated, 
despite the marked changes in the protein expression pattern. However, gene 
expression does not necessarily correlate with protein abundance or activity. On the 
other hand, genes suggested to be involved in the p53 signalling cascade and 
probably developmental fate of renal CD cells (Gdf15, Klf4 and Bdkrb2) were steadily 
upregulated in Ae1 KO mice after postnatal day 3 (P3). 
Together with the immunofluorescent analysis of molecular IC markers, the data 
suggest a late onset of Ae1 related abnormal terminal differentiation of renal CD cells 
which might be mutually affected by systemic or renal acid-base dysregulation. 
However, the impact of dRTA seems to be confined to the renal CCD of adult (P84) 
mouse kidneys, where Pds expressing cells were reduced and Aqp2 positive PCs 
increased. In addition, the loss of cellular Ae1 expression seems to induce the 
abnormal differentiation of Aqp2+/Pds+ coexpressing cells, particularly in the renal 
IMCD. Similarly, a late onset of IC depletion was reported in CaII deficient mice 
(chapter 2.7.6, Fig. 2.15) [103]. 
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11.6 Chronic metabolic acidosis induces adaptive remodelling of the distal renal 
tubule but does not affect terminal differentiation of renal CD cells 
 Disturbances in systemic acid-base homeostasis are known to induce adaptive 
responses of the kidney, including a remodelling of the renal tubule (chapter 5). 
Furthermore, some inherited or acquired defects of renal acid-base transport go 
along with renal tubular acidosis. Ae1 deficient individuals develop chronic dRTA and 
accordingly Pds expressing type B-IC were markedly reduced in adult (P84) Ae1 KO 
mice. Similarly, ICs in the renal CNT and CCD of patients with AE1 related primary 
dRTA appeared smaller in size and reduced in their abundance. In order to investigate 
the impact of chronic acid-base disturbance on the terminal differentiation of the 
renal CD system, immunofluorescent analysis and mRNA expression levels were 
performed on kidneys of mice with induced chronic metabolic acidosis for 8 weeks. 
As expected and consistent with the observations in P84 Ae1 deficient mice, kidneys 
of chronically acid loaded mice showed a reduced abundance of Pds expressing type 
B-ICs in the CCD, while Aqp2+ cells increased. However and in contrast to P84 Ae1 KO 
mice, the relative abundance of Aqp2+ cells decreased in the renal OMCD of acidotic 
animals, while unlabelled cells increased concomitantly. Likewise in contrast to Ae1 
deficient kidneys, CD cells coexpressing markers of ICs and PCs respectively were not 
detected in NH4Cl treated mouse kidneys. Co-immunolabelling using further 
molecular markers for distinct types of ICs (V-ATPase subunits and Ae1), confirmed 
the increase of Aqp2 expressing PCs on the expense of Pds+ type B-ICs in the renal 
CCD of acidotic mice (Fig. 10.25 to 10.28). In addition, assessment of the relative 
protein abundance of Aqp2, Pds, Ae1 and B1 subunit of V-ATPase by western blotting 
revealed comparable results (Fig. 10.29 to 10.32). The relative protein abundance of 
Aqp2 was increased in NH4Cl treated kidneys compared to Control, while Pds 
abundance was significantly reduced. Furthermore and expected, the relative 
abundance of Ae1 and the B1 subunit of V-ATPase was not altered upon chronic acid 
loading.  
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Finally, the renal mRNA expression pattern of acid-base transporters and 
transcriptional regulators was compared between NH4Cl loaded mice and Ae1 
deficient mice (Fig. 10.35, 10.36). As illustrated in the simplified table of Fig. 10.36, 
chronic metabolic acidosis induces a completely distinct adaptive regulation of acid-
base transporters and transcriptional regulators compared to Ae1 related dRTA. 
Consistent with previous observations, NH4Cl treatment induces an upregulation of 
Ae1 mRNA levels with a concomitant downregulation of Pds mRNA. In contrast, Pds 
mRNA expression levels are not different in kidneys of Ae1 WT and KO mice. 
Interestingly and likewise in contrast to Ae1 KO mice, renal Cp2l1 mRNA expression 
was significantly upregulated in NH4Cl treated mice compared to Control. Moreover, 
Gdf15 and Klf4 mRNA expression was significantly upregulated in Ae1 deficient 
kidneys compared to Ae1 WT, while the transcription of target genes of the p53 
signalling pathway were not different in Control and NH4Cl loaded mice.  
Furthermore, western blotting of Gdf15 showed significant downregulation of a 
probably premature variant, while the supposingly secreted and molecularly active 
form of Gdf15 is significantly upregulated in NH4Cl treated mouse kidney (Fig. 10.33). 
In contrast, Gdf15 related variants appeared not regulated in Ae1 deficient mice. 
Whether the secreted active signalling peptide of Gdf15 is also represented and 
regulated in the blood of the mice remains speculative. Gdf15 is a multivariant 
molecule and involved in several distinct cellular responses. Gdf15 has been reported, 
together with p53 and PI3/Akt/mTOR signalling cascade, to be involved in the early 
proliferation of particularly type A-ICs upon induced metabolic acidosis [146]. The 
present study is the first one that shows the protein pattern of renal Gdf15 detected 
on western blot, since previous studies were based on mRNA expression. More 
strikingly, our study suggests for the first time a role for Gdf15 in renal adaptation 
during chronic acid-base disturbance. Cell proliferation events are rather unlikely in 
the compensated late phase of chronic acidosis. Hence, Gdf15 might rather play a 
role in reducing the cellular stress induced by prolonged acidity and may promote 
anti-apoptotic actions. Such anti-apoptotic actions might be necessary to maintain 
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the unusual high abundance of Aqp2 expressing PCs in the CCD of acidotic kidneys. 
Similarly, pro-apoptotic actions of Gdf15 could be necessary to mediate or maintain 
the reduced presence of Pds expressing type B-ICs in acidotic renal CCDs. However, 
further experiments investigating the nature of Gdf15 and the related molecular 
variants detected in the kidney are necessary to determine its precise role in acid-
base disturbances. 
Foxi1 mRNA expression levels were not altered in chronic metabolic acidosis or dRTA. 
Anyhow, quantification of labelled cells by immunofluorescence revealed differences 
in the cellular distribution of Foxi1 in Ae1 KO kidneys compared to WT. Detection of 
Foxi1 by western blot on kidney samples derived from NH4Cl loaded and Control 
mice, demonstrated the presence of distinct Foxi1 related bands which differed 
markedly in size (Fig. 10.34). Even though the Foxi1 related bands did not appear to 
be regulated upon acid-base disturbance, their discovery is meaningful not at least 
because they are detected for the first time. In nuclear protein extracts, three Foxi1 
related bands were detected, of which only one corresponds to the expected 
molecular weight. In contrast, the expected Foxi1 band was absent in cytosolic 
fractions of the respective kidney samples, while the two Foxi1 related bands of 
higher molecular weight were present. This finding may suggest, that the Foxi1 
variant with the expected molecular weight is the transcriptionally active monomer 
and therefore present in the nuclear protein fraction but not in the cytosol. Likewise 
the two Foxi1 related bands of higher molecular weight might be distinct 
homomultimers or heteromultimers which translocate from the cytosol into the 
nucleus upon activation or inactivation. Again, further experiments are necessary to 
proof this idea and characterize the signalling network of Foxi1 in renal CD cells in 
detail. In addition, immunofluorescent analysis and quantification of the Foxi1 
expression pattern for kidneys of Control and NH4Cl treated mice are missing. 
 
166 
 
However, altogether the data presented in this study suggest, that prolonged 
metabolic acidosis induces alterations of the cellular composition of the renal CD 
system which favour the renal excretion of excess acid along with increased water 
retention, but does not alter the distinction between differentiated CD cell types.  
 
11.7 Terminal differentiation of renal CD cells is not affected by incomplete 
dRTA 
 Inherited dRTA is characterized by the inability to acidify the urine and hence a 
primary renal defect. In contrast, induced metabolic acidosis in mouse models is a 
forced disturbance mediated by artificial oral acid loads. Therefore, the two acid-base 
disturbances might somehow result in different renal adaptive responses and are 
difficult to compare. Thus, two more distinct transgenic mouse models were 
examined for the impact of renal acid-base disturbance on CD cell differentiation. 
Mice deficient for the B1 subunit of V-ATPase, as well as mice lacking Rhcg were 
shown to develop dRTA when challenged with increased acid loads [114, 215]. 
Because these mice do not show symptoms of dRTA under basal conditions, adaptive 
mechanisms such as altered CD cell composition, might be activated and compensate 
the obvious renal defect. 
Despite incomplete dRTA and in contrast to Ae1 deficiency, both mouse models did 
not show any signs of abnormal expression of Pds, Ae1, a4 and B1 subunits of V-
ATPase when investigated by immunofluorescence (Fig. 10.37). 
Likewise, Pds deficient mice were not reported to suffer from abnormal CD cell 
differentiation, despite their severe renal defect [213]. 
Therefore, our data suggest that the loss of Ae1 protein in the kidney affects the 
terminal differentiation of cells in the renal IMCD, inducing an abnormal of expression 
of Pds and moreover a coexpression of Pds and Aqp2 independently of the acid-base 
disturbance. 
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11.8 Hensin is not expressed in mouse renal tissue 
 Over the past two decades, the extracellular matrix protein hensin was 
continuously suggested to play a crucial role in the terminal differentiation of renal 
CD cells and recently a hensin deficient mouse model was reported to develop dRTA 
[99, 100]. Accordingly, we set out to investigate a possible dysregulation of hensin in 
Ae1 deficient mouse kidney. However, in the present study we failed to detect mRNA 
expression of hensin in premature and mature kidneys of mice (Fig. 10.21).  
Hensin was originally discovered in vitro, in immortalized cells derived from IMCDs of 
rabbit kidney. Furthermore, in vitro experiments using this cell model suggested a 
role for hensin in the transdifferentiation of type B-ICs to type A-ICs and vice versa. In 
this experimental protocol, a mixed population of rabbit IMCD cells was cultured with 
different initial density, which seemed to affect and alter the identity of cells (A-IC or 
B-IC). Hensin was discovered and reported to mediate the molecular switch that 
determines the differentiation of cells and thus their identity as type A-ICs or B-ICs. 
However, in a similar cell line derived from renal mouse IMCDs neither hensin mRNA 
was detected nor mRNA of Ae1, Pds and V-ATPase (data not shown), suggesting that 
the cell population did not contain any cells resembling the phenotype of type A-ICs 
or type B-ICs. Anyhow, we repeated the experimental protocol as denoted in the 
original publications, but were still unable to detect any mRNA for molecular IC 
markers and hensin in mouse IMCD3 cells (data not shown). The repetitive negative 
result is consistent with the known technical limitation of cultured renal CD derived 
cells, which immediately lose the phenotypic characteristics of ICs and dedifferentiate 
in vitro. However, species differences might explain the opposing results from in vitro 
studies, since the renal CD system of rabbits is slightly different compared to that of 
mouse, rat or human.  
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Notably and in spite of the reported phenotype of the renal CD specific hensin KO 
mouse and its supposingly crucial role in renal IC differentiation, hensin expression 
has never been shown in renal tissue of mice. In addition, the data presenting the 
phenotype of the hensin KO mice are not convincing and raise reasonable doubts on 
the existence and impact of hensin, at least in mouse kidney.   
 
11.8 Ae1 expression is required to maintain terminal differentiation of renal CD 
cells 
 The origin of individual cell types of the renal collecting ducts is not yet 
entirely proven. But some studies suggest that principal cells and types of 
intercalated cells origin from the same precursor population, simultaneously in the 
renal CNT and the inner medullary region [18, 25, 27]. In addition, the transcriptional 
network and other regulatory signalling molecules involved in terminal differentiation 
of the renal CDs are only poorly understood. Although some molecules were 
identified in distinct model organisms, the interaction of the distinct signalling 
pathways and their cellular localization in mouse kidney is still unknown. Therefore, it 
is very difficult to get a clear picture of the necessary events and key molecules of 
renal terminal differentiation and to put all the different information together in the 
right context. Especially, since it needs to account for the complexity of the cellular 
events in distinct renal cell populations, the putative interaction of different cell types 
and signalling networks, and the different systemic and cellular functional demands 
the maturing kidney is requested to fulfil.  
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However, the present study provides some new findings regarding a novel and 
unusual role of Ae1 in the terminal differentiation of renal CD cells, which is most 
likely beyond Cl-/HCO3
- exchange. Ae1 expression in the murine kidney might be a 
key molecule that triggers the maintenance of terminal differentiation of CD cells. 
Our findings offer interesting possibilities to fill some of the open gaps of our 
knowledge and to put important pieces of the puzzle into place. Moreover, we show 
for the first time the cellular localization of the transcription factors Foxi1 and Cp2l1 
in the murine kidney. Furthermore, we provide data indicating a local dysregulation 
of Foxi1 and Cp2l1 upon renal Ae1 deficiency.  
Based on the work by other research groups the following hypothetical model is 
suggested, summarizing the possible role of some key regulatory molecules in the 
terminal differentiation of renal CD cells (Fig. 11.1). The cell cycle and transcriptional 
regulator p53 is expressed in the differentiating zone of the late embryonic kidney 
and was suggested to influence cell lineage differentiation (chapter 2.7.1, Fig. 2.9). 
p53 was found to interact with other transcriptional regulators, like Klf4 and Bdkrb2 
and to regulate the transcription of renal function genes, such as Aqp2 and Na+/K+-
ATPase [65]. Recently, the Notch signalling pathway was elegantly shown to 
determine the cell lineage of renal PC and ICs in the mouse [77]. It is not directly 
proven for the kidney, but in other tissues p53 family members can modulate the 
activity of Notch, suggesting a crosstalk of both pathways during terminal CD 
differentiation [74]. Constitutive activation of the Notch signalling cascade drives the 
expression of PCs in the absence of ICs. Whether another key regulator is 
intermediately necessary is not known. On the other hand, constitutive inactivation of 
Notch leads to the loss of PCs and favours the expression of molecular IC markers, 
such as V-ATPase, Ae1 and Pds. Furthermore, Foxi1 mRNA expression levels were 
significantly increased, suggesting a regulatory interaction of the Notch signalling 
cascade with Foxi1. Accordingly, Foxi1 mediates the transcriptional activation of 
molecular IC markers. These observations were also made in epidermal ionocyte 
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differentiation of Xenopus laevis and zebrafish larvae suggesting a well conserved 
signalling pathway (Fig. 2.7, 2.8) [51, 54].  
  
Fig. 11.1 Proposed model of CD cell lineage decision in mouse kidney. Principal cells (PCs) and 
intercalated cells (ICs) may develop from a common renal precursor. As suggested by El-Dahr, S. and 
colleagues [66], the cell cycle and transcriptional regulator p53 initiates developmental cell 
differentiation and requires the interaction with Klf4 and Bdkrb2 (Fig. 2.9). Furthermore, p53 may 
regulate the Notch signalling pathway promoting cell lineage decisions. The activity of Notch 
determines the later CD cell type. Constitutive activation of Notch favours the differentiation of PCs in 
the absence of ICs, while inactivated Notch leads to the differentiation of ICs in the absence of PCs 
[77]. Whether another transcriptional regulator is involved in the differentiation of PCs is not yet 
known. However, Foxi1 is essentially involved in the terminal differentiation of the IC phenotype [83].  
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In the murine kidney, loss of the transcription factors Foxi1 and Cp2l1 goes along 
with the loss of Ae1, Pds and V-ATPase [83, 90]. Moreover, Foxi1 was directly shown 
to be a transcriptional regulator of V-ATPase, Pds and Ae1 [85, 86]. However, whether 
Foxi1 and Cp2l1 are only expressed in the developing kidney or also during 
adulthood had not been known and shown in the present study. Moreover, the CD 
cell type expressing Foxi1 and Cp2l1 was uncertain and has been analyzed to some 
extent in this work. The present study shows for the first time, that Foxi1 and Cp2l1 
are expressed in distinct CD cell populations of the mature mouse kidney. As 
suggested previously, Foxi1 expression was mainly found in V-ATPase expressing ICs 
along the renal CD system. This is consistent with its role as a transcriptional 
regulator of specific IC transporters. However, we found that Cp2l1 expression 
colocalized mostly with Aqp2 expressing principal cells. This is surprising, since Cp2l1 
deficiency also correlates with the loss of molecular IC markers, rather suggesting its 
expression in the same locus than its target genes. However, Cp2l1 is an unusual 
member of the grainyhead family, because it acts as a transcriptional repressor. 
Interestingly, observations in the epidermis of amphibians suggest an interaction of 
Notch, Foxi1 and Cp2l1 (Fig. 2.7, 2.8). Hence, Cp2l1 in the mouse kidney might be the 
proposed intermediate regulator in the cell lineage differentiation of PCs, similar to 
Foxi1 in the IC lineage (Fig. 11.1). Accordingly, Cp2l1 might modulate the activity of 
Notch in adjacent cells, which results in the activation of Foxi1 and thus 
differentiation of IC phenotype. The expression pattern of both transcription factors, 
Foxi1 and Cp2l1, was altered in Ae1 deficient mature kidneys as already discussed. 
These observations suggest that Foxi1, Cp2l1 and Ae1 somehow interact together in 
renal CD cells, particularly in the inner medulla. A negative regulation by some 
unknown molecule or a negative autoregulation of Cp2l1 might be necessary in 
murine kidney, similarly to observations made in zebrafish epidermal development 
(Fig. 2.8). Accordingly, the loss of nucleic Cp2l1 in some cells of Ae1 deficient renal 
IMCDs might prohibit a repression of Aqp2 or might prevent a negative regulation of 
Foxi1 which promotes the expression of Pds in these cells. Consequently, Foxi1 
positive cells were more abundant in Ae1 deficient renal IMCDs (Fig. 10.13D, 10.16D) 
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leading to the unusual coexpression of Aqp2 and Pds. However, a definite proof is 
pending and further investigations are necessary.  
With respect to our investigations of incomplete dRTA mouse models, the induced 
chronic metabolic acidosis model and the fact that Pds KO mice do not have 
abnormally differentiated CD cells, we can conclude that the presence of Ae1 protein 
is required in the terminal cell differentiation. Respectively, reports by others and our 
immunofluorescence data from patients with dRTA related AE1 mutations suggest 
that the proper expression and subcellular localization of the protein is primarily 
required and not its anion exchanger activity. Moreover, the very preliminary human 
data suggest that the findings from the mouse model may be transferable to the 
human situation. 
Ae1 is known to form multi-protein complexes in the erythrocyte, which is essential 
for the cytoskeletal integrity and transport function (chapter 6.1.2) [186]. Similarly, the 
kidney specific variant of Ae1 is suggested to interact directly or indirectly with 
distinct proteins, such as ILK (integrin-linked kinase) and Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) [228-230]. Moreover, Ae1 was shown to form a transport 
metabolon together with CaII in erythrocytes and the kidney enhancing the transport 
activity [197]. Likewise, the Ae1-CaII transport metabolon might generate a local 
cellular pH microenvironment that influences the activity of vicinal regulatory proteins 
thereby triggering signalling pathways [231].  
Deficiency of CaII results in the depletion of ICs from the renal CD system with a late 
onset in the mature mouse kidney (chapter 2.7.6) [101, 103]. Consistently, 
pharmacologic inhibition of CaII with acetazolamide reduces the abundance of ICs 
and alters their morphology [104]. Interestingly, the CD system of Foxi1 deficient mice 
did not only lack ICs, but consisted of a single cell type which coexpressed Aqp2 and 
CaII (Fig. 2.11) [83]. Indeed we also report here that CaII expression appears normal in 
Aqp2 expressing cells of the CNT and early CCD of mouse and human kidney (data 
not shown). But we did not find CaII and Aqp2 coexpressing cells in the OMCD and 
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IMCD. However, the observation in Foxi1 KO mice implicates that the restrictive 
expression of CaII to ICs of the MCD segments is somehow influenced by Foxi1, even 
though CAII is not a direct transcriptional target of Foxi1. Hence, Foxi1 might interact 
with another regulatory molecule or a signalling pathway to mediate a cross talk 
between subpopulations of CD cells and indirectly suppress the expression of CaII in 
Aqp2+ principal cells.  
Fox factors were reported to unusually interact with proteins other than transcription 
factors [232]. Hence, Foxi1 might unusually interact with a multi-protein complex of 
Ae1 or with Ae1 directly. This speculated interaction could be necessary to maintain 
or conduct terminal cell differentiation of renal ICs, at least in the mature kidney. A 
proposed model integrating this speculation and a possible role of the transcriptional 
repressor Cp2l1 in renal CD differentiation is depicted in Fig. 11.2. In the developing 
mouse kidney the expression of Pds is observed much later than that of V-ATPase 
and Ae1 (Fig. 2.5). Hence, type B-ICs develop after type A-ICs. Neither an 
interconversion of IC phenotypes is proven, nor the question for a common precursor 
of ICs. However, the presence of a certain type of IC might influence the identity of a 
neighbouring cell, maybe by paracrine signalling pathways, such as Notch mediated 
lateral inhibition. This could explain why type B-ICs appear after type A-ICs and our 
observations of abnormally differentiated CD cells in the absence of renal Ae1. A 
regulatory feedback of Foxi1 with Ae1 or a multi-protein complex of Ae1 might be 
required to initiate Pds expression in adjacent cells. The reciprocal signal of a possible 
Foxi1-Ae1 interaction could induce another unknown factor or again Foxi1, which 
modulates the expression of Pds in neighbouring cells. A multi-protein Ae1 complex 
or Ae1 itself might also directly repress the expression of Ae1 in adjacent cells by 
another unknown signalling cascade, thus providing an autoregulatory mechanism 
that simultaneously maintains the identity of the effector cell. Similarly, a putative 
crosstalk of Foxi1 and Cp2l1 might be necessary to repress the expression of CaII in 
principal cells of the renal MCD, while CaII is strongly expressed in adjacent ICs. 
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Consistently, the frequency of Cp2l1 expressing cells seemed to increase from the 
renal cortex towards the inner medulla.  
However, with respect to the different signalling cascades that appear to be involved 
in CD differentiation, the sequential activation of autocrine and paracrine actions 
seems inevitable. Moreover, this would allow a controlled, rapid and locally organized 
response to functional demands of the mature kidney.  
Embryonic terminal differentiation of the CD cells might nevertheless require 
additional or different signalling pathways. During embryonic kidney development 
two populations of precursor cells seem to exist in the CNT and inner medulla, which 
give rise to types of ICs and PCs. However, the renal CNT origins from the 
nephrogenic mesenchyme, while the CDs derive from the ureteric bud epithelium. 
Hence, it is not surprising, that the unusual differentiation of Pds and Aqp2 
coexpressing cells was confined to the renal inner medulla. It might well be, that 
other transcriptional networks and regulators are present in the CNT compared to the 
renal inner medulla as they derive from different primordia. On the other hand, the 
urinary composition is constantly modified along the CD system and the compostion 
is different in the CNT and IMCD. Similarly, the interstitial pH is more acidic and the 
oxygen supply is lower in the inner medulla compared to the renal CNT. Hence, the 
different functional demands and external stimuli in the renal CNT and inner medulla 
might influence the interaction of signalling networks and the behaviour of individual 
molecules.  
However, much more work needs to be done to investigate all the different aspects 
mentioned and to answer all the open questions left. 
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Fig. 11.2 Proposed model of renal CD differentiation in mouse. Notch activity might be modulated 
by p53 in precursor or terminally differentiated cells. Activated Notch interacts with Cp2l1 and 
promotes the differentiation of PCs. The transcriptional repressor Cp2l1 inactivates Notch signalling in 
adjacent cells. Repression of Notch leads to activation of Foxi1, which promotes the differentiation of 
ICs. Interaction of Foxi1 or another transcriptional regulator with Ae1 or an Ae1 related multi-protein 
complex induces a feedback loop that drives the differentiation of type B-ICs and maintains the type 
A-IC phenotype. Cp2l1 might be negatively autoregulated or interacts reciprocally with inactivated 
Notch, Foxi1, or signalling molecules of differentiated CD cells.  
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12. FUTURE PERSPECTIVES 
 The present study provides some new and interesting data that suggest a 
potential role of Ae1 or an Ae1 based multi-protein complex in the terminal 
differentiation of renal CD cells apart from Cl-/HCO3
- exchange. However, further 
investigations are necessary to establish the speculated role of Ae1 and to 
characterize the nature of a potential Ae1 related multi-protein complex. In addition, 
the localization and regulatory role of the transcription factors Foxi1 and Cp2l1 in 
mouse renal ICs, integrative to data from invertebrate model organisms, raise some 
new aspects that need further investigation. Respectively, the following experimental 
approaches are suggestive for future studies: 
 
 Since little is known about potential regulatory pathways and signalling 
molecules involved in terminal CD cell differentiation, RNA microarray analysis 
of mature kidneys from Ae1 WT and KO animals could be useful to identify 
more candidate genes and to further investigate the different signalling 
pathways (p53, Notch, PI3/Akt/mTOR). Consistently, the mRNA expression of 
the transcription factors Gdf15, Klf4 and Bdkrb2, probably involved in p53 
regulated signalling pathway, were already shown to be upregulated in Ae1 
deficient mature kidneys.  
 Likewise, the protein expression levels, posttranslational modifications, as well 
as the cellular localization of p53, Gdf15, Klf4 and Bdkrb2 within the kidney of 
Ae1 WT and KO animals are important to further investigate their role in 
terminal IC differentiation. 
 In the present study, Gdf15 protein abundance was altered in chronic acid 
loaded mouse kidneys. However, the cellular localization of Gdf15 in the 
kidney as well as the relevance of the different Gdf15 forms (propeptide, 
mature and secreted peptide) are not yet known and need to be characterized. 
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 Good evidence from transgenic mice suggests the Notch signalling pathway 
critical for CD cell differentiation. Hence, the signalling cascade should be 
analyzed in Ae1 deficient kidneys with respect to our proposed model (Fig. 
11.2). In addition, investigation of Ae1, Foxi1 and Cp2l1 in transgenic Notch 
mouse models (i.e. Notch deficiency, constitutive activated Notch) would be 
helpful to further establish their function and proposed interaction in renal IC 
differentiation. 
 A number of Ae1 interacting proteins, critical for cytoskleletal integrity and 
trafficking events, were already identified in erythrocytes. However, the 
situation is less clear for the kidney specific Ae1 isoform, since the majority of 
identified interacting erythroidal proteins do not exist in both tissues 
simultaneously. Moreover, the kAe1 isoform lacks a portion of the interactive 
N-terminal domain. Therefore and to proof the hypothesis of an Ae1 based 
multi-protein complex involved in terminal IC differentiation, a profound 
analysis of potential interactive partners would be helpful. Technically, several 
experimental approaches might be applicable such as yeast-two hybrid 
screening, co-immunoprecipitations or pull down assays with subsequent mass 
spectrometry analysis. 
 Identification of upstream triggers for signalling cascades involved in 
remodelling of the collecting duct in response to altered electrolyte or acid-
base status 
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 Unfortunately, cultured cells of the renal CD system tend to lose specific 
protein expression like Ae1, Pds, V-ATPase and dedifferentiate immediately 
when cultured in vitro. Interestingly, the present study revealed the 
endogenous expression of Foxi1 in untransfected Hek293T cells (Fig. 10.34C). 
In addition, Bounoure L, Bourgeois S, and Wagner CA noted the presence of 
the B1 subunit of V-ATPase in these cells (unpublished observation). Therefore, 
Hek293T cells might be a useful model to study the suggested interaction of 
Ae1 with putative signalling pathways of terminal cell differentiation. In 
addition, they could be useful to study a possible interaction of the distinct 
signalling pathways, i.e. by applying pharmacologic inhibitors of the Notch 
signalling cascade or siRNA mediated gene silencing. Moreover, two MDCK 
subtypes were reported with features resembling renal PCs and ICs, 
respectively [233]. A detailed analysis should investigate their suitability as a 
model for terminal CD cell differentiation, as well. Alternatively, transfection of 
cells with transcription factors of interest could provide important information 
about possible inductive signals (i.e. acid-base, electrolyte composition), 
posttranslational modifications and activity, interactions with other molecules, 
their subcellular localization and targeting, as well as suggested interactions 
with other signalling cascades. Last but not least, the terminal differentiation of 
renal CD cells might be studied by in in vitro cultures of mouse embryonic 
stem cells or metanephric mesenchyme and ureteric bud derived progenitor 
cells [234, 235]. 
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 The present study provides novel data on Foxi1 and Cp2l1 expression in the 
mature mouse kidney. Anyhow, these data are preliminary and detailed 
colocalization studies are necessary to further analyze the expressing cell 
populations with respect to the distinct CD segments. Furthermore, the cellular 
distribution and abundance of Foxi1 and Cp2l1 in Ae1 deficient kidneys and 
acid loaded kidneys needs to be determined. Moreover, immunoblot of Foxi1 
on kidney nuclear protein extracts and cytosolic protein fractions suggest 
multimeric presence of Foxi1 in the distinct cellular compartments. Analysis of 
the nature and regulatory relevance of these potential Foxi1 manifestations 
would be necessary to understand the function of Foxi1 in terminal cell 
differentiation. In addition, a potential interaction of Foxi1 and Cp2l1 needs to 
be examined and characterized. Consistently, expression of Foxi1 in Cp2l1 
deficient kidneys and Cp2l1 expression in Foxi1 deficient kidneys would be 
useful. Furthermore, the Notch signalling cascade should be analyzed in Foxi1 
and Cp2l1 deficient animals. 
 In order to definitely exclude dRTA related effects on terminal renal IC 
differentiation mice deficient for either the B1 subunit of V-ATPase or Rhcg 
were analyzed in the present study. However, the analysis was performed 
under standard laboratory conditions where these animals display an 
incomplete form of dRTA. Therefore, a repetitive investigation of kidneys from 
transgenic animals receiving a chronic oral acid load a priori would give more 
substantiated results. 
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